Gene Symbol | Gene ID | Gene Info |
---|---|---|
Klf4
|
ENSMUSG00000003032.8 | Kruppel-like factor 4 (gut) |
Sp3
|
ENSMUSG00000027109.10 | trans-acting transcription factor 3 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr4_55533366_55533571 | Klf4 | 1002 | 0.501513 | 0.27 | 4.1e-02 | Click! |
chr4_55529395_55529551 | Klf4 | 2297 | 0.254545 | 0.24 | 6.7e-02 | Click! |
chr4_55528505_55528715 | Klf4 | 3160 | 0.210514 | 0.22 | 8.6e-02 | Click! |
chr4_55532101_55532671 | Klf4 | 67 | 0.968960 | 0.20 | 1.3e-01 | Click! |
chr4_55530488_55531930 | Klf4 | 561 | 0.726820 | 0.17 | 1.8e-01 | Click! |
chr2_72978014_72978165 | Sp3 | 1197 | 0.314306 | 0.62 | 9.6e-08 | Click! |
chr2_72978455_72978843 | Sp3 | 637 | 0.457253 | 0.49 | 6.7e-05 | Click! |
chr2_72979994_72980353 | Sp3 | 253 | 0.764206 | 0.47 | 1.4e-04 | Click! |
chr2_72977132_72977591 | Sp3 | 1925 | 0.227696 | 0.41 | 1.1e-03 | Click! |
chr2_72980619_72981075 | Sp3 | 401 | 0.740145 | 0.40 | 1.6e-03 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr7_19082814_19086200 | 28.41 |
Dmpk |
dystrophia myotonica-protein kinase |
203 |
0.83 |
chr3_89386729_89388779 | 24.77 |
Zbtb7b |
zinc finger and BTB domain containing 7B |
83 |
0.91 |
chr7_101394207_101396000 | 20.96 |
Arap1 |
ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 1 |
448 |
0.73 |
chr11_116076531_116078496 | 16.14 |
Unc13d |
unc-13 homolog D |
77 |
0.94 |
chr15_76197527_76199931 | 15.71 |
Plec |
plectin |
520 |
0.59 |
chr15_76194294_76195998 | 15.54 |
Plec |
plectin |
564 |
0.56 |
chr1_172501767_172503923 | 14.55 |
Tagln2 |
transgelin 2 |
1593 |
0.22 |
chr5_125056018_125058841 | 13.96 |
Gm42838 |
predicted gene 42838 |
412 |
0.71 |
chr4_154024404_154026596 | 13.80 |
Smim1 |
small integral membrane protein 1 |
116 |
0.93 |
chr9_44486015_44488913 | 13.27 |
Bcl9l |
B cell CLL/lymphoma 9-like |
217 |
0.81 |
chr6_125088526_125090642 | 13.23 |
2010008C14Rik |
RIKEN cDNA 2010008C14 gene |
6147 |
0.07 |
chr8_94976904_94978618 | 12.71 |
Adgrg1 |
adhesion G protein-coupled receptor G1 |
652 |
0.59 |
chr4_130173825_130175545 | 12.62 |
Tinagl1 |
tubulointerstitial nephritis antigen-like 1 |
6 |
0.97 |
chr7_25626920_25628374 | 12.52 |
B3gnt8 |
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 8 |
5 |
0.94 |
chr6_29434692_29436459 | 12.07 |
Flnc |
filamin C, gamma |
2299 |
0.16 |
chr11_6519149_6520926 | 11.77 |
Myo1g |
myosin IG |
533 |
0.57 |
chr11_75655609_75656868 | 11.51 |
Myo1c |
myosin IC |
40 |
0.96 |
chr7_141338447_141340687 | 11.16 |
Eps8l2 |
EPS8-like 2 |
561 |
0.53 |
chr19_53140494_53142630 | 10.97 |
Add3 |
adducin 3 (gamma) |
12 |
0.97 |
chr19_46623097_46624579 | 10.84 |
Wbp1l |
WW domain binding protein 1 like |
437 |
0.77 |
chr5_64810297_64813272 | 10.73 |
Klf3 |
Kruppel-like factor 3 (basic) |
555 |
0.71 |
chr7_31054545_31055836 | 10.67 |
Fxyd1 |
FXYD domain-containing ion transport regulator 1 |
219 |
0.84 |
chr10_76621571_76623890 | 10.29 |
Col6a2 |
collagen, type VI, alpha 2 |
595 |
0.68 |
chr15_78926966_78928482 | 10.10 |
Lgals1 |
lectin, galactose binding, soluble 1 |
998 |
0.29 |
chr10_76724744_76726005 | 10.02 |
Col6a1 |
collagen, type VI, alpha 1 |
794 |
0.59 |
chr7_45920062_45921322 | 10.01 |
Emp3 |
epithelial membrane protein 3 |
159 |
0.87 |
chr11_116615789_116616584 | 9.97 |
Rhbdf2 |
rhomboid 5 homolog 2 |
8014 |
0.1 |
chr7_4163531_4164895 | 9.97 |
Cdc42ep5 |
CDC42 effector protein (Rho GTPase binding) 5 |
229 |
0.84 |
chr15_73747800_73749334 | 9.96 |
Ptp4a3 |
protein tyrosine phosphatase 4a3 |
193 |
0.94 |
chr8_84706606_84708426 | 9.96 |
Nfix |
nuclear factor I/X |
200 |
0.88 |
chr19_5724785_5726881 | 9.94 |
Ehbp1l1 |
EH domain binding protein 1-like 1 |
437 |
0.54 |
chr7_100492685_100494805 | 9.83 |
Ucp2 |
uncoupling protein 2 (mitochondrial, proton carrier) |
50 |
0.95 |
chr8_4212794_4214936 | 9.76 |
Prr36 |
proline rich 36 |
3047 |
0.12 |
chr10_81424113_81425703 | 9.73 |
Nfic |
nuclear factor I/C |
2206 |
0.11 |
chr11_104309715_104311017 | 9.61 |
Mapt |
microtubule-associated protein tau |
7667 |
0.17 |
chr18_12947287_12947788 | 9.61 |
Osbpl1a |
oxysterol binding protein-like 1A |
5696 |
0.19 |
chr18_37997868_37999258 | 9.57 |
Arap3 |
ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 3 |
170 |
0.9 |
chr11_75461625_75462791 | 9.57 |
Tlcd2 |
TLC domain containing 2 |
493 |
0.39 |
chr3_94372701_94373986 | 9.57 |
Rorc |
RAR-related orphan receptor gamma |
549 |
0.5 |
chr19_5842574_5845856 | 9.55 |
Neat1 |
nuclear paraspeckle assembly transcript 1 (non-protein coding) |
1044 |
0.25 |
chr10_80584595_80587584 | 9.45 |
Abhd17a |
abhydrolase domain containing 17A |
535 |
0.53 |
chr19_6400799_6402159 | 9.44 |
Rasgrp2 |
RAS, guanyl releasing protein 2 |
216 |
0.85 |
chr19_5691875_5693863 | 9.37 |
Map3k11 |
mitogen-activated protein kinase kinase kinase 11 |
26 |
0.92 |
chr19_5662426_5664007 | 9.37 |
Sipa1 |
signal-induced proliferation associated gene 1 |
404 |
0.63 |
chr8_71558187_71559532 | 9.22 |
Tmem221 |
transmembrane protein 221 |
12 |
0.94 |
chr10_81140191_81141251 | 9.20 |
Zbtb7a |
zinc finger and BTB domain containing 7a |
2768 |
0.1 |
chr11_97050817_97052901 | 9.13 |
Gm11574 |
predicted gene 11574 |
427 |
0.42 |
chr10_81328518_81330009 | 9.09 |
Tbxa2r |
thromboxane A2 receptor |
532 |
0.47 |
chr17_47832362_47834525 | 8.96 |
Mdfi |
MyoD family inhibitor |
152 |
0.93 |
chr11_77800451_77802048 | 8.95 |
Myo18a |
myosin XVIIIA |
49 |
0.97 |
chr4_152096248_152097724 | 8.89 |
Plekhg5 |
pleckstrin homology domain containing, family G (with RhoGef domain) member 5 |
267 |
0.86 |
chr10_81426043_81427197 | 8.87 |
Nfic |
nuclear factor I/C |
494 |
0.54 |
chr11_116237233_116238527 | 8.87 |
Evpl |
envoplakin |
197 |
0.88 |
chr8_120275935_120277234 | 8.83 |
Gse1 |
genetic suppressor element 1, coiled-coil protein |
48128 |
0.12 |
chr10_7472799_7473709 | 8.77 |
Ulbp1 |
UL16 binding protein 1 |
87 |
0.97 |
chr14_66279066_66281333 | 8.73 |
Ptk2b |
PTK2 protein tyrosine kinase 2 beta |
783 |
0.61 |
chr11_116105976_116108472 | 8.73 |
Trim47 |
tripartite motif-containing 47 |
141 |
0.91 |
chr11_98750268_98751902 | 8.70 |
Thra |
thyroid hormone receptor alpha |
2501 |
0.15 |
chr7_127992791_127993997 | 8.69 |
Gm45205 |
predicted gene 45205 |
125 |
0.49 |
chr15_101134186_101136364 | 8.68 |
Acvrl1 |
activin A receptor, type II-like 1 |
382 |
0.77 |
chr11_102217551_102219283 | 8.64 |
Hdac5 |
histone deacetylase 5 |
511 |
0.62 |
chr14_30625131_30626530 | 8.64 |
Prkcd |
protein kinase C, delta |
342 |
0.84 |
chr8_27106426_27107774 | 8.54 |
Adgra2 |
adhesion G protein-coupled receptor A2 |
7033 |
0.12 |
chr5_134688802_134689456 | 8.54 |
Limk1 |
LIM-domain containing, protein kinase |
531 |
0.7 |
chr5_124094995_124096382 | 8.52 |
Abcb9 |
ATP-binding cassette, sub-family B (MDR/TAP), member 9 |
98 |
0.94 |
chr1_133800027_133801076 | 8.51 |
Atp2b4 |
ATPase, Ca++ transporting, plasma membrane 4 |
485 |
0.75 |
chr2_85049940_85051247 | 8.45 |
Tnks1bp1 |
tankyrase 1 binding protein 1 |
15 |
0.96 |
chr7_142474634_142476734 | 8.44 |
Lsp1 |
lymphocyte specific 1 |
690 |
0.52 |
chr11_100969289_100970720 | 8.31 |
Cavin1 |
caveolae associated 1 |
547 |
0.68 |
chr2_131127028_131128383 | 8.29 |
Hspa12b |
heat shock protein 12B |
211 |
0.88 |
chr11_75165245_75169157 | 8.29 |
Hic1 |
hypermethylated in cancer 1 |
945 |
0.35 |
chr2_85060620_85061523 | 8.27 |
Tnks1bp1 |
tankyrase 1 binding protein 1 |
107 |
0.95 |
chr1_75445319_75447338 | 8.20 |
Gmppa |
GDP-mannose pyrophosphorylase A |
4104 |
0.1 |
chr7_4751858_4753020 | 8.14 |
Cox6b2 |
cytochrome c oxidase subunit 6B2 |
89 |
0.92 |
chr13_55210348_55211522 | 8.12 |
Nsd1 |
nuclear receptor-binding SET-domain protein 1 |
200 |
0.92 |
chr6_55338294_55340060 | 8.00 |
Aqp1 |
aquaporin 1 |
2745 |
0.22 |
chr4_133055332_133056821 | 7.98 |
Ahdc1 |
AT hook, DNA binding motif, containing 1 |
10173 |
0.19 |
chr11_97439854_97442222 | 7.96 |
Arhgap23 |
Rho GTPase activating protein 23 |
4753 |
0.18 |
chr2_93461586_93463194 | 7.95 |
Cd82 |
CD82 antigen |
4 |
0.98 |
chr11_98747803_98749468 | 7.91 |
Thra |
thyroid hormone receptor alpha |
4402 |
0.11 |
chr15_75596786_75598413 | 7.88 |
Gpihbp1 |
GPI-anchored HDL-binding protein 1 |
931 |
0.43 |
chr10_127643084_127644231 | 7.84 |
Stat6 |
signal transducer and activator of transcription 6 |
655 |
0.49 |
chr4_106804374_106805428 | 7.84 |
Acot11 |
acyl-CoA thioesterase 11 |
97 |
0.96 |
chr19_5071378_5072755 | 7.84 |
Tmem151a |
transmembrane protein 151A |
66 |
0.61 |
chr19_47136957_47138509 | 7.83 |
Calhm2 |
calcium homeostasis modulator family member 2 |
561 |
0.6 |
chr19_6014453_6015950 | 7.81 |
Capn1 |
calpain 1 |
2 |
0.92 |
chr11_117779316_117780928 | 7.80 |
Tmc6 |
transmembrane channel-like gene family 6 |
472 |
0.61 |
chr10_81600711_81601281 | 7.76 |
Tle6 |
transducin-like enhancer of split 6 |
77 |
0.92 |
chr3_89391665_89393338 | 7.74 |
Zbtb7b |
zinc finger and BTB domain containing 7B |
432 |
0.43 |
chr5_24426725_24429282 | 7.72 |
Slc4a2 |
solute carrier family 4 (anion exchanger), member 2 |
205 |
0.83 |
chr14_55061871_55064122 | 7.69 |
Gm20687 |
predicted gene 20687 |
7503 |
0.08 |
chr6_17305946_17307996 | 7.68 |
Cav1 |
caveolin 1, caveolae protein |
77 |
0.97 |
chrX_95967402_95968736 | 7.68 |
Las1l |
LAS1-like (S. cerevisiae) |
11107 |
0.24 |
chr8_84200619_84201949 | 7.58 |
Gm37352 |
predicted gene, 37352 |
415 |
0.58 |
chr2_167188530_167189169 | 7.55 |
Kcnb1 |
potassium voltage gated channel, Shab-related subfamily, member 1 |
31 |
0.64 |
chr7_44951825_44952845 | 7.52 |
Tsks |
testis-specific serine kinase substrate |
1979 |
0.12 |
chr14_51912888_51914206 | 7.48 |
Ndrg2 |
N-myc downstream regulated gene 2 |
28 |
0.94 |
chr7_100494865_100496416 | 7.48 |
Ucp2 |
uncoupling protein 2 (mitochondrial, proton carrier) |
439 |
0.68 |
chr15_98775840_98778905 | 7.47 |
Wnt10b |
wingless-type MMTV integration site family, member 10B |
111 |
0.92 |
chr7_17055956_17057150 | 7.47 |
Hif3a |
hypoxia inducible factor 3, alpha subunit |
126 |
0.92 |
chr8_106134496_106135471 | 7.43 |
Esrp2 |
epithelial splicing regulatory protein 2 |
42 |
0.86 |
chr9_56864653_56866648 | 7.42 |
Cspg4 |
chondroitin sulfate proteoglycan 4 |
617 |
0.51 |
chr11_84822134_84823653 | 7.40 |
Mrm1 |
mitochondrial rRNA methyltransferase 1 |
3378 |
0.15 |
chr11_98448535_98449780 | 7.37 |
Grb7 |
growth factor receptor bound protein 7 |
2089 |
0.15 |
chr5_32745567_32746421 | 7.30 |
Pisd |
phosphatidylserine decarboxylase |
318 |
0.82 |
chr10_60346425_60348008 | 7.30 |
Vsir |
V-set immunoregulatory receptor |
204 |
0.94 |
chrX_77432774_77434116 | 7.26 |
Gm5937 |
predicted gene 5937 |
23141 |
0.22 |
chr7_142656274_142657427 | 7.22 |
Igf2 |
insulin-like growth factor 2 |
616 |
0.54 |
chr2_119299920_119301063 | 7.21 |
Vps18 |
VPS18 CORVET/HOPS core subunit |
11704 |
0.1 |
chr5_140610292_140612597 | 7.21 |
Lfng |
LFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase |
65 |
0.96 |
chr2_76648014_76648425 | 7.14 |
Prkra |
protein kinase, interferon inducible double stranded RNA dependent activator |
204 |
0.56 |
chr2_25195300_25197035 | 7.12 |
Tor4a |
torsin family 4, member A |
592 |
0.43 |
chr8_120264530_120265775 | 7.04 |
Gse1 |
genetic suppressor element 1, coiled-coil protein |
36696 |
0.14 |
chr4_141617213_141618510 | 7.03 |
Tmem82 |
transmembrane protein 82 |
120 |
0.93 |
chr7_31040855_31042728 | 7.03 |
Fxyd5 |
FXYD domain-containing ion transport regulator 5 |
48 |
0.93 |
chr11_78984345_78985263 | 7.02 |
Lgals9 |
lectin, galactose binding, soluble 9 |
27 |
0.98 |
chr5_113162796_113163638 | 7.02 |
2900026A02Rik |
RIKEN cDNA 2900026A02 gene |
134 |
0.93 |
chr15_76118017_76119354 | 6.98 |
Eppk1 |
epiplakin 1 |
1510 |
0.2 |
chr19_4268364_4269504 | 6.96 |
Ssh3 |
slingshot protein phosphatase 3 |
146 |
0.87 |
chr7_24462385_24463393 | 6.96 |
Plaur |
plasminogen activator, urokinase receptor |
389 |
0.71 |
chr11_102578519_102579910 | 6.93 |
Gm11627 |
predicted gene 11627 |
61 |
0.95 |
chr4_134766990_134768275 | 6.92 |
Ldlrap1 |
low density lipoprotein receptor adaptor protein 1 |
392 |
0.86 |
chr9_107298004_107299417 | 6.91 |
Cish |
cytokine inducible SH2-containing protein |
445 |
0.63 |
chr19_7294483_7295524 | 6.88 |
Mark2 |
MAP/microtubule affinity regulating kinase 2 |
444 |
0.7 |
chr1_136173661_136174686 | 6.88 |
Kif21b |
kinesin family member 21B |
4859 |
0.13 |
chr10_80322682_80324056 | 6.86 |
Pcsk4 |
proprotein convertase subtilisin/kexin type 4 |
242 |
0.78 |
chr11_97434598_97436859 | 6.84 |
Arhgap23 |
Rho GTPase activating protein 23 |
557 |
0.73 |
chr7_16844794_16846016 | 6.81 |
Prkd2 |
protein kinase D2 |
172 |
0.9 |
chr7_98177150_98178219 | 6.80 |
Gm16938 |
predicted gene, 16938 |
443 |
0.54 |
chr2_155818448_155819565 | 6.77 |
BC029722 |
cDNA sequence BC029722 |
420 |
0.71 |
chr5_115542473_115545179 | 6.75 |
Pxn |
paxillin |
121 |
0.92 |
chr19_4282321_4283738 | 6.75 |
Ankrd13d |
ankyrin repeat domain 13 family, member D |
4 |
0.94 |
chr15_85653123_85654040 | 6.72 |
Lncppara |
long noncoding RNA near Ppara |
35 |
0.97 |
chr5_137749206_137749783 | 6.70 |
Tsc22d4 |
TSC22 domain family, member 4 |
1688 |
0.19 |
chr7_29170097_29170485 | 6.69 |
Ggn |
gametogenetin |
81 |
0.54 |
chr10_79779842_79780833 | 6.68 |
Fstl3 |
follistatin-like 3 |
244 |
0.79 |
chr15_84231290_84232731 | 6.65 |
Parvb |
parvin, beta |
33 |
0.97 |
chr1_74295387_74296968 | 6.65 |
Tmbim1 |
transmembrane BAX inhibitor motif containing 1 |
482 |
0.41 |
chr15_78983098_78984143 | 6.64 |
Triobp |
TRIO and F-actin binding protein |
85 |
0.93 |
chr6_115984719_115988278 | 6.63 |
Plxnd1 |
plexin D1 |
8507 |
0.15 |
chr2_153528339_153529939 | 6.62 |
Nol4l |
nucleolar protein 4-like |
832 |
0.63 |
chr10_80341789_80343949 | 6.61 |
Adamtsl5 |
ADAMTS-like 5 |
2369 |
0.1 |
chr10_127188246_127189758 | 6.60 |
Arhgef25 |
Rho guanine nucleotide exchange factor (GEF) 25 |
230 |
0.83 |
chr9_21337624_21338958 | 6.58 |
Slc44a2 |
solute carrier family 44, member 2 |
463 |
0.67 |
chr7_141079729_141081054 | 6.57 |
Pkp3 |
plakophilin 3 |
611 |
0.5 |
chr5_64969599_64970792 | 6.56 |
Mir574 |
microRNA 574 |
123 |
0.49 |
chr13_37477448_37478630 | 6.54 |
Gm47732 |
predicted gene, 47732 |
4346 |
0.12 |
chr14_33362281_33363618 | 6.54 |
Arhgap22 |
Rho GTPase activating protein 22 |
573 |
0.71 |
chr7_142576289_142578620 | 6.53 |
H19 |
H19, imprinted maternally expressed transcript |
68 |
0.78 |
chr3_89277040_89278334 | 6.52 |
Efna1 |
ephrin A1 |
1954 |
0.13 |
chr2_30807391_30807886 | 6.51 |
Ntmt1 |
N-terminal Xaa-Pro-Lys N-methyltransferase 1 |
188 |
0.91 |
chr11_101448217_101448875 | 6.48 |
Ifi35 |
interferon-induced protein 35 |
24 |
0.92 |
chr13_38151091_38152938 | 6.45 |
Gm10129 |
predicted gene 10129 |
222 |
0.82 |
chr10_81497570_81499812 | 6.45 |
S1pr4 |
sphingosine-1-phosphate receptor 4 |
1441 |
0.16 |
chr5_134985697_134987808 | 6.44 |
Cldn3 |
claudin 3 |
538 |
0.55 |
chr14_31166307_31168596 | 6.41 |
Stab1 |
stabilin 1 |
1144 |
0.34 |
chr7_25688520_25689615 | 6.41 |
Tgfb1 |
transforming growth factor, beta 1 |
140 |
0.91 |
chr7_27330548_27331710 | 6.41 |
Ltbp4 |
latent transforming growth factor beta binding protein 4 |
2484 |
0.17 |
chr7_101377838_101379825 | 6.38 |
Arap1 |
ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 1 |
462 |
0.71 |
chr7_15962240_15963472 | 6.36 |
Ehd2 |
EH-domain containing 2 |
4619 |
0.11 |
chr1_74067852_74069114 | 6.36 |
Tns1 |
tensin 1 |
22868 |
0.17 |
chr4_152130657_152132083 | 6.35 |
Espn |
espin |
140 |
0.93 |
chr5_121833321_121834947 | 6.33 |
1700008B11Rik |
RIKEN cDNA 1700008B11 gene |
1061 |
0.33 |
chr11_78194258_78195234 | 6.32 |
Proca1 |
protein interacting with cyclin A1 |
0 |
0.93 |
chr17_28345051_28346589 | 6.29 |
Tead3 |
TEA domain family member 3 |
4526 |
0.11 |
chr7_43465303_43466656 | 6.28 |
Vsig10l |
V-set and immunoglobulin domain containing 10 like |
265 |
0.76 |
chr17_56883299_56884280 | 6.26 |
Acsbg3 |
acyl-CoA synthetase bubblegum family member 3 |
8286 |
0.12 |
chr14_100284227_100286288 | 6.25 |
Klf12 |
Kruppel-like factor 12 |
578 |
0.59 |
chr17_88628874_88630550 | 6.24 |
Ston1 |
stonin 1 |
2348 |
0.25 |
chr11_70026049_70028279 | 6.22 |
Dlg4 |
discs large MAGUK scaffold protein 4 |
165 |
0.87 |
chr9_108449561_108451508 | 6.22 |
Klhdc8b |
kelch domain containing 8B |
165 |
0.86 |
chr16_5131498_5132854 | 6.21 |
Ppl |
periplakin |
234 |
0.89 |
chr8_70072397_70073269 | 6.19 |
Tm6sf2 |
transmembrane 6 superfamily member 2 |
91 |
0.93 |
chr5_115433807_115437237 | 6.14 |
Msi1 |
musashi RNA-binding protein 1 |
24 |
0.93 |
chr3_84269309_84270900 | 6.13 |
Trim2 |
tripartite motif-containing 2 |
687 |
0.77 |
chr11_103102696_103105788 | 6.13 |
Acbd4 |
acyl-Coenzyme A binding domain containing 4 |
463 |
0.7 |
chr15_97766466_97767934 | 6.11 |
Rapgef3 |
Rap guanine nucleotide exchange factor (GEF) 3 |
64 |
0.91 |
chr7_142658126_142659753 | 6.10 |
Igf2 |
insulin-like growth factor 2 |
550 |
0.47 |
chr11_116109279_116110529 | 6.10 |
Trim47 |
tripartite motif-containing 47 |
333 |
0.78 |
chr9_48648789_48650102 | 6.09 |
Nnmt |
nicotinamide N-methyltransferase |
44292 |
0.16 |
chr12_103336858_103338251 | 6.08 |
Gm15523 |
predicted gene 15523 |
648 |
0.43 |
chr7_25686795_25687582 | 6.07 |
Tgfb1 |
transforming growth factor, beta 1 |
186 |
0.88 |
chr4_47437269_47438175 | 6.06 |
Gm12430 |
predicted gene 12430 |
15910 |
0.18 |
chr2_25290133_25293095 | 6.02 |
Grin1os |
glutamate receptor, ionotropic, NMDA1 (zeta 1), opposite strand |
394 |
0.57 |
chr4_154926952_154928851 | 6.02 |
Tnfrsf14 |
tumor necrosis factor receptor superfamily, member 14 (herpesvirus entry mediator) |
176 |
0.92 |
chr9_21961394_21962913 | 5.98 |
Epor |
erythropoietin receptor |
411 |
0.68 |
chr11_101260098_101261392 | 5.96 |
Wnk4 |
WNK lysine deficient protein kinase 4 |
90 |
0.91 |
chr14_70625458_70627688 | 5.96 |
Dmtn |
dematin actin binding protein |
418 |
0.75 |
chr5_115506738_115507941 | 5.94 |
Pxn |
paxillin |
483 |
0.61 |
chr17_45594287_45595840 | 5.92 |
Slc29a1 |
solute carrier family 29 (nucleoside transporters), member 1 |
439 |
0.67 |
chr2_165503533_165504813 | 5.91 |
Slc2a10 |
solute carrier family 2 (facilitated glucose transporter), member 10 |
386 |
0.83 |
chr7_3290557_3291613 | 5.91 |
Myadm |
myeloid-associated differentiation marker |
405 |
0.65 |
chr11_117792124_117792979 | 5.91 |
Gm11724 |
predicted gene 11724 |
1238 |
0.21 |
chr4_126286388_126288681 | 5.90 |
Col8a2 |
collagen, type VIII, alpha 2 |
741 |
0.53 |
chr11_102308792_102311562 | 5.89 |
Ubtf |
upstream binding transcription factor, RNA polymerase I |
269 |
0.84 |
chr7_98176104_98177065 | 5.88 |
Gm16938 |
predicted gene, 16938 |
610 |
0.62 |
chr4_156197699_156198179 | 5.87 |
Agrn |
agrin |
451 |
0.65 |
chr7_3292731_3293965 | 5.87 |
Myadm |
myeloid-associated differentiation marker |
254 |
0.81 |
chr11_98741842_98743057 | 5.86 |
Thra |
thyroid hormone receptor alpha |
291 |
0.81 |
chr11_96823513_96824552 | 5.84 |
Nfe2l1 |
nuclear factor, erythroid derived 2,-like 1 |
19 |
0.95 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
7.6 | 30.5 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
6.9 | 20.6 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
6.2 | 18.6 | GO:0060375 | regulation of mast cell differentiation(GO:0060375) |
5.9 | 17.6 | GO:0002432 | granuloma formation(GO:0002432) |
5.8 | 23.0 | GO:2000562 | negative regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000562) |
5.3 | 16.0 | GO:1900169 | regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
5.2 | 15.7 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
5.0 | 15.0 | GO:1905005 | regulation of epithelial to mesenchymal transition involved in endocardial cushion formation(GO:1905005) |
5.0 | 19.9 | GO:0030309 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
4.7 | 9.5 | GO:1902083 | negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
4.5 | 31.2 | GO:2001185 | regulation of CD8-positive, alpha-beta T cell activation(GO:2001185) |
4.4 | 4.4 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
4.2 | 12.6 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
4.2 | 21.0 | GO:1903689 | regulation of wound healing, spreading of epidermal cells(GO:1903689) |
4.1 | 12.2 | GO:1900740 | regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
4.0 | 11.9 | GO:2000286 | receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
3.9 | 11.7 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
3.8 | 23.0 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
3.7 | 11.2 | GO:0032079 | positive regulation of endodeoxyribonuclease activity(GO:0032079) |
3.6 | 10.9 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
3.6 | 10.7 | GO:0043553 | negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
3.5 | 13.8 | GO:1903275 | positive regulation of sodium ion export(GO:1903275) positive regulation of sodium ion export from cell(GO:1903278) |
3.4 | 17.1 | GO:1900454 | positive regulation of long term synaptic depression(GO:1900454) |
3.4 | 13.5 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
3.3 | 10.0 | GO:0008050 | female courtship behavior(GO:0008050) |
3.2 | 6.5 | GO:1901509 | regulation of endothelial tube morphogenesis(GO:1901509) |
3.2 | 35.2 | GO:0060396 | growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
3.2 | 12.8 | GO:0032802 | low-density lipoprotein particle receptor catabolic process(GO:0032802) regulation of low-density lipoprotein particle receptor catabolic process(GO:0032803) |
3.2 | 6.4 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
3.2 | 3.2 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
3.1 | 9.3 | GO:1903061 | positive regulation of protein lipidation(GO:1903061) |
3.1 | 3.1 | GO:0018992 | germ-line sex determination(GO:0018992) |
3.0 | 3.0 | GO:2000646 | positive regulation of receptor catabolic process(GO:2000646) |
3.0 | 9.1 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
3.0 | 18.2 | GO:0090315 | negative regulation of protein targeting to membrane(GO:0090315) |
3.0 | 9.0 | GO:0097460 | ferrous iron import into cell(GO:0097460) |
3.0 | 12.0 | GO:0051791 | medium-chain fatty acid metabolic process(GO:0051791) |
3.0 | 9.0 | GO:0032485 | regulation of Ral protein signal transduction(GO:0032485) |
2.9 | 17.4 | GO:0034242 | negative regulation of syncytium formation by plasma membrane fusion(GO:0034242) |
2.9 | 20.3 | GO:0045602 | negative regulation of endothelial cell differentiation(GO:0045602) |
2.9 | 17.3 | GO:1900746 | regulation of vascular endothelial growth factor signaling pathway(GO:1900746) |
2.9 | 8.6 | GO:0003186 | tricuspid valve morphogenesis(GO:0003186) tricuspid valve formation(GO:0003195) |
2.8 | 8.5 | GO:0089700 | protein kinase D signaling(GO:0089700) |
2.8 | 2.8 | GO:0061158 | 3'-UTR-mediated mRNA destabilization(GO:0061158) |
2.8 | 8.4 | GO:0035771 | interleukin-4-mediated signaling pathway(GO:0035771) |
2.8 | 11.1 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
2.8 | 2.8 | GO:0002019 | regulation of renal output by angiotensin(GO:0002019) |
2.7 | 10.9 | GO:0000414 | regulation of histone H3-K36 methylation(GO:0000414) |
2.7 | 2.7 | GO:0048769 | sarcomerogenesis(GO:0048769) |
2.7 | 8.1 | GO:0030950 | establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
2.7 | 8.1 | GO:0046078 | dUMP metabolic process(GO:0046078) |
2.6 | 10.6 | GO:0097048 | dendritic cell apoptotic process(GO:0097048) regulation of dendritic cell apoptotic process(GO:2000668) |
2.6 | 5.3 | GO:1904261 | regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904259) positive regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904261) basement membrane assembly involved in embryonic body morphogenesis(GO:2001197) |
2.6 | 7.9 | GO:0070294 | renal sodium ion absorption(GO:0070294) |
2.6 | 2.6 | GO:0055005 | ventricular cardiac myofibril assembly(GO:0055005) |
2.6 | 7.7 | GO:0090361 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
2.6 | 7.7 | GO:2000870 | regulation of progesterone secretion(GO:2000870) |
2.5 | 7.6 | GO:2000483 | negative regulation of interleukin-8 secretion(GO:2000483) |
2.5 | 10.1 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
2.5 | 7.6 | GO:0042167 | heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
2.5 | 7.5 | GO:1902966 | regulation of protein localization to early endosome(GO:1902965) positive regulation of protein localization to early endosome(GO:1902966) |
2.4 | 12.1 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
2.4 | 7.3 | GO:0000432 | regulation of transcription from RNA polymerase II promoter by glucose(GO:0000430) positive regulation of transcription from RNA polymerase II promoter by glucose(GO:0000432) |
2.4 | 9.7 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
2.4 | 12.1 | GO:0007256 | activation of JNKK activity(GO:0007256) |
2.4 | 4.8 | GO:2000468 | regulation of peroxidase activity(GO:2000468) |
2.4 | 26.5 | GO:0032060 | bleb assembly(GO:0032060) |
2.4 | 14.5 | GO:0071499 | response to laminar fluid shear stress(GO:0034616) cellular response to laminar fluid shear stress(GO:0071499) |
2.4 | 12.0 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
2.4 | 7.2 | GO:0010725 | regulation of primitive erythrocyte differentiation(GO:0010725) |
2.3 | 7.0 | GO:0006344 | maintenance of chromatin silencing(GO:0006344) |
2.3 | 9.4 | GO:0071374 | cellular response to parathyroid hormone stimulus(GO:0071374) |
2.3 | 2.3 | GO:0003096 | renal sodium ion transport(GO:0003096) |
2.3 | 2.3 | GO:1990705 | cholangiocyte proliferation(GO:1990705) |
2.3 | 6.8 | GO:0002414 | immunoglobulin transcytosis in epithelial cells(GO:0002414) |
2.3 | 20.4 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
2.3 | 13.6 | GO:0002441 | histamine production involved in inflammatory response(GO:0002349) histamine secretion involved in inflammatory response(GO:0002441) histamine secretion by mast cell(GO:0002553) |
2.3 | 2.3 | GO:1903059 | regulation of protein lipidation(GO:1903059) |
2.3 | 13.5 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
2.2 | 6.7 | GO:1901420 | negative regulation of response to alcohol(GO:1901420) |
2.2 | 6.7 | GO:0007039 | protein catabolic process in the vacuole(GO:0007039) |
2.2 | 4.5 | GO:0044337 | canonical Wnt signaling pathway involved in positive regulation of apoptotic process(GO:0044337) |
2.2 | 4.5 | GO:0043101 | purine-containing compound salvage(GO:0043101) |
2.2 | 6.7 | GO:0008228 | opsonization(GO:0008228) |
2.2 | 20.0 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
2.2 | 6.6 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) |
2.2 | 17.5 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
2.2 | 28.2 | GO:0001921 | positive regulation of receptor recycling(GO:0001921) |
2.2 | 4.3 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
2.2 | 8.7 | GO:2001046 | positive regulation of integrin-mediated signaling pathway(GO:2001046) |
2.1 | 6.4 | GO:1903800 | positive regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903800) |
2.1 | 4.3 | GO:0035283 | central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
2.1 | 8.5 | GO:0010887 | negative regulation of cholesterol storage(GO:0010887) |
2.1 | 6.4 | GO:0045658 | regulation of neutrophil differentiation(GO:0045658) |
2.1 | 8.5 | GO:0060480 | lung goblet cell differentiation(GO:0060480) |
2.1 | 4.3 | GO:0019254 | carnitine metabolic process, CoA-linked(GO:0019254) |
2.1 | 2.1 | GO:0090219 | negative regulation of lipid kinase activity(GO:0090219) |
2.1 | 10.6 | GO:0030046 | parallel actin filament bundle assembly(GO:0030046) |
2.1 | 6.3 | GO:0002277 | myeloid dendritic cell activation involved in immune response(GO:0002277) |
2.1 | 4.2 | GO:1903898 | negative regulation of PERK-mediated unfolded protein response(GO:1903898) |
2.1 | 2.1 | GO:0051182 | coenzyme transport(GO:0051182) |
2.1 | 4.2 | GO:0034499 | late endosome to Golgi transport(GO:0034499) |
2.1 | 4.1 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
2.1 | 6.2 | GO:0070671 | response to interleukin-12(GO:0070671) |
2.1 | 37.0 | GO:0070208 | protein heterotrimerization(GO:0070208) |
2.1 | 6.2 | GO:2001286 | regulation of caveolin-mediated endocytosis(GO:2001286) |
2.1 | 2.1 | GO:1902947 | regulation of tau-protein kinase activity(GO:1902947) |
2.0 | 6.1 | GO:2000449 | regulation of CD8-positive, alpha-beta T cell extravasation(GO:2000449) |
2.0 | 4.0 | GO:0051891 | positive regulation of cardioblast differentiation(GO:0051891) |
2.0 | 4.0 | GO:2000586 | regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000586) negative regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000587) |
2.0 | 6.1 | GO:1901382 | chorionic trophoblast cell proliferation(GO:0097360) regulation of chorionic trophoblast cell proliferation(GO:1901382) |
2.0 | 2.0 | GO:0038180 | nerve growth factor signaling pathway(GO:0038180) |
2.0 | 14.1 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
2.0 | 6.0 | GO:0030952 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) establishment or maintenance of cytoskeleton polarity(GO:0030952) |
2.0 | 4.0 | GO:0000720 | pyrimidine dimer repair by nucleotide-excision repair(GO:0000720) |
2.0 | 6.0 | GO:0003062 | regulation of heart rate by chemical signal(GO:0003062) |
2.0 | 4.0 | GO:0045627 | positive regulation of T-helper 1 cell differentiation(GO:0045627) |
2.0 | 20.0 | GO:0032460 | negative regulation of protein oligomerization(GO:0032460) |
2.0 | 6.0 | GO:0023021 | termination of signal transduction(GO:0023021) |
2.0 | 6.0 | GO:0030241 | skeletal muscle myosin thick filament assembly(GO:0030241) striated muscle myosin thick filament assembly(GO:0071688) |
2.0 | 2.0 | GO:0045213 | neurotransmitter receptor metabolic process(GO:0045213) |
2.0 | 2.0 | GO:0045626 | negative regulation of T-helper 1 cell differentiation(GO:0045626) |
2.0 | 7.8 | GO:0044857 | plasma membrane raft assembly(GO:0044854) plasma membrane raft organization(GO:0044857) |
1.9 | 7.7 | GO:0072180 | mesonephric duct morphogenesis(GO:0072180) |
1.9 | 9.6 | GO:0042270 | protection from natural killer cell mediated cytotoxicity(GO:0042270) |
1.9 | 7.7 | GO:1901300 | positive regulation of hydrogen peroxide-mediated programmed cell death(GO:1901300) positive regulation of hydrogen peroxide-induced cell death(GO:1905206) |
1.9 | 5.7 | GO:0010482 | epidermal cell division(GO:0010481) regulation of epidermal cell division(GO:0010482) |
1.9 | 5.7 | GO:0033159 | negative regulation of protein import into nucleus, translocation(GO:0033159) |
1.9 | 1.9 | GO:0032849 | regulation of cellular pH reduction(GO:0032847) positive regulation of cellular pH reduction(GO:0032849) |
1.9 | 3.8 | GO:0010985 | regulation of very-low-density lipoprotein particle clearance(GO:0010915) negative regulation of very-low-density lipoprotein particle clearance(GO:0010916) negative regulation of lipoprotein particle clearance(GO:0010985) |
1.9 | 5.7 | GO:0046208 | spermine catabolic process(GO:0046208) |
1.9 | 13.2 | GO:0031579 | membrane raft organization(GO:0031579) |
1.9 | 5.7 | GO:0060154 | cellular process regulating host cell cycle in response to virus(GO:0060154) |
1.9 | 5.7 | GO:0097012 | response to granulocyte macrophage colony-stimulating factor(GO:0097012) |
1.9 | 5.7 | GO:0046391 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
1.9 | 7.5 | GO:0038094 | Fc-gamma receptor signaling pathway(GO:0038094) |
1.9 | 5.6 | GO:1901252 | regulation of intracellular transport of viral material(GO:1901252) |
1.9 | 1.9 | GO:1904017 | response to Thyroglobulin triiodothyronine(GO:1904016) cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
1.9 | 18.7 | GO:0033623 | regulation of integrin activation(GO:0033623) |
1.9 | 5.6 | GO:0035788 | cell migration involved in metanephros development(GO:0035788) metanephric mesenchymal cell migration(GO:0035789) regulation of metanephric mesenchymal cell migration(GO:2000589) |
1.9 | 14.9 | GO:1903392 | negative regulation of adherens junction organization(GO:1903392) |
1.9 | 7.4 | GO:0072656 | maintenance of protein location in mitochondrion(GO:0072656) |
1.8 | 5.5 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
1.8 | 1.8 | GO:0003221 | right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
1.8 | 7.3 | GO:0006499 | N-terminal protein myristoylation(GO:0006499) |
1.8 | 1.8 | GO:0039530 | MDA-5 signaling pathway(GO:0039530) |
1.8 | 1.8 | GO:0010891 | negative regulation of sequestering of triglyceride(GO:0010891) |
1.8 | 3.6 | GO:0048320 | axial mesoderm formation(GO:0048320) |
1.8 | 1.8 | GO:0045578 | negative regulation of B cell differentiation(GO:0045578) |
1.8 | 26.9 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
1.8 | 1.8 | GO:0051295 | establishment of meiotic spindle localization(GO:0051295) |
1.8 | 7.2 | GO:0007042 | lysosomal lumen acidification(GO:0007042) |
1.8 | 5.3 | GO:0048208 | vesicle targeting, rough ER to cis-Golgi(GO:0048207) COPII vesicle coating(GO:0048208) |
1.8 | 1.8 | GO:0033273 | response to vitamin(GO:0033273) |
1.8 | 7.1 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
1.7 | 1.7 | GO:0010751 | negative regulation of nitric oxide mediated signal transduction(GO:0010751) |
1.7 | 5.2 | GO:0003431 | growth plate cartilage chondrocyte development(GO:0003431) |
1.7 | 3.5 | GO:0090170 | regulation of Golgi inheritance(GO:0090170) |
1.7 | 1.7 | GO:1902416 | positive regulation of mRNA binding(GO:1902416) positive regulation of RNA binding(GO:1905216) |
1.7 | 1.7 | GO:0071224 | cellular response to peptidoglycan(GO:0071224) |
1.7 | 19.1 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
1.7 | 5.2 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
1.7 | 5.1 | GO:0071635 | negative regulation of transforming growth factor beta production(GO:0071635) |
1.7 | 5.1 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
1.7 | 1.7 | GO:0071072 | negative regulation of phospholipid biosynthetic process(GO:0071072) |
1.7 | 6.8 | GO:0018214 | protein carboxylation(GO:0018214) |
1.7 | 1.7 | GO:1900026 | positive regulation of substrate adhesion-dependent cell spreading(GO:1900026) |
1.7 | 8.5 | GO:0060753 | regulation of mast cell chemotaxis(GO:0060753) |
1.7 | 6.7 | GO:2001269 | positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001269) |
1.7 | 5.1 | GO:0060591 | chondroblast differentiation(GO:0060591) |
1.7 | 5.0 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
1.7 | 13.4 | GO:0000183 | chromatin silencing at rDNA(GO:0000183) |
1.7 | 3.4 | GO:0055118 | negative regulation of cardiac muscle contraction(GO:0055118) |
1.7 | 10.1 | GO:0046643 | regulation of gamma-delta T cell differentiation(GO:0045586) regulation of gamma-delta T cell activation(GO:0046643) |
1.7 | 6.7 | GO:0070574 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
1.7 | 8.3 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
1.6 | 6.6 | GO:0035087 | siRNA loading onto RISC involved in RNA interference(GO:0035087) |
1.6 | 4.9 | GO:2001137 | positive regulation of endocytic recycling(GO:2001137) |
1.6 | 4.9 | GO:0048143 | astrocyte activation(GO:0048143) |
1.6 | 6.5 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
1.6 | 8.1 | GO:0030948 | negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
1.6 | 1.6 | GO:1903012 | positive regulation of bone development(GO:1903012) |
1.6 | 8.1 | GO:0044359 | modulation of molecular function in other organism(GO:0044359) negative regulation of molecular function in other organism(GO:0044362) negative regulation of molecular function in other organism involved in symbiotic interaction(GO:0052204) modulation of molecular function in other organism involved in symbiotic interaction(GO:0052205) |
1.6 | 3.2 | GO:0032763 | regulation of mast cell cytokine production(GO:0032763) |
1.6 | 14.5 | GO:0045019 | negative regulation of nitric oxide biosynthetic process(GO:0045019) negative regulation of nitric oxide metabolic process(GO:1904406) |
1.6 | 12.9 | GO:0060546 | negative regulation of necroptotic process(GO:0060546) |
1.6 | 1.6 | GO:1904706 | negative regulation of vascular smooth muscle cell proliferation(GO:1904706) |
1.6 | 9.6 | GO:0060605 | tube lumen cavitation(GO:0060605) salivary gland cavitation(GO:0060662) |
1.6 | 3.2 | GO:0032484 | Ral protein signal transduction(GO:0032484) |
1.6 | 6.3 | GO:0002159 | desmosome assembly(GO:0002159) |
1.6 | 4.7 | GO:0014067 | negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) |
1.6 | 4.7 | GO:0050904 | diapedesis(GO:0050904) |
1.6 | 7.9 | GO:0033184 | positive regulation of histone ubiquitination(GO:0033184) |
1.6 | 4.7 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
1.6 | 9.4 | GO:0032825 | positive regulation of natural killer cell differentiation(GO:0032825) |
1.6 | 6.3 | GO:0006166 | purine ribonucleoside salvage(GO:0006166) |
1.6 | 6.3 | GO:0042699 | follicle-stimulating hormone signaling pathway(GO:0042699) |
1.6 | 7.8 | GO:0009438 | methylglyoxal metabolic process(GO:0009438) |
1.6 | 4.7 | GO:1903912 | negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation(GO:1903912) |
1.6 | 14.0 | GO:0006677 | glycosylceramide metabolic process(GO:0006677) |
1.6 | 4.7 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
1.6 | 3.1 | GO:0070368 | positive regulation of hepatocyte differentiation(GO:0070368) |
1.5 | 4.6 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
1.5 | 4.6 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
1.5 | 9.2 | GO:0043173 | nucleotide salvage(GO:0043173) |
1.5 | 4.6 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
1.5 | 1.5 | GO:0051503 | adenine nucleotide transport(GO:0051503) |
1.5 | 4.6 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
1.5 | 6.1 | GO:0071447 | cellular response to hydroperoxide(GO:0071447) |
1.5 | 1.5 | GO:2000407 | regulation of T cell extravasation(GO:2000407) positive regulation of T cell extravasation(GO:2000409) |
1.5 | 4.6 | GO:2001267 | regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001267) negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001268) |
1.5 | 3.0 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
1.5 | 6.0 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
1.5 | 10.5 | GO:0007021 | tubulin complex assembly(GO:0007021) |
1.5 | 1.5 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
1.5 | 4.5 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
1.5 | 3.0 | GO:0030997 | regulation of centriole-centriole cohesion(GO:0030997) |
1.5 | 10.4 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
1.5 | 3.0 | GO:0071462 | cellular response to water stimulus(GO:0071462) |
1.5 | 8.9 | GO:0070293 | renal absorption(GO:0070293) |
1.5 | 10.4 | GO:0006729 | tetrahydrobiopterin biosynthetic process(GO:0006729) |
1.5 | 4.4 | GO:0010694 | positive regulation of alkaline phosphatase activity(GO:0010694) |
1.5 | 5.9 | GO:0051541 | elastin metabolic process(GO:0051541) |
1.5 | 1.5 | GO:0002071 | glandular epithelial cell maturation(GO:0002071) |
1.5 | 4.4 | GO:0000087 | mitotic M phase(GO:0000087) |
1.5 | 4.4 | GO:0006172 | ADP biosynthetic process(GO:0006172) |
1.5 | 2.9 | GO:0032058 | positive regulation of translational initiation in response to stress(GO:0032058) |
1.5 | 1.5 | GO:1903972 | regulation of macrophage colony-stimulating factor signaling pathway(GO:1902226) regulation of response to macrophage colony-stimulating factor(GO:1903969) regulation of cellular response to macrophage colony-stimulating factor stimulus(GO:1903972) |
1.5 | 8.8 | GO:0060056 | mammary gland involution(GO:0060056) |
1.5 | 4.4 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
1.5 | 17.5 | GO:0002115 | store-operated calcium entry(GO:0002115) |
1.5 | 2.9 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
1.5 | 1.5 | GO:0060696 | regulation of phospholipid catabolic process(GO:0060696) |
1.5 | 2.9 | GO:0019661 | fermentation(GO:0006113) glucose catabolic process to lactate(GO:0019659) glycolytic fermentation(GO:0019660) glucose catabolic process to lactate via pyruvate(GO:0019661) |
1.5 | 4.4 | GO:2001270 | regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001270) negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
1.5 | 2.9 | GO:0002278 | eosinophil activation involved in immune response(GO:0002278) eosinophil mediated immunity(GO:0002447) eosinophil degranulation(GO:0043308) |
1.4 | 10.1 | GO:0000042 | protein targeting to Golgi(GO:0000042) |
1.4 | 4.3 | GO:0006543 | glutamine catabolic process(GO:0006543) |
1.4 | 4.3 | GO:0070278 | extracellular matrix constituent secretion(GO:0070278) |
1.4 | 1.4 | GO:2000644 | regulation of receptor catabolic process(GO:2000644) |
1.4 | 2.9 | GO:0035795 | negative regulation of mitochondrial membrane permeability(GO:0035795) negative regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902109) |
1.4 | 4.3 | GO:0046271 | phenylpropanoid catabolic process(GO:0046271) |
1.4 | 4.3 | GO:0002884 | negative regulation of hypersensitivity(GO:0002884) |
1.4 | 1.4 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
1.4 | 4.3 | GO:0007525 | somatic muscle development(GO:0007525) |
1.4 | 12.8 | GO:0006851 | mitochondrial calcium ion transport(GO:0006851) |
1.4 | 4.3 | GO:0090306 | spindle assembly involved in meiosis(GO:0090306) |
1.4 | 4.3 | GO:0010832 | negative regulation of myotube differentiation(GO:0010832) |
1.4 | 18.5 | GO:0015858 | nucleoside transport(GO:0015858) |
1.4 | 1.4 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
1.4 | 5.7 | GO:2001199 | negative regulation of dendritic cell differentiation(GO:2001199) |
1.4 | 4.3 | GO:0010796 | regulation of multivesicular body size(GO:0010796) |
1.4 | 2.8 | GO:0002036 | regulation of L-glutamate transport(GO:0002036) |
1.4 | 1.4 | GO:0071351 | cellular response to interleukin-18(GO:0071351) |
1.4 | 19.7 | GO:0034383 | low-density lipoprotein particle clearance(GO:0034383) |
1.4 | 5.6 | GO:0019478 | D-amino acid catabolic process(GO:0019478) |
1.4 | 2.8 | GO:1903223 | positive regulation of oxidative stress-induced neuron death(GO:1903223) |
1.4 | 1.4 | GO:0060481 | lobar bronchus epithelium development(GO:0060481) |
1.4 | 2.8 | GO:0070103 | regulation of interleukin-6-mediated signaling pathway(GO:0070103) |
1.4 | 4.2 | GO:0042758 | long-chain fatty acid catabolic process(GO:0042758) |
1.4 | 7.0 | GO:0019695 | choline metabolic process(GO:0019695) |
1.4 | 4.2 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
1.4 | 9.8 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
1.4 | 12.5 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
1.4 | 7.0 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
1.4 | 4.2 | GO:1903334 | positive regulation of protein folding(GO:1903334) |
1.4 | 1.4 | GO:2000774 | positive regulation of cellular senescence(GO:2000774) |
1.4 | 4.2 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) platelet activating factor metabolic process(GO:0046469) |
1.4 | 4.2 | GO:0048102 | autophagic cell death(GO:0048102) |
1.4 | 4.2 | GO:1903142 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
1.4 | 6.9 | GO:2001275 | positive regulation of glucose import in response to insulin stimulus(GO:2001275) |
1.4 | 1.4 | GO:0007195 | adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
1.4 | 4.1 | GO:2000523 | regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) |
1.4 | 5.5 | GO:0046292 | formaldehyde metabolic process(GO:0046292) |
1.4 | 5.5 | GO:0071404 | cellular response to low-density lipoprotein particle stimulus(GO:0071404) |
1.4 | 2.8 | GO:0006975 | DNA damage induced protein phosphorylation(GO:0006975) |
1.4 | 4.1 | GO:0035020 | regulation of Rac protein signal transduction(GO:0035020) |
1.4 | 6.9 | GO:0046836 | glycolipid transport(GO:0046836) |
1.4 | 1.4 | GO:0035791 | platelet-derived growth factor receptor-beta signaling pathway(GO:0035791) |
1.4 | 9.6 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
1.4 | 2.7 | GO:0060847 | endothelial cell fate specification(GO:0060847) |
1.4 | 2.7 | GO:0010042 | response to manganese ion(GO:0010042) |
1.4 | 4.1 | GO:0006537 | glutamate biosynthetic process(GO:0006537) |
1.4 | 5.5 | GO:0006382 | adenosine to inosine editing(GO:0006382) |
1.4 | 1.4 | GO:0010182 | carbohydrate mediated signaling(GO:0009756) hexose mediated signaling(GO:0009757) sugar mediated signaling pathway(GO:0010182) glucose mediated signaling pathway(GO:0010255) |
1.4 | 1.4 | GO:0051571 | positive regulation of histone H3-K4 methylation(GO:0051571) |
1.4 | 4.1 | GO:1900095 | regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
1.4 | 2.7 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
1.4 | 2.7 | GO:0035022 | positive regulation of Rac protein signal transduction(GO:0035022) |
1.4 | 1.4 | GO:0034141 | positive regulation of toll-like receptor 3 signaling pathway(GO:0034141) |
1.4 | 2.7 | GO:0061146 | Peyer's patch morphogenesis(GO:0061146) |
1.4 | 8.1 | GO:0090043 | regulation of tubulin deacetylation(GO:0090043) |
1.4 | 4.1 | GO:0061687 | detoxification of copper ion(GO:0010273) detoxification of inorganic compound(GO:0061687) stress response to copper ion(GO:1990169) |
1.3 | 8.1 | GO:0002589 | regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002589) |
1.3 | 4.0 | GO:0044351 | macropinocytosis(GO:0044351) |
1.3 | 4.0 | GO:1904154 | positive regulation of retrograde protein transport, ER to cytosol(GO:1904154) |
1.3 | 2.7 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
1.3 | 12.1 | GO:0071380 | cellular response to prostaglandin E stimulus(GO:0071380) |
1.3 | 9.4 | GO:0010764 | negative regulation of fibroblast migration(GO:0010764) |
1.3 | 5.4 | GO:0007182 | common-partner SMAD protein phosphorylation(GO:0007182) |
1.3 | 4.0 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
1.3 | 8.0 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
1.3 | 8.0 | GO:0043116 | negative regulation of vascular permeability(GO:0043116) |
1.3 | 8.0 | GO:0046473 | phosphatidic acid biosynthetic process(GO:0006654) phosphatidic acid metabolic process(GO:0046473) |
1.3 | 7.9 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
1.3 | 4.0 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
1.3 | 6.6 | GO:0009052 | pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
1.3 | 1.3 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
1.3 | 7.9 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
1.3 | 11.8 | GO:0034405 | response to fluid shear stress(GO:0034405) |
1.3 | 14.4 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
1.3 | 11.7 | GO:0030213 | hyaluronan biosynthetic process(GO:0030213) |
1.3 | 114.8 | GO:0035023 | regulation of Rho protein signal transduction(GO:0035023) |
1.3 | 3.9 | GO:0010571 | positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
1.3 | 21.9 | GO:0043153 | entrainment of circadian clock by photoperiod(GO:0043153) |
1.3 | 7.7 | GO:0032462 | regulation of protein homooligomerization(GO:0032462) positive regulation of protein homooligomerization(GO:0032464) |
1.3 | 2.6 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
1.3 | 1.3 | GO:0042520 | positive regulation of tyrosine phosphorylation of Stat4 protein(GO:0042520) |
1.3 | 2.6 | GO:0030240 | skeletal myofibril assembly(GO:0014866) skeletal muscle thin filament assembly(GO:0030240) |
1.3 | 3.8 | GO:0035672 | oligopeptide transmembrane transport(GO:0035672) |
1.3 | 2.6 | GO:0061355 | Wnt protein secretion(GO:0061355) regulation of Wnt protein secretion(GO:0061356) |
1.3 | 3.8 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
1.3 | 1.3 | GO:0060435 | bronchiole development(GO:0060435) |
1.3 | 6.4 | GO:1901836 | regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901836) |
1.3 | 8.9 | GO:0001955 | blood vessel maturation(GO:0001955) |
1.3 | 3.8 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
1.3 | 3.8 | GO:0070235 | regulation of activation-induced cell death of T cells(GO:0070235) negative regulation of activation-induced cell death of T cells(GO:0070236) |
1.3 | 8.9 | GO:0060586 | multicellular organismal iron ion homeostasis(GO:0060586) |
1.3 | 17.7 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
1.3 | 7.6 | GO:0070995 | NADPH oxidation(GO:0070995) |
1.3 | 3.8 | GO:0042891 | antibiotic transport(GO:0042891) |
1.3 | 5.0 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
1.3 | 1.3 | GO:0097252 | oligodendrocyte apoptotic process(GO:0097252) |
1.3 | 3.8 | GO:0090086 | negative regulation of protein deubiquitination(GO:0090086) |
1.3 | 3.8 | GO:0046654 | tetrahydrofolate biosynthetic process(GO:0046654) |
1.3 | 5.0 | GO:0046125 | pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
1.2 | 15.0 | GO:0006691 | leukotriene metabolic process(GO:0006691) |
1.2 | 7.5 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
1.2 | 3.7 | GO:0070827 | chromatin maintenance(GO:0070827) |
1.2 | 6.2 | GO:2000489 | regulation of hepatic stellate cell activation(GO:2000489) |
1.2 | 2.5 | GO:0051305 | chromosome movement towards spindle pole(GO:0051305) |
1.2 | 3.7 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
1.2 | 8.7 | GO:0010310 | regulation of hydrogen peroxide metabolic process(GO:0010310) |
1.2 | 2.5 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
1.2 | 8.7 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
1.2 | 2.5 | GO:0032497 | detection of lipopolysaccharide(GO:0032497) |
1.2 | 1.2 | GO:2000343 | positive regulation of chemokine (C-X-C motif) ligand 2 production(GO:2000343) |
1.2 | 12.3 | GO:0018904 | ether metabolic process(GO:0018904) |
1.2 | 6.2 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
1.2 | 13.5 | GO:0006047 | UDP-N-acetylglucosamine metabolic process(GO:0006047) |
1.2 | 4.9 | GO:0090666 | scaRNA localization to Cajal body(GO:0090666) |
1.2 | 12.2 | GO:0051601 | exocyst localization(GO:0051601) |
1.2 | 1.2 | GO:1904238 | pericyte cell differentiation(GO:1904238) |
1.2 | 4.9 | GO:0030422 | production of siRNA involved in RNA interference(GO:0030422) |
1.2 | 7.3 | GO:0061154 | endothelial tube morphogenesis(GO:0061154) |
1.2 | 1.2 | GO:0046416 | D-amino acid metabolic process(GO:0046416) |
1.2 | 7.3 | GO:0045820 | negative regulation of glycolytic process(GO:0045820) |
1.2 | 3.6 | GO:0035166 | post-embryonic hemopoiesis(GO:0035166) |
1.2 | 1.2 | GO:0003093 | regulation of glomerular filtration(GO:0003093) |
1.2 | 2.4 | GO:1900245 | positive regulation of MDA-5 signaling pathway(GO:1900245) |
1.2 | 3.6 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
1.2 | 7.3 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
1.2 | 1.2 | GO:0051599 | response to hydrostatic pressure(GO:0051599) |
1.2 | 4.8 | GO:0010510 | regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) |
1.2 | 26.6 | GO:0033014 | porphyrin-containing compound biosynthetic process(GO:0006779) tetrapyrrole biosynthetic process(GO:0033014) |
1.2 | 13.3 | GO:0032926 | negative regulation of activin receptor signaling pathway(GO:0032926) |
1.2 | 4.8 | GO:1903887 | motile primary cilium assembly(GO:1903887) |
1.2 | 4.8 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
1.2 | 39.7 | GO:0030032 | lamellipodium assembly(GO:0030032) |
1.2 | 7.2 | GO:0051444 | negative regulation of ligase activity(GO:0051352) negative regulation of ubiquitin-protein transferase activity(GO:0051444) |
1.2 | 1.2 | GO:0055099 | response to high density lipoprotein particle(GO:0055099) |
1.2 | 4.8 | GO:0046642 | negative regulation of alpha-beta T cell proliferation(GO:0046642) |
1.2 | 2.4 | GO:0061083 | regulation of protein refolding(GO:0061083) negative regulation of protein refolding(GO:0061084) |
1.2 | 3.6 | GO:0097067 | cellular response to thyroid hormone stimulus(GO:0097067) |
1.2 | 3.6 | GO:0031944 | negative regulation of glucocorticoid metabolic process(GO:0031944) negative regulation of glucocorticoid biosynthetic process(GO:0031947) |
1.2 | 1.2 | GO:0006808 | regulation of nitrogen utilization(GO:0006808) |
1.2 | 1.2 | GO:0046083 | adenine metabolic process(GO:0046083) adenine biosynthetic process(GO:0046084) |
1.2 | 3.6 | GO:2001044 | regulation of integrin-mediated signaling pathway(GO:2001044) |
1.2 | 3.6 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
1.2 | 1.2 | GO:2001225 | regulation of chloride transport(GO:2001225) |
1.2 | 2.3 | GO:0071918 | urea transmembrane transport(GO:0071918) |
1.2 | 8.2 | GO:0051560 | mitochondrial calcium ion homeostasis(GO:0051560) |
1.2 | 1.2 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
1.2 | 3.5 | GO:0006772 | thiamine metabolic process(GO:0006772) thiamine-containing compound metabolic process(GO:0042723) |
1.2 | 1.2 | GO:0038161 | prolactin signaling pathway(GO:0038161) |
1.2 | 1.2 | GO:0043382 | regulation of memory T cell differentiation(GO:0043380) positive regulation of memory T cell differentiation(GO:0043382) |
1.2 | 3.5 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
1.2 | 7.0 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
1.2 | 14.0 | GO:0014850 | response to muscle activity(GO:0014850) |
1.2 | 2.3 | GO:0060684 | epithelial-mesenchymal cell signaling(GO:0060684) |
1.2 | 15.0 | GO:0014733 | regulation of skeletal muscle adaptation(GO:0014733) |
1.1 | 3.4 | GO:0019042 | viral latency(GO:0019042) |
1.1 | 3.4 | GO:0031659 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle(GO:0031657) positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle(GO:0031659) |
1.1 | 2.3 | GO:0051602 | response to electrical stimulus(GO:0051602) |
1.1 | 4.6 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
1.1 | 1.1 | GO:0036089 | cleavage furrow formation(GO:0036089) |
1.1 | 4.6 | GO:1902895 | positive regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902895) |
1.1 | 2.3 | GO:0072223 | metanephric glomerular mesangium development(GO:0072223) metanephric glomerular mesangial cell proliferation involved in metanephros development(GO:0072262) |
1.1 | 1.1 | GO:0035811 | negative regulation of urine volume(GO:0035811) |
1.1 | 1.1 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
1.1 | 2.3 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
1.1 | 4.5 | GO:0045636 | regulation of melanocyte differentiation(GO:0045634) positive regulation of melanocyte differentiation(GO:0045636) |
1.1 | 2.3 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
1.1 | 5.7 | GO:0002756 | MyD88-independent toll-like receptor signaling pathway(GO:0002756) |
1.1 | 2.3 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
1.1 | 3.4 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
1.1 | 4.5 | GO:0050857 | positive regulation of antigen receptor-mediated signaling pathway(GO:0050857) |
1.1 | 2.3 | GO:1901800 | positive regulation of proteasomal protein catabolic process(GO:1901800) |
1.1 | 2.3 | GO:0032304 | negative regulation of icosanoid secretion(GO:0032304) |
1.1 | 1.1 | GO:0007100 | mitotic centrosome separation(GO:0007100) regulation of mitotic centrosome separation(GO:0046602) |
1.1 | 5.6 | GO:0033194 | response to hydroperoxide(GO:0033194) |
1.1 | 1.1 | GO:1903332 | regulation of protein folding(GO:1903332) negative regulation of protein folding(GO:1903333) |
1.1 | 6.7 | GO:0034162 | toll-like receptor 9 signaling pathway(GO:0034162) |
1.1 | 3.4 | GO:1901475 | pyruvate transmembrane transport(GO:1901475) |
1.1 | 5.6 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
1.1 | 4.5 | GO:0072383 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
1.1 | 5.6 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
1.1 | 3.3 | GO:0019346 | homoserine metabolic process(GO:0009092) transsulfuration(GO:0019346) |
1.1 | 10.0 | GO:2000353 | positive regulation of endothelial cell apoptotic process(GO:2000353) |
1.1 | 1.1 | GO:0071139 | resolution of recombination intermediates(GO:0071139) |
1.1 | 2.2 | GO:0016584 | nucleosome positioning(GO:0016584) |
1.1 | 3.3 | GO:0061087 | positive regulation of histone H3-K27 methylation(GO:0061087) |
1.1 | 3.3 | GO:0010626 | negative regulation of Schwann cell proliferation(GO:0010626) |
1.1 | 4.4 | GO:0086073 | bundle of His cell-Purkinje myocyte adhesion involved in cell communication(GO:0086073) |
1.1 | 3.3 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
1.1 | 1.1 | GO:0010745 | negative regulation of macrophage derived foam cell differentiation(GO:0010745) |
1.1 | 3.3 | GO:0060352 | cell adhesion molecule production(GO:0060352) |
1.1 | 4.4 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
1.1 | 4.4 | GO:0044789 | modulation by host of viral release from host cell(GO:0044789) positive regulation by host of viral release from host cell(GO:0044791) |
1.1 | 5.5 | GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
1.1 | 6.6 | GO:0035999 | tetrahydrofolate interconversion(GO:0035999) |
1.1 | 11.0 | GO:0050860 | negative regulation of T cell receptor signaling pathway(GO:0050860) |
1.1 | 1.1 | GO:0060523 | prostate epithelial cord elongation(GO:0060523) |
1.1 | 7.6 | GO:0043981 | histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
1.1 | 3.3 | GO:0071830 | chylomicron remnant clearance(GO:0034382) triglyceride-rich lipoprotein particle clearance(GO:0071830) |
1.1 | 5.5 | GO:0007035 | vacuolar acidification(GO:0007035) |
1.1 | 4.4 | GO:2001280 | positive regulation of prostaglandin biosynthetic process(GO:0031394) positive regulation of unsaturated fatty acid biosynthetic process(GO:2001280) |
1.1 | 4.4 | GO:0010792 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) |
1.1 | 13.1 | GO:0042761 | very long-chain fatty acid biosynthetic process(GO:0042761) |
1.1 | 6.5 | GO:0042168 | heme metabolic process(GO:0042168) |
1.1 | 13.1 | GO:0032728 | positive regulation of interferon-beta production(GO:0032728) |
1.1 | 3.3 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
1.1 | 8.7 | GO:0010971 | positive regulation of G2/M transition of mitotic cell cycle(GO:0010971) |
1.1 | 2.2 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
1.1 | 4.3 | GO:1902837 | amino acid import into cell(GO:1902837) |
1.1 | 2.2 | GO:0010040 | response to iron(II) ion(GO:0010040) |
1.1 | 10.8 | GO:0071218 | cellular response to misfolded protein(GO:0071218) |
1.1 | 1.1 | GO:0046122 | purine deoxyribonucleoside metabolic process(GO:0046122) |
1.1 | 4.3 | GO:2000504 | positive regulation of blood vessel remodeling(GO:2000504) |
1.1 | 3.2 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
1.1 | 2.2 | GO:0035973 | aggrephagy(GO:0035973) |
1.1 | 3.2 | GO:2000641 | regulation of early endosome to late endosome transport(GO:2000641) |
1.1 | 3.2 | GO:0042148 | strand invasion(GO:0042148) |
1.1 | 2.1 | GO:2001245 | regulation of phosphatidylcholine biosynthetic process(GO:2001245) |
1.1 | 1.1 | GO:0051340 | regulation of ligase activity(GO:0051340) |
1.1 | 6.4 | GO:0060613 | fat pad development(GO:0060613) |
1.1 | 2.1 | GO:1901896 | positive regulation of calcium-transporting ATPase activity(GO:1901896) |
1.1 | 1.1 | GO:0048016 | inositol phosphate-mediated signaling(GO:0048016) |
1.1 | 5.3 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
1.1 | 2.1 | GO:0032897 | negative regulation of viral transcription(GO:0032897) |
1.1 | 3.2 | GO:1990928 | response to amino acid starvation(GO:1990928) |
1.1 | 2.1 | GO:0035441 | cell migration involved in vasculogenesis(GO:0035441) |
1.1 | 21.1 | GO:0016578 | histone deubiquitination(GO:0016578) |
1.1 | 3.2 | GO:0035928 | rRNA import into mitochondrion(GO:0035928) |
1.1 | 2.1 | GO:1904996 | positive regulation of leukocyte adhesion to vascular endothelial cell(GO:1904996) |
1.1 | 5.3 | GO:0060623 | regulation of chromosome condensation(GO:0060623) |
1.1 | 5.3 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
1.0 | 7.3 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
1.0 | 13.6 | GO:0045116 | protein neddylation(GO:0045116) |
1.0 | 2.1 | GO:0070427 | nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070427) |
1.0 | 10.4 | GO:0006144 | purine nucleobase metabolic process(GO:0006144) |
1.0 | 2.1 | GO:0002339 | B cell selection(GO:0002339) |
1.0 | 5.2 | GO:0035459 | cargo loading into vesicle(GO:0035459) |
1.0 | 6.2 | GO:0009226 | nucleotide-sugar biosynthetic process(GO:0009226) |
1.0 | 3.1 | GO:0018916 | nitrobenzene metabolic process(GO:0018916) |
1.0 | 2.1 | GO:0035630 | bone mineralization involved in bone maturation(GO:0035630) |
1.0 | 6.2 | GO:1901339 | regulation of store-operated calcium channel activity(GO:1901339) |
1.0 | 14.4 | GO:0032012 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
1.0 | 16.4 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
1.0 | 1.0 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
1.0 | 8.2 | GO:0006656 | phosphatidylcholine biosynthetic process(GO:0006656) |
1.0 | 2.0 | GO:1902071 | regulation of hypoxia-inducible factor-1alpha signaling pathway(GO:1902071) |
1.0 | 1.0 | GO:1900246 | positive regulation of RIG-I signaling pathway(GO:1900246) |
1.0 | 4.1 | GO:0035814 | negative regulation of renal sodium excretion(GO:0035814) |
1.0 | 3.0 | GO:0040031 | snRNA modification(GO:0040031) |
1.0 | 3.0 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
1.0 | 10.1 | GO:0060213 | regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060211) positive regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060213) |
1.0 | 2.0 | GO:0090238 | positive regulation of arachidonic acid secretion(GO:0090238) |
1.0 | 1.0 | GO:1901069 | guanosine-containing compound catabolic process(GO:1901069) |
1.0 | 2.0 | GO:0090435 | protein localization to nuclear envelope(GO:0090435) |
1.0 | 6.0 | GO:0009437 | carnitine metabolic process(GO:0009437) |
1.0 | 5.0 | GO:0048680 | positive regulation of axon regeneration(GO:0048680) |
1.0 | 2.0 | GO:0015791 | polyol transport(GO:0015791) |
1.0 | 7.0 | GO:0042026 | protein refolding(GO:0042026) |
1.0 | 2.0 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
1.0 | 3.0 | GO:1901674 | histone H3-K27 acetylation(GO:0043974) regulation of histone H3-K27 acetylation(GO:1901674) |
1.0 | 7.0 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
1.0 | 6.0 | GO:0090141 | positive regulation of mitochondrial fission(GO:0090141) |
1.0 | 5.0 | GO:0098728 | germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) germline stem cell asymmetric division(GO:0098728) |
1.0 | 4.0 | GO:0033132 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
1.0 | 14.9 | GO:0060445 | branching involved in salivary gland morphogenesis(GO:0060445) |
1.0 | 4.0 | GO:2000391 | regulation of neutrophil extravasation(GO:2000389) positive regulation of neutrophil extravasation(GO:2000391) |
1.0 | 5.0 | GO:0050651 | dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
1.0 | 3.0 | GO:0042420 | dopamine catabolic process(GO:0042420) |
1.0 | 4.0 | GO:0080009 | mRNA methylation(GO:0080009) |
1.0 | 2.0 | GO:0072310 | glomerular visceral epithelial cell development(GO:0072015) glomerular epithelial cell development(GO:0072310) |
1.0 | 6.9 | GO:0000059 | protein import into nucleus, docking(GO:0000059) |
1.0 | 4.9 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
1.0 | 4.9 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
1.0 | 3.9 | GO:0002155 | regulation of thyroid hormone mediated signaling pathway(GO:0002155) |
1.0 | 3.0 | GO:0009436 | glyoxylate catabolic process(GO:0009436) |
1.0 | 2.0 | GO:0016095 | polyprenol catabolic process(GO:0016095) |
1.0 | 1.0 | GO:1904478 | regulation of intestinal cholesterol absorption(GO:0030300) regulation of intestinal absorption(GO:1904478) regulation of intestinal lipid absorption(GO:1904729) |
1.0 | 3.0 | GO:0010897 | negative regulation of triglyceride catabolic process(GO:0010897) |
1.0 | 3.0 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
1.0 | 9.8 | GO:0046827 | positive regulation of protein export from nucleus(GO:0046827) |
1.0 | 2.9 | GO:0060689 | cell differentiation involved in salivary gland development(GO:0060689) |
1.0 | 6.9 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
1.0 | 1.0 | GO:1903427 | negative regulation of reactive oxygen species biosynthetic process(GO:1903427) |
1.0 | 1.0 | GO:2000015 | regulation of determination of dorsal identity(GO:2000015) |
1.0 | 1.0 | GO:0035509 | negative regulation of myosin-light-chain-phosphatase activity(GO:0035509) |
1.0 | 1.9 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
1.0 | 1.0 | GO:0046185 | aldehyde catabolic process(GO:0046185) |
1.0 | 1.9 | GO:0042701 | progesterone secretion(GO:0042701) |
1.0 | 9.7 | GO:0051383 | kinetochore organization(GO:0051383) |
1.0 | 1.9 | GO:0015886 | heme transport(GO:0015886) |
1.0 | 1.0 | GO:0009648 | photoperiodism(GO:0009648) |
1.0 | 1.9 | GO:1901421 | positive regulation of response to alcohol(GO:1901421) |
1.0 | 3.9 | GO:2000279 | negative regulation of DNA biosynthetic process(GO:2000279) |
1.0 | 1.9 | GO:0033131 | regulation of glucokinase activity(GO:0033131) regulation of hexokinase activity(GO:1903299) |
1.0 | 1.9 | GO:0042126 | nitrate metabolic process(GO:0042126) |
1.0 | 5.8 | GO:0042416 | dopamine biosynthetic process(GO:0042416) |
1.0 | 6.7 | GO:0006000 | fructose metabolic process(GO:0006000) |
1.0 | 1.9 | GO:1901550 | regulation of endothelial cell development(GO:1901550) regulation of establishment of endothelial barrier(GO:1903140) |
1.0 | 7.7 | GO:0070131 | positive regulation of mitochondrial translation(GO:0070131) |
1.0 | 2.9 | GO:1900060 | negative regulation of ceramide biosynthetic process(GO:1900060) |
1.0 | 2.9 | GO:1902608 | regulation of large conductance calcium-activated potassium channel activity(GO:1902606) positive regulation of large conductance calcium-activated potassium channel activity(GO:1902608) |
1.0 | 2.9 | GO:0000491 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
1.0 | 2.9 | GO:0097466 | glycoprotein ERAD pathway(GO:0097466) response to glycoprotein(GO:1904587) |
0.9 | 1.9 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
0.9 | 28.5 | GO:0070936 | protein K48-linked ubiquitination(GO:0070936) |
0.9 | 2.8 | GO:0044068 | modulation by symbiont of host cellular process(GO:0044068) |
0.9 | 1.9 | GO:0072710 | response to hydroxyurea(GO:0072710) cellular response to hydroxyurea(GO:0072711) |
0.9 | 1.9 | GO:0006068 | ethanol catabolic process(GO:0006068) |
0.9 | 3.8 | GO:0045964 | positive regulation of catecholamine metabolic process(GO:0045915) positive regulation of dopamine metabolic process(GO:0045964) |
0.9 | 3.8 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
0.9 | 4.7 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
0.9 | 9.4 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.9 | 6.6 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.9 | 3.8 | GO:0014043 | negative regulation of neuron maturation(GO:0014043) |
0.9 | 0.9 | GO:0045657 | positive regulation of monocyte differentiation(GO:0045657) |
0.9 | 22.5 | GO:0018279 | protein N-linked glycosylation via asparagine(GO:0018279) |
0.9 | 1.9 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
0.9 | 1.9 | GO:0014878 | response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) |
0.9 | 3.7 | GO:0061641 | CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
0.9 | 2.8 | GO:0042097 | interleukin-4 biosynthetic process(GO:0042097) regulation of interleukin-4 biosynthetic process(GO:0045402) |
0.9 | 0.9 | GO:0000320 | re-entry into mitotic cell cycle(GO:0000320) |
0.9 | 5.6 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
0.9 | 3.7 | GO:0060718 | chorionic trophoblast cell differentiation(GO:0060718) |
0.9 | 15.9 | GO:0032786 | positive regulation of DNA-templated transcription, elongation(GO:0032786) |
0.9 | 3.7 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
0.9 | 12.1 | GO:0033006 | regulation of mast cell activation involved in immune response(GO:0033006) regulation of mast cell degranulation(GO:0043304) |
0.9 | 9.3 | GO:0033235 | positive regulation of protein sumoylation(GO:0033235) |
0.9 | 2.8 | GO:0000710 | meiotic mismatch repair(GO:0000710) |
0.9 | 3.7 | GO:0002679 | respiratory burst involved in defense response(GO:0002679) |
0.9 | 19.5 | GO:0010761 | fibroblast migration(GO:0010761) |
0.9 | 4.6 | GO:2000427 | positive regulation of apoptotic cell clearance(GO:2000427) |
0.9 | 2.8 | GO:0033182 | regulation of histone ubiquitination(GO:0033182) |
0.9 | 2.8 | GO:0090241 | negative regulation of histone H4 acetylation(GO:0090241) |
0.9 | 2.8 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.9 | 5.5 | GO:0046874 | quinolinate metabolic process(GO:0046874) |
0.9 | 0.9 | GO:0071450 | cellular response to oxygen radical(GO:0071450) cellular response to superoxide(GO:0071451) |
0.9 | 0.9 | GO:0042117 | monocyte activation(GO:0042117) |
0.9 | 3.7 | GO:0048070 | regulation of developmental pigmentation(GO:0048070) |
0.9 | 7.4 | GO:0031954 | positive regulation of protein autophosphorylation(GO:0031954) |
0.9 | 3.7 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
0.9 | 2.8 | GO:0072537 | fibroblast activation(GO:0072537) |
0.9 | 12.8 | GO:0070536 | protein K63-linked deubiquitination(GO:0070536) |
0.9 | 2.8 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
0.9 | 4.6 | GO:0045579 | positive regulation of B cell differentiation(GO:0045579) |
0.9 | 2.7 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
0.9 | 0.9 | GO:1904180 | negative regulation of mitochondrial depolarization(GO:0051902) negative regulation of membrane depolarization(GO:1904180) |
0.9 | 17.3 | GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
0.9 | 2.7 | GO:0090166 | Golgi disassembly(GO:0090166) |
0.9 | 8.2 | GO:0006878 | cellular copper ion homeostasis(GO:0006878) |
0.9 | 2.7 | GO:0006534 | cysteine metabolic process(GO:0006534) |
0.9 | 2.7 | GO:0030242 | pexophagy(GO:0030242) |
0.9 | 4.5 | GO:0031953 | negative regulation of protein autophosphorylation(GO:0031953) |
0.9 | 1.8 | GO:1904707 | positive regulation of vascular smooth muscle cell proliferation(GO:1904707) |
0.9 | 3.6 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
0.9 | 0.9 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
0.9 | 4.5 | GO:0007097 | nuclear migration(GO:0007097) |
0.9 | 1.8 | GO:0033088 | negative regulation of immature T cell proliferation in thymus(GO:0033088) |
0.9 | 1.8 | GO:0042908 | xenobiotic transport(GO:0042908) |
0.9 | 2.7 | GO:1902990 | mitotic telomere maintenance via semi-conservative replication(GO:1902990) |
0.9 | 3.6 | GO:0010529 | regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
0.9 | 9.0 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
0.9 | 9.8 | GO:0035384 | thioester biosynthetic process(GO:0035384) acyl-CoA biosynthetic process(GO:0071616) |
0.9 | 8.0 | GO:2000001 | regulation of DNA damage checkpoint(GO:2000001) |
0.9 | 10.7 | GO:0006465 | signal peptide processing(GO:0006465) |
0.9 | 3.5 | GO:0044827 | modulation by host of viral genome replication(GO:0044827) |
0.9 | 2.7 | GO:0045897 | regulation of transcription during mitosis(GO:0045896) positive regulation of transcription during mitosis(GO:0045897) |
0.9 | 5.3 | GO:0033003 | regulation of mast cell activation(GO:0033003) |
0.9 | 1.8 | GO:1902445 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
0.9 | 34.5 | GO:0045454 | cell redox homeostasis(GO:0045454) |
0.9 | 1.8 | GO:0019676 | ammonia assimilation cycle(GO:0019676) |
0.9 | 3.5 | GO:0031577 | spindle checkpoint(GO:0031577) |
0.9 | 2.6 | GO:0071577 | zinc II ion transmembrane transport(GO:0071577) |
0.9 | 5.3 | GO:0032516 | positive regulation of phosphoprotein phosphatase activity(GO:0032516) |
0.9 | 3.5 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.9 | 7.9 | GO:0016601 | Rac protein signal transduction(GO:0016601) |
0.9 | 2.6 | GO:0032066 | nucleolus to nucleoplasm transport(GO:0032066) |
0.9 | 1.7 | GO:0060633 | negative regulation of transcription initiation from RNA polymerase II promoter(GO:0060633) negative regulation of DNA-templated transcription, initiation(GO:2000143) |
0.9 | 7.9 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
0.9 | 4.4 | GO:0043922 | negative regulation by host of viral transcription(GO:0043922) |
0.9 | 3.5 | GO:1900194 | negative regulation of oocyte maturation(GO:1900194) |
0.9 | 0.9 | GO:0070431 | nucleotide-binding oligomerization domain containing signaling pathway(GO:0070423) nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070431) |
0.9 | 3.5 | GO:0060763 | mammary duct terminal end bud growth(GO:0060763) |
0.9 | 1.7 | GO:0002282 | microglial cell activation involved in immune response(GO:0002282) |
0.9 | 5.2 | GO:0051013 | microtubule severing(GO:0051013) |
0.9 | 2.6 | GO:0031952 | regulation of protein autophosphorylation(GO:0031952) |
0.9 | 0.9 | GO:0061198 | fungiform papilla formation(GO:0061198) |
0.9 | 1.7 | GO:0051386 | regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) |
0.9 | 4.3 | GO:0072364 | regulation of cellular ketone metabolic process by regulation of transcription from RNA polymerase II promoter(GO:0072364) |
0.9 | 2.6 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
0.9 | 0.9 | GO:0010909 | regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
0.9 | 2.6 | GO:0009838 | abscission(GO:0009838) |
0.9 | 0.9 | GO:0006545 | glycine biosynthetic process(GO:0006545) |
0.9 | 1.7 | GO:0070070 | proton-transporting V-type ATPase complex assembly(GO:0070070) |
0.9 | 1.7 | GO:0001827 | inner cell mass cell fate commitment(GO:0001827) |
0.9 | 6.8 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
0.9 | 6.0 | GO:0033617 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
0.9 | 2.6 | GO:0048478 | replication fork protection(GO:0048478) |
0.9 | 14.5 | GO:0070830 | bicellular tight junction assembly(GO:0070830) |
0.9 | 0.9 | GO:0042494 | detection of bacterial lipoprotein(GO:0042494) |
0.9 | 0.9 | GO:0006549 | isoleucine metabolic process(GO:0006549) |
0.9 | 1.7 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
0.9 | 1.7 | GO:1902415 | regulation of mRNA binding(GO:1902415) regulation of RNA binding(GO:1905214) |
0.9 | 0.9 | GO:0090209 | negative regulation of triglyceride metabolic process(GO:0090209) |
0.9 | 4.3 | GO:0034508 | centromere complex assembly(GO:0034508) |
0.8 | 8.5 | GO:0031365 | N-terminal protein amino acid modification(GO:0031365) |
0.8 | 1.7 | GO:2001135 | regulation of endocytic recycling(GO:2001135) |
0.8 | 4.2 | GO:0060333 | interferon-gamma-mediated signaling pathway(GO:0060333) |
0.8 | 0.8 | GO:0002904 | positive regulation of B cell apoptotic process(GO:0002904) |
0.8 | 4.2 | GO:0035562 | negative regulation of chromatin binding(GO:0035562) |
0.8 | 1.7 | GO:1904378 | maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
0.8 | 1.7 | GO:1902075 | cellular response to salt(GO:1902075) |
0.8 | 5.1 | GO:0007253 | cytoplasmic sequestering of NF-kappaB(GO:0007253) |
0.8 | 1.7 | GO:0045869 | negative regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045869) |
0.8 | 2.5 | GO:0060706 | cell differentiation involved in embryonic placenta development(GO:0060706) |
0.8 | 3.4 | GO:0042149 | cellular response to glucose starvation(GO:0042149) |
0.8 | 1.7 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
0.8 | 2.5 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.8 | 3.3 | GO:0051900 | regulation of mitochondrial depolarization(GO:0051900) |
0.8 | 0.8 | GO:0032816 | positive regulation of natural killer cell activation(GO:0032816) |
0.8 | 5.8 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.8 | 4.2 | GO:0045943 | positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
0.8 | 8.3 | GO:0035873 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
0.8 | 0.8 | GO:0031958 | corticosteroid receptor signaling pathway(GO:0031958) |
0.8 | 2.5 | GO:1903578 | regulation of nucleoside metabolic process(GO:0009118) regulation of ATP metabolic process(GO:1903578) |
0.8 | 3.3 | GO:0051697 | protein delipidation(GO:0051697) |
0.8 | 3.3 | GO:0070244 | negative regulation of thymocyte apoptotic process(GO:0070244) |
0.8 | 3.3 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
0.8 | 0.8 | GO:0042374 | phylloquinone metabolic process(GO:0042374) phylloquinone catabolic process(GO:0042376) quinone catabolic process(GO:1901662) |
0.8 | 0.8 | GO:0017014 | protein nitrosylation(GO:0017014) |
0.8 | 1.7 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
0.8 | 0.8 | GO:0072757 | cellular response to camptothecin(GO:0072757) |
0.8 | 2.5 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
0.8 | 0.8 | GO:0042182 | ketone catabolic process(GO:0042182) |
0.8 | 4.1 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.8 | 4.1 | GO:0048563 | post-embryonic organ morphogenesis(GO:0048563) |
0.8 | 2.5 | GO:0070126 | mitochondrial translational termination(GO:0070126) |
0.8 | 0.8 | GO:0060916 | mesenchymal cell proliferation involved in lung development(GO:0060916) |
0.8 | 2.5 | GO:0019377 | glycolipid catabolic process(GO:0019377) |
0.8 | 4.1 | GO:0000281 | mitotic cytokinesis(GO:0000281) |
0.8 | 0.8 | GO:0051572 | negative regulation of histone H3-K4 methylation(GO:0051572) |
0.8 | 0.8 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
0.8 | 1.6 | GO:0033030 | negative regulation of neutrophil apoptotic process(GO:0033030) |
0.8 | 0.8 | GO:0002442 | serotonin production involved in inflammatory response(GO:0002351) serotonin secretion involved in inflammatory response(GO:0002442) |
0.8 | 15.4 | GO:0042832 | defense response to protozoan(GO:0042832) |
0.8 | 5.7 | GO:0032801 | receptor catabolic process(GO:0032801) |
0.8 | 1.6 | GO:0060921 | sinoatrial node cell differentiation(GO:0060921) sinoatrial node cell development(GO:0060931) |
0.8 | 4.1 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
0.8 | 3.2 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
0.8 | 2.4 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
0.8 | 2.4 | GO:0000022 | mitotic spindle elongation(GO:0000022) mitotic spindle midzone assembly(GO:0051256) |
0.8 | 2.4 | GO:0061668 | mitochondrial ribosome assembly(GO:0061668) mitochondrial large ribosomal subunit assembly(GO:1902775) |
0.8 | 2.4 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
0.8 | 9.7 | GO:0001913 | T cell mediated cytotoxicity(GO:0001913) |
0.8 | 15.3 | GO:0046834 | lipid phosphorylation(GO:0046834) |
0.8 | 1.6 | GO:0060447 | bud outgrowth involved in lung branching(GO:0060447) |
0.8 | 1.6 | GO:0035360 | positive regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035360) |
0.8 | 6.4 | GO:0043249 | erythrocyte maturation(GO:0043249) |
0.8 | 0.8 | GO:1903273 | regulation of sodium ion export(GO:1903273) regulation of sodium ion export from cell(GO:1903276) |
0.8 | 4.0 | GO:0001866 | NK T cell proliferation(GO:0001866) |
0.8 | 0.8 | GO:0019885 | antigen processing and presentation of endogenous peptide antigen(GO:0002483) antigen processing and presentation of endogenous peptide antigen via MHC class I(GO:0019885) |
0.8 | 2.4 | GO:0006590 | thyroid hormone generation(GO:0006590) |
0.8 | 3.2 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.8 | 3.2 | GO:0016556 | mRNA modification(GO:0016556) |
0.8 | 1.6 | GO:0021938 | smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation(GO:0021938) |
0.8 | 1.6 | GO:0060767 | epithelial cell proliferation involved in prostate gland development(GO:0060767) |
0.8 | 11.0 | GO:0033173 | calcineurin-NFAT signaling cascade(GO:0033173) |
0.8 | 1.6 | GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I(GO:0042590) |
0.8 | 0.8 | GO:0042362 | fat-soluble vitamin biosynthetic process(GO:0042362) |
0.8 | 1.6 | GO:0034454 | microtubule anchoring at centrosome(GO:0034454) |
0.8 | 1.6 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
0.8 | 0.8 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
0.8 | 3.1 | GO:0046784 | viral mRNA export from host cell nucleus(GO:0046784) intracellular transport of virus(GO:0075733) multi-organism intracellular transport(GO:1902583) |
0.8 | 0.8 | GO:0006188 | IMP biosynthetic process(GO:0006188) 'de novo' IMP biosynthetic process(GO:0006189) |
0.8 | 0.8 | GO:0032513 | negative regulation of protein phosphatase type 2B activity(GO:0032513) |
0.8 | 2.3 | GO:0010835 | regulation of protein ADP-ribosylation(GO:0010835) |
0.8 | 6.2 | GO:0006098 | pentose-phosphate shunt(GO:0006098) |
0.8 | 2.3 | GO:0034331 | cell junction maintenance(GO:0034331) |
0.8 | 2.3 | GO:0043312 | neutrophil degranulation(GO:0043312) |
0.8 | 2.3 | GO:0046470 | phosphatidylcholine metabolic process(GO:0046470) |
0.8 | 3.9 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
0.8 | 1.6 | GO:1904528 | regulation of microtubule binding(GO:1904526) positive regulation of microtubule binding(GO:1904528) |
0.8 | 1.6 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.8 | 1.6 | GO:0045084 | positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
0.8 | 6.2 | GO:0009313 | oligosaccharide catabolic process(GO:0009313) |
0.8 | 0.8 | GO:0001951 | intestinal D-glucose absorption(GO:0001951) |
0.8 | 3.9 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
0.8 | 0.8 | GO:0071816 | protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
0.8 | 4.6 | GO:0051131 | chaperone-mediated protein complex assembly(GO:0051131) |
0.8 | 0.8 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
0.8 | 9.3 | GO:0016226 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.8 | 2.3 | GO:0006684 | sphingomyelin metabolic process(GO:0006684) |
0.8 | 6.9 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.8 | 1.5 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
0.8 | 2.3 | GO:0032305 | positive regulation of icosanoid secretion(GO:0032305) regulation of prostaglandin secretion(GO:0032306) |
0.8 | 3.1 | GO:0048757 | endosome to melanosome transport(GO:0035646) endosome to pigment granule transport(GO:0043485) pigment granule maturation(GO:0048757) |
0.8 | 0.8 | GO:0044860 | protein localization to plasma membrane raft(GO:0044860) |
0.8 | 26.9 | GO:0044784 | metaphase/anaphase transition of mitotic cell cycle(GO:0007091) metaphase/anaphase transition of cell cycle(GO:0044784) |
0.8 | 1.5 | GO:0043102 | amino acid salvage(GO:0043102) L-methionine biosynthetic process(GO:0071265) L-methionine salvage(GO:0071267) |
0.8 | 8.4 | GO:0071800 | podosome assembly(GO:0071800) |
0.8 | 0.8 | GO:2001279 | regulation of prostaglandin biosynthetic process(GO:0031392) regulation of unsaturated fatty acid biosynthetic process(GO:2001279) |
0.8 | 2.3 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
0.8 | 0.8 | GO:0009078 | alanine metabolic process(GO:0006522) pyruvate family amino acid metabolic process(GO:0009078) L-alanine metabolic process(GO:0042851) |
0.8 | 3.8 | GO:0006561 | proline biosynthetic process(GO:0006561) |
0.8 | 2.3 | GO:0002934 | desmosome organization(GO:0002934) |
0.8 | 0.8 | GO:0045002 | double-strand break repair via single-strand annealing(GO:0045002) |
0.8 | 1.5 | GO:1904415 | regulation of xenophagy(GO:1904415) positive regulation of xenophagy(GO:1904417) |
0.8 | 0.8 | GO:0072393 | microtubule anchoring at microtubule organizing center(GO:0072393) |
0.8 | 2.3 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.8 | 11.4 | GO:0043124 | negative regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043124) |
0.8 | 3.8 | GO:0007549 | dosage compensation(GO:0007549) dosage compensation by inactivation of X chromosome(GO:0009048) |
0.8 | 3.0 | GO:0019348 | dolichol metabolic process(GO:0019348) |
0.8 | 3.8 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.8 | 0.8 | GO:1900037 | regulation of cellular response to hypoxia(GO:1900037) |
0.8 | 3.8 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
0.7 | 1.5 | GO:0018343 | protein farnesylation(GO:0018343) |
0.7 | 3.7 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.7 | 6.0 | GO:0000467 | exonucleolytic trimming involved in rRNA processing(GO:0000459) exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000467) |
0.7 | 2.2 | GO:0042256 | mature ribosome assembly(GO:0042256) |
0.7 | 0.7 | GO:0034447 | very-low-density lipoprotein particle clearance(GO:0034447) |
0.7 | 3.0 | GO:0051775 | response to redox state(GO:0051775) |
0.7 | 0.7 | GO:0045472 | response to ether(GO:0045472) |
0.7 | 2.2 | GO:0006290 | pyrimidine dimer repair(GO:0006290) |
0.7 | 3.0 | GO:0015838 | amino-acid betaine transport(GO:0015838) |
0.7 | 14.9 | GO:0043044 | ATP-dependent chromatin remodeling(GO:0043044) |
0.7 | 0.7 | GO:0006059 | hexitol metabolic process(GO:0006059) |
0.7 | 5.2 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
0.7 | 0.7 | GO:0061511 | centriole elongation(GO:0061511) |
0.7 | 1.5 | GO:0015884 | folic acid transport(GO:0015884) |
0.7 | 2.2 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
0.7 | 3.0 | GO:0019262 | N-acetylneuraminate catabolic process(GO:0019262) |
0.7 | 0.7 | GO:0043633 | polyadenylation-dependent RNA catabolic process(GO:0043633) polyadenylation-dependent ncRNA catabolic process(GO:0043634) nuclear ncRNA surveillance(GO:0071029) nuclear polyadenylation-dependent rRNA catabolic process(GO:0071035) nuclear polyadenylation-dependent ncRNA catabolic process(GO:0071046) |
0.7 | 5.2 | GO:0043206 | extracellular fibril organization(GO:0043206) |
0.7 | 2.9 | GO:0010613 | positive regulation of cardiac muscle hypertrophy(GO:0010613) positive regulation of muscle hypertrophy(GO:0014742) |
0.7 | 5.2 | GO:0043011 | myeloid dendritic cell differentiation(GO:0043011) |
0.7 | 10.3 | GO:0035456 | response to interferon-beta(GO:0035456) |
0.7 | 1.5 | GO:1901096 | regulation of autophagosome maturation(GO:1901096) |
0.7 | 2.9 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.7 | 2.9 | GO:0006637 | acyl-CoA metabolic process(GO:0006637) thioester metabolic process(GO:0035383) |
0.7 | 1.5 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
0.7 | 0.7 | GO:0060948 | cardiac vascular smooth muscle cell development(GO:0060948) |
0.7 | 37.7 | GO:0043123 | positive regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043123) |
0.7 | 1.4 | GO:0000820 | regulation of glutamine family amino acid metabolic process(GO:0000820) |
0.7 | 6.5 | GO:0006614 | SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
0.7 | 2.2 | GO:0042447 | hormone catabolic process(GO:0042447) |
0.7 | 1.4 | GO:0061051 | positive regulation of cell growth involved in cardiac muscle cell development(GO:0061051) |
0.7 | 27.4 | GO:0006334 | nucleosome assembly(GO:0006334) |
0.7 | 2.2 | GO:0033566 | gamma-tubulin complex localization(GO:0033566) |
0.7 | 2.2 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
0.7 | 0.7 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
0.7 | 4.3 | GO:0070875 | positive regulation of glycogen metabolic process(GO:0070875) |
0.7 | 2.2 | GO:1902188 | positive regulation of viral release from host cell(GO:1902188) |
0.7 | 0.7 | GO:1902897 | regulation of postsynaptic density protein 95 clustering(GO:1902897) |
0.7 | 14.3 | GO:0016574 | histone ubiquitination(GO:0016574) |
0.7 | 1.4 | GO:0035751 | regulation of lysosomal lumen pH(GO:0035751) |
0.7 | 2.1 | GO:0006768 | biotin metabolic process(GO:0006768) |
0.7 | 2.8 | GO:0000480 | endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000480) |
0.7 | 8.5 | GO:0006801 | superoxide metabolic process(GO:0006801) |
0.7 | 5.0 | GO:0002467 | germinal center formation(GO:0002467) |
0.7 | 2.1 | GO:0009196 | dUDP biosynthetic process(GO:0006227) pyrimidine nucleoside diphosphate biosynthetic process(GO:0009139) pyrimidine deoxyribonucleoside diphosphate metabolic process(GO:0009196) pyrimidine deoxyribonucleoside diphosphate biosynthetic process(GO:0009197) dUDP metabolic process(GO:0046077) |
0.7 | 5.7 | GO:0070328 | acylglycerol homeostasis(GO:0055090) triglyceride homeostasis(GO:0070328) |
0.7 | 2.1 | GO:0010560 | positive regulation of glycoprotein biosynthetic process(GO:0010560) |
0.7 | 11.3 | GO:0051058 | negative regulation of small GTPase mediated signal transduction(GO:0051058) |
0.7 | 6.3 | GO:0030449 | regulation of complement activation(GO:0030449) |
0.7 | 4.2 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) |
0.7 | 1.4 | GO:0060416 | response to growth hormone(GO:0060416) |
0.7 | 2.8 | GO:0009446 | putrescine biosynthetic process(GO:0009446) |
0.7 | 0.7 | GO:0045059 | positive thymic T cell selection(GO:0045059) |
0.7 | 0.7 | GO:0070189 | kynurenine metabolic process(GO:0070189) |
0.7 | 0.7 | GO:0002693 | positive regulation of cellular extravasation(GO:0002693) |
0.7 | 1.4 | GO:0060391 | positive regulation of SMAD protein import into nucleus(GO:0060391) |
0.7 | 11.2 | GO:0016180 | snRNA processing(GO:0016180) |
0.7 | 1.4 | GO:0050869 | negative regulation of B cell activation(GO:0050869) |
0.7 | 2.1 | GO:0031848 | protection from non-homologous end joining at telomere(GO:0031848) |
0.7 | 6.3 | GO:0060712 | spongiotrophoblast layer development(GO:0060712) |
0.7 | 2.1 | GO:0000098 | sulfur amino acid catabolic process(GO:0000098) |
0.7 | 2.1 | GO:0031087 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
0.7 | 2.1 | GO:0045053 | protein retention in Golgi apparatus(GO:0045053) |
0.7 | 4.9 | GO:1990748 | cellular detoxification(GO:1990748) |
0.7 | 2.1 | GO:0006107 | oxaloacetate metabolic process(GO:0006107) |
0.7 | 3.5 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.7 | 1.4 | GO:0035927 | RNA import into mitochondrion(GO:0035927) |
0.7 | 0.7 | GO:0070813 | hydrogen sulfide metabolic process(GO:0070813) |
0.7 | 1.4 | GO:0000966 | RNA 5'-end processing(GO:0000966) |
0.7 | 3.5 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
0.7 | 20.8 | GO:0016126 | sterol biosynthetic process(GO:0016126) |
0.7 | 0.7 | GO:1901894 | regulation of calcium-transporting ATPase activity(GO:1901894) |
0.7 | 1.4 | GO:0036462 | TRAIL-activated apoptotic signaling pathway(GO:0036462) |
0.7 | 4.8 | GO:0045736 | negative regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045736) negative regulation of cyclin-dependent protein kinase activity(GO:1904030) |
0.7 | 0.7 | GO:0001698 | gastrin-induced gastric acid secretion(GO:0001698) |
0.7 | 3.5 | GO:0060612 | adipose tissue development(GO:0060612) |
0.7 | 4.8 | GO:0071636 | positive regulation of transforming growth factor beta production(GO:0071636) |
0.7 | 2.1 | GO:0008608 | attachment of spindle microtubules to kinetochore(GO:0008608) |
0.7 | 5.5 | GO:1904353 | regulation of telomere capping(GO:1904353) |
0.7 | 16.5 | GO:0006749 | glutathione metabolic process(GO:0006749) |
0.7 | 8.9 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
0.7 | 1.4 | GO:0044273 | sulfur compound catabolic process(GO:0044273) |
0.7 | 0.7 | GO:0009223 | pyrimidine deoxyribonucleotide catabolic process(GO:0009223) |
0.7 | 2.7 | GO:0030091 | protein repair(GO:0030091) |
0.7 | 0.7 | GO:0036151 | phosphatidylcholine acyl-chain remodeling(GO:0036151) |
0.7 | 0.7 | GO:0072600 | establishment of protein localization to Golgi(GO:0072600) |
0.7 | 4.1 | GO:0051881 | regulation of mitochondrial membrane potential(GO:0051881) |
0.7 | 0.7 | GO:0010940 | positive regulation of necrotic cell death(GO:0010940) |
0.7 | 1.4 | GO:0034196 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
0.7 | 1.4 | GO:0035622 | intrahepatic bile duct development(GO:0035622) |
0.7 | 6.1 | GO:0060707 | trophoblast giant cell differentiation(GO:0060707) |
0.7 | 4.1 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
0.7 | 4.0 | GO:0046415 | urate metabolic process(GO:0046415) |
0.7 | 3.4 | GO:0055059 | asymmetric neuroblast division(GO:0055059) |
0.7 | 2.7 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.7 | 1.3 | GO:0060099 | regulation of phagocytosis, engulfment(GO:0060099) |
0.7 | 2.0 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
0.7 | 2.7 | GO:0001514 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.7 | 4.7 | GO:0006110 | regulation of glycolytic process(GO:0006110) |
0.7 | 1.3 | GO:0034214 | protein hexamerization(GO:0034214) |
0.7 | 3.3 | GO:0000289 | nuclear-transcribed mRNA poly(A) tail shortening(GO:0000289) |
0.7 | 3.3 | GO:0032324 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
0.7 | 2.0 | GO:0010701 | positive regulation of norepinephrine secretion(GO:0010701) |
0.7 | 0.7 | GO:0006501 | C-terminal protein lipidation(GO:0006501) |
0.7 | 0.7 | GO:0039692 | single stranded viral RNA replication via double stranded DNA intermediate(GO:0039692) regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045091) |
0.7 | 0.7 | GO:0006624 | vacuolar protein processing(GO:0006624) |
0.7 | 2.6 | GO:0018211 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
0.7 | 3.3 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.7 | 0.7 | GO:0071921 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
0.7 | 0.7 | GO:0043276 | anoikis(GO:0043276) |
0.7 | 0.7 | GO:1902309 | negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
0.7 | 3.3 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
0.7 | 3.9 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.7 | 0.7 | GO:0002318 | myeloid progenitor cell differentiation(GO:0002318) |
0.7 | 0.7 | GO:0051665 | membrane raft localization(GO:0051665) |
0.7 | 0.7 | GO:0010642 | negative regulation of platelet-derived growth factor receptor signaling pathway(GO:0010642) |
0.7 | 3.9 | GO:0016266 | O-glycan processing(GO:0016266) |
0.7 | 3.3 | GO:0032048 | cardiolipin metabolic process(GO:0032048) |
0.7 | 14.4 | GO:0006506 | GPI anchor biosynthetic process(GO:0006506) |
0.7 | 3.3 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
0.7 | 2.0 | GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
0.7 | 1.3 | GO:0001923 | B-1 B cell differentiation(GO:0001923) |
0.7 | 3.3 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
0.6 | 1.3 | GO:0002829 | negative regulation of type 2 immune response(GO:0002829) |
0.6 | 5.8 | GO:0046825 | regulation of protein export from nucleus(GO:0046825) |
0.6 | 2.6 | GO:1904970 | brush border assembly(GO:1904970) |
0.6 | 1.3 | GO:0032474 | otolith morphogenesis(GO:0032474) |
0.6 | 1.3 | GO:0031268 | pseudopodium organization(GO:0031268) |
0.6 | 2.6 | GO:2000778 | positive regulation of interleukin-6 secretion(GO:2000778) |
0.6 | 3.2 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.6 | 0.6 | GO:0035962 | response to interleukin-13(GO:0035962) cellular response to interleukin-13(GO:0035963) |
0.6 | 3.2 | GO:0006266 | DNA ligation(GO:0006266) |
0.6 | 2.6 | GO:0043461 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
0.6 | 2.6 | GO:0032494 | response to peptidoglycan(GO:0032494) |
0.6 | 2.6 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
0.6 | 2.6 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
0.6 | 0.6 | GO:0019086 | late viral transcription(GO:0019086) |
0.6 | 1.3 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
0.6 | 3.2 | GO:0046130 | purine nucleoside catabolic process(GO:0006152) purine ribonucleoside catabolic process(GO:0046130) |
0.6 | 1.3 | GO:0014827 | intestine smooth muscle contraction(GO:0014827) |
0.6 | 1.3 | GO:0043923 | positive regulation by host of viral transcription(GO:0043923) |
0.6 | 1.9 | GO:0030219 | megakaryocyte differentiation(GO:0030219) |
0.6 | 6.4 | GO:0046500 | S-adenosylmethionine metabolic process(GO:0046500) |
0.6 | 0.6 | GO:0046718 | viral entry into host cell(GO:0046718) |
0.6 | 3.2 | GO:0052805 | histidine catabolic process(GO:0006548) imidazole-containing compound catabolic process(GO:0052805) |
0.6 | 1.3 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
0.6 | 3.1 | GO:0046218 | tryptophan catabolic process(GO:0006569) tryptophan catabolic process to kynurenine(GO:0019441) indole-containing compound catabolic process(GO:0042436) indolalkylamine catabolic process(GO:0046218) |
0.6 | 3.8 | GO:0097286 | iron ion import(GO:0097286) |
0.6 | 1.3 | GO:0031642 | negative regulation of myelination(GO:0031642) |
0.6 | 2.5 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
0.6 | 1.3 | GO:0009181 | purine nucleoside diphosphate catabolic process(GO:0009137) purine ribonucleoside diphosphate catabolic process(GO:0009181) |
0.6 | 1.9 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
0.6 | 1.9 | GO:0043654 | recognition of apoptotic cell(GO:0043654) |
0.6 | 27.0 | GO:0006633 | fatty acid biosynthetic process(GO:0006633) |
0.6 | 4.4 | GO:0010388 | cullin deneddylation(GO:0010388) |
0.6 | 0.6 | GO:0034695 | response to prostaglandin E(GO:0034695) |
0.6 | 1.9 | GO:0035635 | entry of bacterium into host cell(GO:0035635) regulation of entry of bacterium into host cell(GO:2000535) |
0.6 | 3.7 | GO:0002024 | diet induced thermogenesis(GO:0002024) adaptive thermogenesis(GO:1990845) |
0.6 | 0.6 | GO:1903525 | regulation of membrane tubulation(GO:1903525) |
0.6 | 1.2 | GO:0030214 | hyaluronan catabolic process(GO:0030214) |
0.6 | 1.2 | GO:0060315 | negative regulation of ryanodine-sensitive calcium-release channel activity(GO:0060315) |
0.6 | 1.2 | GO:0051000 | positive regulation of nitric-oxide synthase activity(GO:0051000) |
0.6 | 1.9 | GO:0051315 | attachment of mitotic spindle microtubules to kinetochore(GO:0051315) |
0.6 | 1.2 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
0.6 | 3.7 | GO:0032988 | ribonucleoprotein complex disassembly(GO:0032988) |
0.6 | 4.3 | GO:0010758 | regulation of macrophage chemotaxis(GO:0010758) |
0.6 | 2.5 | GO:0031468 | nuclear envelope reassembly(GO:0031468) |
0.6 | 1.2 | GO:0033762 | response to glucagon(GO:0033762) |
0.6 | 0.6 | GO:0021943 | formation of radial glial scaffolds(GO:0021943) |
0.6 | 0.6 | GO:0035435 | phosphate ion transmembrane transport(GO:0035435) |
0.6 | 3.7 | GO:0006103 | 2-oxoglutarate metabolic process(GO:0006103) |
0.6 | 0.6 | GO:0021747 | cochlear nucleus development(GO:0021747) |
0.6 | 0.6 | GO:1901970 | positive regulation of mitotic sister chromatid separation(GO:1901970) |
0.6 | 3.1 | GO:0035493 | SNARE complex assembly(GO:0035493) |
0.6 | 1.2 | GO:1900745 | positive regulation of p38MAPK cascade(GO:1900745) |
0.6 | 1.8 | GO:0051639 | actin filament network formation(GO:0051639) |
0.6 | 2.4 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
0.6 | 0.6 | GO:0090324 | negative regulation of oxidative phosphorylation(GO:0090324) regulation of mitochondrial electron transport, NADH to ubiquinone(GO:1902956) |
0.6 | 1.8 | GO:0031506 | cell wall mannoprotein biosynthetic process(GO:0000032) mannoprotein metabolic process(GO:0006056) mannoprotein biosynthetic process(GO:0006057) cell wall glycoprotein biosynthetic process(GO:0031506) cell wall biogenesis(GO:0042546) cell wall macromolecule biosynthetic process(GO:0044038) chain elongation of O-linked mannose residue(GO:0044845) cellular component macromolecule biosynthetic process(GO:0070589) |
0.6 | 6.7 | GO:0071622 | regulation of granulocyte chemotaxis(GO:0071622) |
0.6 | 7.9 | GO:0030866 | cortical actin cytoskeleton organization(GO:0030866) |
0.6 | 3.6 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
0.6 | 2.4 | GO:2000773 | negative regulation of cellular senescence(GO:2000773) |
0.6 | 3.0 | GO:0048702 | embryonic neurocranium morphogenesis(GO:0048702) |
0.6 | 0.6 | GO:0042525 | tyrosine phosphorylation of Stat6 protein(GO:0042505) regulation of tyrosine phosphorylation of Stat6 protein(GO:0042525) |
0.6 | 3.0 | GO:0009650 | UV protection(GO:0009650) |
0.6 | 4.2 | GO:0014823 | response to activity(GO:0014823) |
0.6 | 4.8 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
0.6 | 0.6 | GO:0060971 | embryonic heart tube left/right pattern formation(GO:0060971) |
0.6 | 1.2 | GO:0035983 | response to trichostatin A(GO:0035983) cellular response to trichostatin A(GO:0035984) |
0.6 | 3.0 | GO:0070265 | necrotic cell death(GO:0070265) |
0.6 | 1.8 | GO:0046167 | glycerol-3-phosphate biosynthetic process(GO:0046167) |
0.6 | 0.6 | GO:0009642 | response to light intensity(GO:0009642) |
0.6 | 2.4 | GO:1900153 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900151) positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900153) |
0.6 | 0.6 | GO:0097680 | double-strand break repair via classical nonhomologous end joining(GO:0097680) |
0.6 | 1.2 | GO:0050427 | 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
0.6 | 1.8 | GO:0006983 | ER overload response(GO:0006983) |
0.6 | 1.2 | GO:0010637 | negative regulation of mitochondrial fusion(GO:0010637) |
0.6 | 14.3 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
0.6 | 0.6 | GO:1900122 | positive regulation of receptor binding(GO:1900122) |
0.6 | 3.0 | GO:0048821 | erythrocyte development(GO:0048821) |
0.6 | 1.8 | GO:0031573 | intra-S DNA damage checkpoint(GO:0031573) |
0.6 | 1.2 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
0.6 | 0.6 | GO:0006244 | pyrimidine nucleotide catabolic process(GO:0006244) |
0.6 | 1.8 | GO:0000729 | DNA double-strand break processing(GO:0000729) |
0.6 | 5.3 | GO:0032435 | negative regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032435) |
0.6 | 1.2 | GO:0031666 | positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
0.6 | 12.4 | GO:0016575 | histone deacetylation(GO:0016575) |
0.6 | 2.9 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
0.6 | 1.8 | GO:0033262 | regulation of nuclear cell cycle DNA replication(GO:0033262) |
0.6 | 1.8 | GO:0042373 | vitamin K metabolic process(GO:0042373) |
0.6 | 7.0 | GO:1904031 | positive regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045737) positive regulation of cyclin-dependent protein kinase activity(GO:1904031) |
0.6 | 4.7 | GO:0035855 | megakaryocyte development(GO:0035855) |
0.6 | 4.1 | GO:0070269 | pyroptosis(GO:0070269) |
0.6 | 0.6 | GO:0002901 | mature B cell apoptotic process(GO:0002901) regulation of mature B cell apoptotic process(GO:0002905) negative regulation of mature B cell apoptotic process(GO:0002906) |
0.6 | 2.9 | GO:0051418 | interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
0.6 | 4.7 | GO:0006271 | DNA strand elongation involved in DNA replication(GO:0006271) |
0.6 | 1.7 | GO:0034393 | positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
0.6 | 1.2 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
0.6 | 2.9 | GO:0015919 | peroxisomal membrane transport(GO:0015919) protein import into peroxisome membrane(GO:0045046) |
0.6 | 1.7 | GO:0070586 | cell-cell adhesion involved in gastrulation(GO:0070586) |
0.6 | 0.6 | GO:0052200 | response to defenses of other organism involved in symbiotic interaction(GO:0052173) response to host defenses(GO:0052200) response to host(GO:0075136) |
0.6 | 0.6 | GO:0019048 | modulation by virus of host morphology or physiology(GO:0019048) |
0.6 | 0.6 | GO:0036023 | limb joint morphogenesis(GO:0036022) embryonic skeletal limb joint morphogenesis(GO:0036023) |
0.6 | 1.1 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
0.6 | 0.6 | GO:0002638 | negative regulation of immunoglobulin production(GO:0002638) |
0.6 | 4.0 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.6 | 0.6 | GO:0009133 | nucleoside diphosphate biosynthetic process(GO:0009133) |
0.6 | 0.6 | GO:0046533 | negative regulation of photoreceptor cell differentiation(GO:0046533) |
0.6 | 5.1 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
0.6 | 7.4 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.6 | 1.7 | GO:2000609 | regulation of thyroid hormone generation(GO:2000609) |
0.6 | 0.6 | GO:0031627 | telomeric loop formation(GO:0031627) |
0.6 | 3.4 | GO:0051292 | nuclear pore complex assembly(GO:0051292) |
0.6 | 5.1 | GO:0031648 | protein destabilization(GO:0031648) |
0.6 | 5.1 | GO:0014829 | vascular smooth muscle contraction(GO:0014829) |
0.6 | 6.2 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
0.6 | 1.7 | GO:0060055 | angiogenesis involved in wound healing(GO:0060055) |
0.6 | 0.6 | GO:0045003 | DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
0.6 | 4.5 | GO:0033209 | tumor necrosis factor-mediated signaling pathway(GO:0033209) |
0.6 | 5.0 | GO:1902750 | negative regulation of cell cycle G2/M phase transition(GO:1902750) |
0.6 | 10.0 | GO:0006611 | protein export from nucleus(GO:0006611) |
0.6 | 6.1 | GO:0007032 | endosome organization(GO:0007032) |
0.6 | 2.8 | GO:0000920 | cell separation after cytokinesis(GO:0000920) |
0.6 | 4.4 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
0.6 | 0.6 | GO:0016125 | sterol metabolic process(GO:0016125) |
0.6 | 2.2 | GO:0045792 | negative regulation of cell size(GO:0045792) |
0.6 | 2.8 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
0.6 | 2.2 | GO:0006541 | glutamine metabolic process(GO:0006541) |
0.5 | 3.3 | GO:0051642 | centrosome localization(GO:0051642) |
0.5 | 2.2 | GO:0035162 | embryonic hemopoiesis(GO:0035162) |
0.5 | 0.5 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
0.5 | 0.5 | GO:1901524 | regulation of macromitophagy(GO:1901524) negative regulation of macromitophagy(GO:1901525) negative regulation of mitophagy(GO:1903147) |
0.5 | 1.1 | GO:0071440 | regulation of histone H3-K14 acetylation(GO:0071440) |
0.5 | 1.1 | GO:0030210 | heparin biosynthetic process(GO:0030210) |
0.5 | 1.1 | GO:0006285 | base-excision repair, AP site formation(GO:0006285) |
0.5 | 3.3 | GO:0048305 | immunoglobulin secretion(GO:0048305) |
0.5 | 0.5 | GO:1902514 | regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1902514) |
0.5 | 2.2 | GO:0035455 | response to interferon-alpha(GO:0035455) |
0.5 | 0.5 | GO:2000097 | regulation of smooth muscle cell-matrix adhesion(GO:2000097) |
0.5 | 6.5 | GO:0010257 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.5 | 1.6 | GO:0035513 | oxidative RNA demethylation(GO:0035513) oxidative single-stranded RNA demethylation(GO:0035553) |
0.5 | 1.6 | GO:0010225 | response to UV-C(GO:0010225) |
0.5 | 2.2 | GO:0006526 | arginine biosynthetic process(GO:0006526) |
0.5 | 8.7 | GO:0034314 | Arp2/3 complex-mediated actin nucleation(GO:0034314) |
0.5 | 0.5 | GO:0032570 | response to progesterone(GO:0032570) |
0.5 | 1.6 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
0.5 | 1.1 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
0.5 | 1.1 | GO:0046087 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
0.5 | 1.6 | GO:0034243 | regulation of transcription elongation from RNA polymerase II promoter(GO:0034243) |
0.5 | 12.4 | GO:0006754 | ATP biosynthetic process(GO:0006754) |
0.5 | 1.1 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
0.5 | 5.9 | GO:0031069 | hair follicle morphogenesis(GO:0031069) |
0.5 | 1.6 | GO:0015705 | iodide transport(GO:0015705) |
0.5 | 0.5 | GO:0010742 | macrophage derived foam cell differentiation(GO:0010742) |
0.5 | 0.5 | GO:0043928 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay(GO:0043928) |
0.5 | 1.6 | GO:0010446 | response to alkaline pH(GO:0010446) |
0.5 | 8.5 | GO:0006376 | mRNA splice site selection(GO:0006376) |
0.5 | 2.6 | GO:0015012 | heparan sulfate proteoglycan biosynthetic process(GO:0015012) |
0.5 | 0.5 | GO:0032239 | regulation of nucleobase-containing compound transport(GO:0032239) regulation of RNA export from nucleus(GO:0046831) |
0.5 | 2.1 | GO:0042492 | gamma-delta T cell differentiation(GO:0042492) |
0.5 | 1.0 | GO:0010165 | response to X-ray(GO:0010165) |
0.5 | 1.6 | GO:0070127 | tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
0.5 | 7.3 | GO:0000002 | mitochondrial genome maintenance(GO:0000002) |
0.5 | 1.6 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.5 | 58.7 | GO:0006260 | DNA replication(GO:0006260) |
0.5 | 2.6 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.5 | 0.5 | GO:0045900 | negative regulation of translational elongation(GO:0045900) |
0.5 | 10.9 | GO:0007569 | cell aging(GO:0007569) |
0.5 | 2.1 | GO:1904666 | regulation of ubiquitin protein ligase activity(GO:1904666) positive regulation of ubiquitin protein ligase activity(GO:1904668) |
0.5 | 1.6 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.5 | 1.0 | GO:0045793 | positive regulation of cell size(GO:0045793) |
0.5 | 1.6 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
0.5 | 2.1 | GO:0039703 | viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
0.5 | 9.8 | GO:0048240 | sperm capacitation(GO:0048240) |
0.5 | 1.0 | GO:0010459 | negative regulation of heart rate(GO:0010459) |
0.5 | 2.1 | GO:0034114 | regulation of heterotypic cell-cell adhesion(GO:0034114) |
0.5 | 1.5 | GO:0006361 | transcription initiation from RNA polymerase I promoter(GO:0006361) |
0.5 | 3.1 | GO:0006517 | protein deglycosylation(GO:0006517) |
0.5 | 1.0 | GO:0019532 | oxalate transport(GO:0019532) |
0.5 | 1.0 | GO:0033632 | regulation of cell-cell adhesion mediated by integrin(GO:0033632) |
0.5 | 5.6 | GO:0032088 | negative regulation of NF-kappaB transcription factor activity(GO:0032088) |
0.5 | 4.1 | GO:0006896 | Golgi to vacuole transport(GO:0006896) |
0.5 | 3.6 | GO:0046835 | carbohydrate phosphorylation(GO:0046835) |
0.5 | 0.5 | GO:2000042 | negative regulation of double-strand break repair via homologous recombination(GO:2000042) |
0.5 | 3.0 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
0.5 | 0.5 | GO:0016139 | glycoside catabolic process(GO:0016139) |
0.5 | 7.1 | GO:0045670 | regulation of osteoclast differentiation(GO:0045670) |
0.5 | 1.0 | GO:0061304 | retinal blood vessel morphogenesis(GO:0061304) |
0.5 | 2.0 | GO:0080111 | DNA demethylation(GO:0080111) |
0.5 | 0.5 | GO:0010922 | positive regulation of phosphatase activity(GO:0010922) |
0.5 | 0.5 | GO:0072012 | glomerulus vasculature development(GO:0072012) |
0.5 | 1.0 | GO:0007227 | signal transduction downstream of smoothened(GO:0007227) |
0.5 | 0.5 | GO:0055070 | copper ion homeostasis(GO:0055070) |
0.5 | 0.5 | GO:0042992 | negative regulation of transcription factor import into nucleus(GO:0042992) |
0.5 | 1.5 | GO:0009597 | detection of virus(GO:0009597) |
0.5 | 0.5 | GO:0071034 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
0.5 | 0.5 | GO:0071670 | smooth muscle cell chemotaxis(GO:0071670) |
0.5 | 3.0 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.5 | 0.5 | GO:0044403 | symbiosis, encompassing mutualism through parasitism(GO:0044403) interspecies interaction between organisms(GO:0044419) |
0.5 | 2.5 | GO:0035871 | protein K11-linked deubiquitination(GO:0035871) |
0.5 | 0.5 | GO:0051549 | regulation of keratinocyte migration(GO:0051547) positive regulation of keratinocyte migration(GO:0051549) |
0.5 | 1.0 | GO:0032717 | negative regulation of interleukin-8 production(GO:0032717) |
0.5 | 14.8 | GO:0006635 | fatty acid beta-oxidation(GO:0006635) |
0.5 | 1.5 | GO:0034770 | histone H4-K20 methylation(GO:0034770) histone H4-K20 trimethylation(GO:0034773) |
0.5 | 3.9 | GO:0034063 | stress granule assembly(GO:0034063) |
0.5 | 6.9 | GO:0006829 | zinc II ion transport(GO:0006829) |
0.5 | 3.0 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.5 | 2.5 | GO:0006883 | cellular sodium ion homeostasis(GO:0006883) |
0.5 | 1.0 | GO:0034433 | steroid esterification(GO:0034433) sterol esterification(GO:0034434) cholesterol esterification(GO:0034435) |
0.5 | 14.2 | GO:0098840 | protein transport along microtubule(GO:0098840) |
0.5 | 0.5 | GO:0060486 | Clara cell differentiation(GO:0060486) |
0.5 | 2.4 | GO:0007031 | peroxisome organization(GO:0007031) |
0.5 | 0.5 | GO:2000144 | positive regulation of DNA-templated transcription, initiation(GO:2000144) |
0.5 | 2.9 | GO:1902236 | negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902236) |
0.5 | 1.5 | GO:0035372 | protein localization to microtubule(GO:0035372) |
0.5 | 3.4 | GO:0043949 | regulation of cAMP-mediated signaling(GO:0043949) |
0.5 | 16.5 | GO:0032434 | regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032434) |
0.5 | 1.9 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.5 | 1.0 | GO:0000460 | maturation of 5.8S rRNA(GO:0000460) |
0.5 | 1.5 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
0.5 | 0.5 | GO:0060236 | regulation of mitotic spindle organization(GO:0060236) regulation of spindle organization(GO:0090224) |
0.5 | 0.5 | GO:0071971 | extracellular exosome assembly(GO:0071971) |
0.5 | 1.9 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
0.5 | 3.4 | GO:0000079 | regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0000079) |
0.5 | 5.8 | GO:1903146 | regulation of mitophagy(GO:1903146) |
0.5 | 3.9 | GO:0035428 | hexose transmembrane transport(GO:0035428) |
0.5 | 3.4 | GO:1903205 | regulation of hydrogen peroxide-induced cell death(GO:1903205) |
0.5 | 3.4 | GO:0032515 | negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
0.5 | 0.5 | GO:0046039 | GTP metabolic process(GO:0046039) |
0.5 | 1.0 | GO:0009191 | ribonucleoside diphosphate catabolic process(GO:0009191) |
0.5 | 7.2 | GO:0007029 | endoplasmic reticulum organization(GO:0007029) |
0.5 | 1.0 | GO:1902809 | regulation of skeletal muscle fiber differentiation(GO:1902809) |
0.5 | 1.0 | GO:0051031 | tRNA transport(GO:0051031) |
0.5 | 0.5 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) |
0.5 | 7.2 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
0.5 | 0.5 | GO:0031125 | rRNA 3'-end processing(GO:0031125) |
0.5 | 0.5 | GO:0031034 | myosin filament assembly(GO:0031034) |
0.5 | 0.5 | GO:2000780 | negative regulation of DNA repair(GO:0045738) negative regulation of double-strand break repair(GO:2000780) |
0.5 | 0.5 | GO:1902186 | regulation of viral release from host cell(GO:1902186) |
0.5 | 0.5 | GO:0022417 | protein maturation by protein folding(GO:0022417) |
0.5 | 1.9 | GO:0045070 | positive regulation of viral genome replication(GO:0045070) |
0.5 | 1.4 | GO:0045618 | positive regulation of keratinocyte differentiation(GO:0045618) |
0.5 | 2.8 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.5 | 4.2 | GO:0045672 | positive regulation of osteoclast differentiation(GO:0045672) |
0.5 | 0.5 | GO:0030007 | cellular potassium ion homeostasis(GO:0030007) |
0.5 | 4.2 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
0.5 | 1.4 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
0.5 | 0.5 | GO:0002031 | G-protein coupled receptor internalization(GO:0002031) |
0.5 | 7.0 | GO:0051693 | actin filament capping(GO:0051693) |
0.5 | 1.9 | GO:0060372 | regulation of atrial cardiac muscle cell membrane repolarization(GO:0060372) atrial cardiac muscle cell membrane repolarization(GO:0099624) |
0.5 | 4.6 | GO:0001675 | acrosome assembly(GO:0001675) |
0.5 | 0.9 | GO:0050858 | negative regulation of antigen receptor-mediated signaling pathway(GO:0050858) |
0.5 | 0.9 | GO:0006368 | transcription elongation from RNA polymerase II promoter(GO:0006368) |
0.5 | 2.8 | GO:0061462 | protein localization to lysosome(GO:0061462) |
0.5 | 15.6 | GO:0031338 | regulation of vesicle fusion(GO:0031338) |
0.5 | 2.3 | GO:0003299 | muscle hypertrophy in response to stress(GO:0003299) cardiac muscle adaptation(GO:0014887) cardiac muscle hypertrophy in response to stress(GO:0014898) |
0.5 | 1.4 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.5 | 1.4 | GO:0061013 | regulation of mRNA catabolic process(GO:0061013) |
0.5 | 0.9 | GO:0035357 | peroxisome proliferator activated receptor signaling pathway(GO:0035357) |
0.5 | 2.3 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
0.5 | 0.5 | GO:0072718 | response to cisplatin(GO:0072718) |
0.5 | 1.8 | GO:0016075 | rRNA catabolic process(GO:0016075) |
0.5 | 2.7 | GO:0072527 | pyrimidine-containing compound metabolic process(GO:0072527) |
0.5 | 0.9 | GO:1903363 | negative regulation of cellular protein catabolic process(GO:1903363) |
0.5 | 0.9 | GO:0070102 | interleukin-6-mediated signaling pathway(GO:0070102) |
0.5 | 1.8 | GO:1904293 | negative regulation of protein exit from endoplasmic reticulum(GO:0070862) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) negative regulation of ERAD pathway(GO:1904293) |
0.4 | 1.3 | GO:0019388 | galactose catabolic process(GO:0019388) |
0.4 | 7.2 | GO:0071277 | cellular response to calcium ion(GO:0071277) |
0.4 | 1.8 | GO:0051127 | regulation of actin nucleation(GO:0051125) positive regulation of actin nucleation(GO:0051127) |
0.4 | 0.4 | GO:0006586 | tryptophan metabolic process(GO:0006568) indolalkylamine metabolic process(GO:0006586) |
0.4 | 3.1 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
0.4 | 1.3 | GO:0015074 | DNA integration(GO:0015074) |
0.4 | 2.2 | GO:0014911 | positive regulation of smooth muscle cell migration(GO:0014911) |
0.4 | 12.0 | GO:0000724 | double-strand break repair via homologous recombination(GO:0000724) recombinational repair(GO:0000725) |
0.4 | 0.9 | GO:0015755 | fructose transport(GO:0015755) |
0.4 | 6.6 | GO:1901998 | toxin transport(GO:1901998) |
0.4 | 0.9 | GO:0006278 | RNA-dependent DNA biosynthetic process(GO:0006278) telomere maintenance via telomerase(GO:0007004) |
0.4 | 0.4 | GO:0046666 | retinal cell programmed cell death(GO:0046666) |
0.4 | 1.3 | GO:0090151 | establishment of protein localization to mitochondrial membrane(GO:0090151) |
0.4 | 2.6 | GO:0036473 | cell death in response to oxidative stress(GO:0036473) |
0.4 | 7.0 | GO:0071806 | intracellular protein transmembrane transport(GO:0065002) protein transmembrane transport(GO:0071806) |
0.4 | 1.3 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
0.4 | 3.1 | GO:0006353 | DNA-templated transcription, termination(GO:0006353) |
0.4 | 7.9 | GO:0043966 | histone H3 acetylation(GO:0043966) |
0.4 | 1.3 | GO:0060244 | negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
0.4 | 1.3 | GO:1901387 | positive regulation of voltage-gated calcium channel activity(GO:1901387) |
0.4 | 2.6 | GO:0071549 | response to dexamethasone(GO:0071548) cellular response to dexamethasone stimulus(GO:0071549) |
0.4 | 0.9 | GO:0048246 | macrophage chemotaxis(GO:0048246) |
0.4 | 1.3 | GO:0042036 | negative regulation of cytokine biosynthetic process(GO:0042036) |
0.4 | 0.4 | GO:0086042 | cardiac muscle cell-cardiac muscle cell adhesion(GO:0086042) |
0.4 | 1.7 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
0.4 | 1.3 | GO:0006004 | fucose metabolic process(GO:0006004) |
0.4 | 1.3 | GO:0008655 | pyrimidine-containing compound salvage(GO:0008655) pyrimidine nucleoside salvage(GO:0043097) |
0.4 | 5.1 | GO:0000266 | mitochondrial fission(GO:0000266) |
0.4 | 1.3 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.4 | 4.3 | GO:0007249 | I-kappaB kinase/NF-kappaB signaling(GO:0007249) |
0.4 | 1.3 | GO:0035608 | protein deglutamylation(GO:0035608) |
0.4 | 0.8 | GO:0060087 | relaxation of vascular smooth muscle(GO:0060087) |
0.4 | 2.1 | GO:1904037 | positive regulation of epithelial cell apoptotic process(GO:1904037) |
0.4 | 10.5 | GO:0051225 | spindle assembly(GO:0051225) |
0.4 | 5.0 | GO:0046856 | phosphatidylinositol dephosphorylation(GO:0046856) |
0.4 | 1.3 | GO:0034728 | nucleosome organization(GO:0034728) |
0.4 | 0.8 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
0.4 | 2.1 | GO:0030575 | nuclear body organization(GO:0030575) |
0.4 | 4.2 | GO:0070306 | lens fiber cell differentiation(GO:0070306) |
0.4 | 1.3 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
0.4 | 5.8 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
0.4 | 1.2 | GO:0014041 | regulation of neuron maturation(GO:0014041) |
0.4 | 0.8 | GO:0051984 | positive regulation of chromosome segregation(GO:0051984) |
0.4 | 7.1 | GO:0051592 | response to calcium ion(GO:0051592) |
0.4 | 0.8 | GO:0090201 | negative regulation of release of cytochrome c from mitochondria(GO:0090201) |
0.4 | 0.4 | GO:2000767 | positive regulation of cytoplasmic translation(GO:2000767) |
0.4 | 0.4 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
0.4 | 1.7 | GO:0009146 | purine nucleoside triphosphate catabolic process(GO:0009146) |
0.4 | 0.8 | GO:0048525 | negative regulation of viral process(GO:0048525) |
0.4 | 2.0 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.4 | 1.6 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.4 | 1.2 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
0.4 | 15.9 | GO:0016579 | protein deubiquitination(GO:0016579) |
0.4 | 4.9 | GO:0006099 | tricarboxylic acid cycle(GO:0006099) |
0.4 | 2.0 | GO:1901799 | negative regulation of proteasomal protein catabolic process(GO:1901799) |
0.4 | 1.6 | GO:0010611 | regulation of cardiac muscle hypertrophy(GO:0010611) |
0.4 | 2.0 | GO:0006857 | oligopeptide transport(GO:0006857) |
0.4 | 10.9 | GO:0006418 | tRNA aminoacylation for protein translation(GO:0006418) |
0.4 | 0.8 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
0.4 | 2.0 | GO:0009225 | nucleotide-sugar metabolic process(GO:0009225) |
0.4 | 0.4 | GO:0034035 | purine ribonucleoside bisphosphate metabolic process(GO:0034035) |
0.4 | 0.4 | GO:0007000 | nucleolus organization(GO:0007000) |
0.4 | 2.4 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.4 | 1.6 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
0.4 | 8.0 | GO:0061077 | chaperone-mediated protein folding(GO:0061077) |
0.4 | 2.0 | GO:0006183 | GTP biosynthetic process(GO:0006183) UTP biosynthetic process(GO:0006228) |
0.4 | 1.6 | GO:0000956 | nuclear-transcribed mRNA catabolic process(GO:0000956) |
0.4 | 0.8 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
0.4 | 0.4 | GO:0045898 | regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045898) |
0.4 | 8.7 | GO:0030218 | erythrocyte differentiation(GO:0030218) |
0.4 | 0.8 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
0.4 | 1.6 | GO:0045639 | positive regulation of myeloid cell differentiation(GO:0045639) |
0.4 | 0.8 | GO:0033363 | secretory granule organization(GO:0033363) |
0.4 | 0.4 | GO:0032439 | endosome localization(GO:0032439) |
0.4 | 0.8 | GO:0033631 | cell-cell adhesion mediated by integrin(GO:0033631) |
0.4 | 0.8 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
0.4 | 0.8 | GO:0001865 | NK T cell differentiation(GO:0001865) |
0.4 | 0.8 | GO:1990036 | calcium ion import into sarcoplasmic reticulum(GO:1990036) |
0.4 | 0.4 | GO:0002576 | platelet degranulation(GO:0002576) |
0.4 | 0.4 | GO:0045986 | negative regulation of smooth muscle contraction(GO:0045986) |
0.4 | 1.6 | GO:0016188 | synaptic vesicle maturation(GO:0016188) |
0.4 | 1.2 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
0.4 | 0.8 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
0.4 | 1.2 | GO:0048242 | epinephrine secretion(GO:0048242) |
0.4 | 0.4 | GO:0051181 | cofactor transport(GO:0051181) |
0.4 | 15.7 | GO:0051028 | mRNA transport(GO:0051028) |
0.4 | 0.4 | GO:0036119 | response to platelet-derived growth factor(GO:0036119) |
0.4 | 1.9 | GO:0000726 | non-recombinational repair(GO:0000726) |
0.4 | 0.4 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
0.4 | 0.4 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
0.4 | 3.4 | GO:0042574 | retinal metabolic process(GO:0042574) |
0.4 | 0.8 | GO:0007584 | response to nutrient(GO:0007584) |
0.4 | 1.5 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.4 | 0.8 | GO:0035898 | parathyroid hormone secretion(GO:0035898) |
0.4 | 0.4 | GO:2000637 | positive regulation of posttranscriptional gene silencing(GO:0060148) positive regulation of gene silencing by miRNA(GO:2000637) |
0.4 | 1.9 | GO:0030947 | regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030947) |
0.4 | 3.4 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
0.4 | 1.9 | GO:0030261 | chromosome condensation(GO:0030261) |
0.4 | 1.9 | GO:0006388 | tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
0.4 | 0.7 | GO:0071236 | cellular response to antibiotic(GO:0071236) |
0.4 | 1.1 | GO:0051053 | negative regulation of DNA metabolic process(GO:0051053) |
0.4 | 3.0 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
0.4 | 0.7 | GO:0006907 | pinocytosis(GO:0006907) |
0.4 | 2.2 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
0.4 | 0.4 | GO:0033085 | negative regulation of T cell differentiation in thymus(GO:0033085) |
0.4 | 1.5 | GO:0006621 | protein retention in ER lumen(GO:0006621) maintenance of protein localization in endoplasmic reticulum(GO:0035437) |
0.4 | 0.4 | GO:0032252 | secretory granule localization(GO:0032252) |
0.4 | 0.4 | GO:0019336 | phenol-containing compound catabolic process(GO:0019336) |
0.4 | 2.2 | GO:0016114 | terpenoid biosynthetic process(GO:0016114) |
0.4 | 2.9 | GO:0048008 | platelet-derived growth factor receptor signaling pathway(GO:0048008) |
0.4 | 1.5 | GO:0002566 | somatic diversification of immune receptors via somatic mutation(GO:0002566) |
0.4 | 1.5 | GO:0051304 | chromosome separation(GO:0051304) |
0.4 | 1.8 | GO:0001893 | maternal placenta development(GO:0001893) |
0.4 | 3.3 | GO:0036159 | inner dynein arm assembly(GO:0036159) |
0.4 | 1.1 | GO:0044804 | nucleophagy(GO:0044804) |
0.4 | 1.5 | GO:0030836 | positive regulation of actin filament depolymerization(GO:0030836) |
0.4 | 2.2 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.4 | 2.2 | GO:0001937 | negative regulation of endothelial cell proliferation(GO:0001937) |
0.4 | 1.1 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
0.4 | 1.4 | GO:0001712 | ectodermal cell fate commitment(GO:0001712) |
0.4 | 2.1 | GO:0006968 | cellular defense response(GO:0006968) |
0.4 | 0.4 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
0.4 | 5.6 | GO:2001238 | positive regulation of extrinsic apoptotic signaling pathway(GO:2001238) |
0.4 | 0.4 | GO:2000010 | positive regulation of protein localization to cell surface(GO:2000010) |
0.4 | 0.7 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
0.3 | 3.1 | GO:0016925 | protein sumoylation(GO:0016925) |
0.3 | 2.4 | GO:0009303 | rRNA transcription(GO:0009303) |
0.3 | 6.2 | GO:0051865 | protein autoubiquitination(GO:0051865) |
0.3 | 0.3 | GO:1901031 | regulation of response to reactive oxygen species(GO:1901031) |
0.3 | 4.5 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.3 | 0.7 | GO:0030889 | negative regulation of B cell proliferation(GO:0030889) |
0.3 | 10.7 | GO:1902652 | secondary alcohol metabolic process(GO:1902652) |
0.3 | 2.7 | GO:0019884 | antigen processing and presentation of exogenous antigen(GO:0019884) |
0.3 | 1.0 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
0.3 | 3.8 | GO:0006289 | nucleotide-excision repair(GO:0006289) |
0.3 | 0.7 | GO:2001214 | positive regulation of vasculogenesis(GO:2001214) |
0.3 | 0.7 | GO:0031440 | regulation of mRNA 3'-end processing(GO:0031440) |
0.3 | 1.0 | GO:0048012 | hepatocyte growth factor receptor signaling pathway(GO:0048012) |
0.3 | 0.7 | GO:0007296 | vitellogenesis(GO:0007296) |
0.3 | 1.7 | GO:0040033 | negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
0.3 | 1.4 | GO:0036124 | histone H3-K9 trimethylation(GO:0036124) |
0.3 | 0.3 | GO:0006415 | translational termination(GO:0006415) |
0.3 | 0.3 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
0.3 | 1.4 | GO:0090199 | regulation of release of cytochrome c from mitochondria(GO:0090199) |
0.3 | 2.0 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
0.3 | 0.7 | GO:0060988 | lipid tube assembly(GO:0060988) |
0.3 | 2.4 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
0.3 | 1.7 | GO:0006706 | steroid catabolic process(GO:0006706) |
0.3 | 0.3 | GO:0000305 | response to oxygen radical(GO:0000305) |
0.3 | 1.0 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
0.3 | 4.7 | GO:0007130 | synaptonemal complex assembly(GO:0007130) |
0.3 | 1.3 | GO:0051014 | actin filament severing(GO:0051014) |
0.3 | 0.3 | GO:0045342 | MHC class II biosynthetic process(GO:0045342) |
0.3 | 1.7 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.3 | 0.3 | GO:0009074 | aromatic amino acid family catabolic process(GO:0009074) |
0.3 | 12.9 | GO:0019882 | antigen processing and presentation(GO:0019882) |
0.3 | 5.6 | GO:1903845 | negative regulation of transforming growth factor beta receptor signaling pathway(GO:0030512) negative regulation of cellular response to transforming growth factor beta stimulus(GO:1903845) |
0.3 | 2.6 | GO:1901186 | positive regulation of ERBB signaling pathway(GO:1901186) |
0.3 | 1.0 | GO:2000628 | regulation of miRNA metabolic process(GO:2000628) |
0.3 | 1.3 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
0.3 | 2.0 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
0.3 | 1.6 | GO:0061003 | positive regulation of dendritic spine morphogenesis(GO:0061003) |
0.3 | 1.0 | GO:0000963 | mitochondrial RNA processing(GO:0000963) |
0.3 | 8.2 | GO:0006986 | response to unfolded protein(GO:0006986) |
0.3 | 1.0 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
0.3 | 0.3 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.3 | 1.0 | GO:0051769 | nitric-oxide synthase biosynthetic process(GO:0051767) regulation of nitric-oxide synthase biosynthetic process(GO:0051769) |
0.3 | 3.3 | GO:0000154 | rRNA modification(GO:0000154) |
0.3 | 1.3 | GO:0034227 | tRNA thio-modification(GO:0034227) |
0.3 | 1.3 | GO:0070475 | rRNA base methylation(GO:0070475) |
0.3 | 4.5 | GO:0016032 | viral process(GO:0016032) |
0.3 | 0.6 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.3 | 2.2 | GO:1903077 | negative regulation of protein localization to plasma membrane(GO:1903077) negative regulation of protein localization to cell periphery(GO:1904376) |
0.3 | 0.3 | GO:0042998 | positive regulation of Golgi to plasma membrane protein transport(GO:0042998) |
0.3 | 0.3 | GO:1902916 | positive regulation of protein polyubiquitination(GO:1902916) |
0.3 | 1.0 | GO:0061469 | regulation of type B pancreatic cell proliferation(GO:0061469) |
0.3 | 49.4 | GO:0016567 | protein ubiquitination(GO:0016567) |
0.3 | 1.0 | GO:0060575 | intestinal epithelial cell differentiation(GO:0060575) |
0.3 | 0.6 | GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
0.3 | 1.6 | GO:0034453 | microtubule anchoring(GO:0034453) |
0.3 | 4.8 | GO:0030488 | tRNA methylation(GO:0030488) |
0.3 | 1.0 | GO:0042135 | neurotransmitter catabolic process(GO:0042135) |
0.3 | 0.6 | GO:0051156 | glucose 6-phosphate metabolic process(GO:0051156) |
0.3 | 0.9 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
0.3 | 0.6 | GO:0044872 | lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
0.3 | 0.9 | GO:0097211 | response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
0.3 | 1.3 | GO:0033081 | regulation of T cell differentiation in thymus(GO:0033081) regulation of thymocyte aggregation(GO:2000398) |
0.3 | 0.6 | GO:0019068 | virion assembly(GO:0019068) |
0.3 | 1.3 | GO:0042780 | tRNA 3'-end processing(GO:0042780) |
0.3 | 2.2 | GO:0009142 | nucleoside triphosphate biosynthetic process(GO:0009142) |
0.3 | 0.3 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
0.3 | 8.4 | GO:0031424 | keratinization(GO:0031424) |
0.3 | 0.3 | GO:0022007 | neural plate elongation(GO:0014022) convergent extension involved in neural plate elongation(GO:0022007) |
0.3 | 0.9 | GO:0043031 | negative regulation of macrophage activation(GO:0043031) |
0.3 | 2.1 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.3 | 0.3 | GO:0090026 | positive regulation of monocyte chemotaxis(GO:0090026) |
0.3 | 1.5 | GO:0015825 | L-serine transport(GO:0015825) |
0.3 | 0.6 | GO:0045824 | negative regulation of innate immune response(GO:0045824) |
0.3 | 1.2 | GO:0046909 | intermembrane transport(GO:0046909) |
0.3 | 0.6 | GO:0006071 | glycerol metabolic process(GO:0006071) |
0.3 | 8.4 | GO:0007030 | Golgi organization(GO:0007030) |
0.3 | 1.2 | GO:0017183 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.3 | 0.3 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.3 | 0.3 | GO:0043330 | response to exogenous dsRNA(GO:0043330) |
0.3 | 1.2 | GO:0009404 | toxin metabolic process(GO:0009404) |
0.3 | 8.9 | GO:0033139 | regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033139) positive regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033141) |
0.3 | 0.6 | GO:0007468 | regulation of rhodopsin gene expression(GO:0007468) |
0.3 | 0.6 | GO:1901874 | regulation of post-translational protein modification(GO:1901873) negative regulation of post-translational protein modification(GO:1901874) |
0.3 | 2.7 | GO:0038083 | peptidyl-tyrosine autophosphorylation(GO:0038083) |
0.3 | 0.3 | GO:2000169 | regulation of peptidyl-cysteine S-nitrosylation(GO:2000169) |
0.3 | 1.5 | GO:0043248 | proteasome assembly(GO:0043248) |
0.3 | 1.8 | GO:0032743 | positive regulation of interleukin-2 production(GO:0032743) |
0.3 | 1.5 | GO:0015732 | prostaglandin transport(GO:0015732) |
0.3 | 0.3 | GO:0009826 | unidimensional cell growth(GO:0009826) |
0.3 | 5.2 | GO:0000470 | maturation of LSU-rRNA(GO:0000470) |
0.3 | 4.9 | GO:0043632 | modification-dependent macromolecule catabolic process(GO:0043632) |
0.3 | 0.9 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.3 | 1.2 | GO:0010884 | positive regulation of lipid storage(GO:0010884) |
0.3 | 7.0 | GO:0051453 | regulation of intracellular pH(GO:0051453) |
0.3 | 0.6 | GO:0065005 | protein-lipid complex assembly(GO:0065005) |
0.3 | 0.6 | GO:0022401 | desensitization of G-protein coupled receptor protein signaling pathway(GO:0002029) negative adaptation of signaling pathway(GO:0022401) |
0.3 | 0.9 | GO:0075522 | IRES-dependent viral translational initiation(GO:0075522) |
0.3 | 0.3 | GO:0071028 | nuclear RNA surveillance(GO:0071027) nuclear mRNA surveillance(GO:0071028) |
0.3 | 0.6 | GO:1902031 | regulation of NADP metabolic process(GO:1902031) |
0.3 | 0.6 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.3 | 2.8 | GO:0030838 | positive regulation of actin filament polymerization(GO:0030838) |
0.3 | 0.3 | GO:0046633 | alpha-beta T cell proliferation(GO:0046633) |
0.3 | 0.3 | GO:0033685 | negative regulation of luteinizing hormone secretion(GO:0033685) |
0.3 | 14.4 | GO:0008033 | tRNA processing(GO:0008033) |
0.3 | 8.7 | GO:0042273 | ribosomal large subunit biogenesis(GO:0042273) |
0.3 | 3.4 | GO:0006893 | Golgi to plasma membrane transport(GO:0006893) |
0.3 | 0.6 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.3 | 0.6 | GO:0016137 | glycoside metabolic process(GO:0016137) |
0.3 | 2.0 | GO:0051310 | metaphase plate congression(GO:0051310) |
0.3 | 3.6 | GO:0009395 | phospholipid catabolic process(GO:0009395) |
0.3 | 0.8 | GO:0002002 | regulation of angiotensin levels in blood(GO:0002002) |
0.3 | 1.1 | GO:0052646 | alditol phosphate metabolic process(GO:0052646) |
0.3 | 7.1 | GO:0071391 | cellular response to estrogen stimulus(GO:0071391) |
0.3 | 0.8 | GO:0070986 | left/right axis specification(GO:0070986) |
0.3 | 0.3 | GO:0070459 | prolactin secretion(GO:0070459) |
0.3 | 7.9 | GO:0043161 | proteasome-mediated ubiquitin-dependent protein catabolic process(GO:0043161) |
0.3 | 1.4 | GO:0045945 | positive regulation of transcription from RNA polymerase III promoter(GO:0045945) |
0.3 | 0.3 | GO:0009134 | nucleoside diphosphate catabolic process(GO:0009134) |
0.3 | 1.6 | GO:1901264 | carbohydrate derivative transport(GO:1901264) |
0.3 | 0.3 | GO:1900378 | positive regulation of melanin biosynthetic process(GO:0048023) positive regulation of secondary metabolite biosynthetic process(GO:1900378) |
0.3 | 1.9 | GO:0033599 | regulation of mammary gland epithelial cell proliferation(GO:0033599) |
0.3 | 1.3 | GO:0042448 | progesterone metabolic process(GO:0042448) |
0.3 | 2.9 | GO:0043171 | peptide catabolic process(GO:0043171) |
0.3 | 0.3 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
0.3 | 1.6 | GO:0030042 | actin filament depolymerization(GO:0030042) |
0.3 | 0.8 | GO:0018243 | protein O-linked glycosylation via threonine(GO:0018243) |
0.3 | 0.8 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
0.3 | 20.7 | GO:0051607 | defense response to virus(GO:0051607) |
0.3 | 0.3 | GO:0002326 | B cell lineage commitment(GO:0002326) |
0.3 | 0.8 | GO:0009299 | mRNA transcription(GO:0009299) |
0.3 | 0.3 | GO:0006760 | folic acid-containing compound metabolic process(GO:0006760) |
0.3 | 0.5 | GO:0072672 | neutrophil extravasation(GO:0072672) |
0.3 | 5.9 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
0.3 | 0.5 | GO:1901620 | regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901620) |
0.3 | 0.3 | GO:2001022 | positive regulation of response to DNA damage stimulus(GO:2001022) |
0.3 | 5.1 | GO:0042147 | retrograde transport, endosome to Golgi(GO:0042147) |
0.3 | 2.0 | GO:0006302 | double-strand break repair(GO:0006302) |
0.3 | 1.5 | GO:0033344 | cholesterol efflux(GO:0033344) |
0.3 | 1.3 | GO:0050832 | defense response to fungus(GO:0050832) |
0.3 | 2.5 | GO:0010212 | response to ionizing radiation(GO:0010212) |
0.3 | 0.8 | GO:0042255 | ribosome assembly(GO:0042255) |
0.3 | 2.8 | GO:0030239 | myofibril assembly(GO:0030239) |
0.3 | 1.0 | GO:0071557 | histone H3-K27 demethylation(GO:0071557) |
0.3 | 0.3 | GO:0071824 | protein-DNA complex subunit organization(GO:0071824) |
0.3 | 0.3 | GO:0009445 | putrescine metabolic process(GO:0009445) |
0.3 | 2.0 | GO:0055088 | lipid homeostasis(GO:0055088) |
0.2 | 0.2 | GO:0034088 | maintenance of sister chromatid cohesion(GO:0034086) maintenance of mitotic sister chromatid cohesion(GO:0034088) |
0.2 | 0.5 | GO:2000659 | regulation of interleukin-1-mediated signaling pathway(GO:2000659) |
0.2 | 1.2 | GO:0008340 | determination of adult lifespan(GO:0008340) |
0.2 | 0.2 | GO:0071044 | histone mRNA catabolic process(GO:0071044) |
0.2 | 1.0 | GO:0010719 | negative regulation of epithelial to mesenchymal transition(GO:0010719) |
0.2 | 0.5 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
0.2 | 1.5 | GO:0060576 | intestinal epithelial cell development(GO:0060576) |
0.2 | 1.5 | GO:0009060 | aerobic respiration(GO:0009060) |
0.2 | 0.7 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) |
0.2 | 0.7 | GO:0071468 | cellular response to acidic pH(GO:0071468) |
0.2 | 1.2 | GO:0018023 | peptidyl-lysine trimethylation(GO:0018023) |
0.2 | 0.2 | GO:0045923 | positive regulation of fatty acid metabolic process(GO:0045923) |
0.2 | 1.2 | GO:0007379 | segment specification(GO:0007379) |
0.2 | 0.7 | GO:0045815 | positive regulation of gene expression, epigenetic(GO:0045815) |
0.2 | 1.0 | GO:0002227 | innate immune response in mucosa(GO:0002227) |
0.2 | 3.4 | GO:0050819 | negative regulation of coagulation(GO:0050819) |
0.2 | 0.2 | GO:0002643 | regulation of tolerance induction(GO:0002643) |
0.2 | 1.9 | GO:0014066 | regulation of phosphatidylinositol 3-kinase signaling(GO:0014066) |
0.2 | 0.5 | GO:0032099 | negative regulation of appetite(GO:0032099) |
0.2 | 3.8 | GO:0008625 | extrinsic apoptotic signaling pathway via death domain receptors(GO:0008625) |
0.2 | 1.0 | GO:0003084 | positive regulation of systemic arterial blood pressure(GO:0003084) |
0.2 | 0.5 | GO:0002215 | defense response to nematode(GO:0002215) |
0.2 | 0.2 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
0.2 | 6.4 | GO:0032543 | mitochondrial translation(GO:0032543) |
0.2 | 1.2 | GO:0034308 | primary alcohol metabolic process(GO:0034308) |
0.2 | 0.5 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.2 | 1.2 | GO:0042407 | cristae formation(GO:0042407) |
0.2 | 2.1 | GO:0015936 | coenzyme A metabolic process(GO:0015936) |
0.2 | 1.9 | GO:0008333 | endosome to lysosome transport(GO:0008333) |
0.2 | 0.7 | GO:2001260 | regulation of semaphorin-plexin signaling pathway(GO:2001260) |
0.2 | 0.2 | GO:0042090 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
0.2 | 0.7 | GO:0044346 | fibroblast apoptotic process(GO:0044346) |
0.2 | 0.2 | GO:0070669 | response to interleukin-2(GO:0070669) |
0.2 | 0.5 | GO:0006693 | prostanoid metabolic process(GO:0006692) prostaglandin metabolic process(GO:0006693) |
0.2 | 0.7 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
0.2 | 0.7 | GO:0018101 | protein citrullination(GO:0018101) |
0.2 | 0.5 | GO:2000505 | regulation of energy homeostasis(GO:2000505) |
0.2 | 10.7 | GO:0007599 | hemostasis(GO:0007599) |
0.2 | 1.8 | GO:0046916 | cellular transition metal ion homeostasis(GO:0046916) |
0.2 | 3.8 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.2 | 0.2 | GO:1902260 | negative regulation of delayed rectifier potassium channel activity(GO:1902260) negative regulation of voltage-gated potassium channel activity(GO:1903817) |
0.2 | 0.2 | GO:0002378 | immunoglobulin biosynthetic process(GO:0002378) |
0.2 | 1.1 | GO:0006509 | membrane protein ectodomain proteolysis(GO:0006509) |
0.2 | 1.3 | GO:1901739 | regulation of myoblast fusion(GO:1901739) positive regulation of myoblast fusion(GO:1901741) |
0.2 | 2.0 | GO:0006743 | ubiquinone metabolic process(GO:0006743) ubiquinone biosynthetic process(GO:0006744) quinone biosynthetic process(GO:1901663) |
0.2 | 6.2 | GO:0030490 | maturation of SSU-rRNA(GO:0030490) |
0.2 | 3.1 | GO:0008154 | actin polymerization or depolymerization(GO:0008154) |
0.2 | 1.7 | GO:0006030 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
0.2 | 0.2 | GO:0060312 | regulation of blood vessel remodeling(GO:0060312) |
0.2 | 0.2 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
0.2 | 0.6 | GO:0019321 | pentose metabolic process(GO:0019321) |
0.2 | 0.2 | GO:0019530 | taurine metabolic process(GO:0019530) |
0.2 | 0.4 | GO:0006911 | phagocytosis, engulfment(GO:0006911) |
0.2 | 0.2 | GO:0070255 | regulation of mucus secretion(GO:0070255) |
0.2 | 0.4 | GO:0045056 | transcytosis(GO:0045056) |
0.2 | 0.2 | GO:0009624 | response to nematode(GO:0009624) |
0.2 | 0.2 | GO:0086103 | G-protein coupled receptor signaling pathway involved in heart process(GO:0086103) |
0.2 | 0.2 | GO:0051029 | rRNA transport(GO:0051029) |
0.2 | 0.4 | GO:0008299 | isoprenoid biosynthetic process(GO:0008299) |
0.2 | 4.3 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
0.2 | 0.2 | GO:0097284 | hepatocyte apoptotic process(GO:0097284) |
0.2 | 0.2 | GO:0036260 | 7-methylguanosine RNA capping(GO:0009452) RNA capping(GO:0036260) |
0.2 | 0.6 | GO:0015808 | L-alanine transport(GO:0015808) |
0.2 | 5.1 | GO:0016072 | rRNA metabolic process(GO:0016072) |
0.2 | 0.2 | GO:0002248 | wound healing involved in inflammatory response(GO:0002246) connective tissue replacement involved in inflammatory response wound healing(GO:0002248) inflammatory response to wounding(GO:0090594) connective tissue replacement(GO:0097709) |
0.2 | 0.2 | GO:0006553 | lysine metabolic process(GO:0006553) |
0.2 | 0.6 | GO:0044144 | regulation of growth of symbiont in host(GO:0044126) modulation of growth of symbiont involved in interaction with host(GO:0044144) |
0.2 | 0.2 | GO:0006600 | creatine metabolic process(GO:0006600) |
0.2 | 0.4 | GO:0046069 | cGMP catabolic process(GO:0046069) |
0.2 | 0.6 | GO:1902047 | polyamine transport(GO:0015846) polyamine transmembrane transport(GO:1902047) regulation of polyamine transmembrane transport(GO:1902267) negative regulation of polyamine transmembrane transport(GO:1902268) |
0.2 | 6.3 | GO:0008654 | phospholipid biosynthetic process(GO:0008654) |
0.2 | 0.6 | GO:0070233 | negative regulation of T cell apoptotic process(GO:0070233) |
0.2 | 2.4 | GO:0043434 | response to peptide hormone(GO:0043434) |
0.2 | 0.2 | GO:0090503 | RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
0.2 | 2.0 | GO:0055013 | cardiac muscle cell development(GO:0055013) |
0.2 | 0.2 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
0.2 | 1.2 | GO:0009166 | nucleotide catabolic process(GO:0009166) |
0.2 | 16.1 | GO:0006631 | fatty acid metabolic process(GO:0006631) |
0.2 | 0.4 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
0.2 | 1.9 | GO:0031124 | mRNA 3'-end processing(GO:0031124) |
0.2 | 6.0 | GO:0005976 | polysaccharide metabolic process(GO:0005976) |
0.2 | 0.4 | GO:0032527 | protein exit from endoplasmic reticulum(GO:0032527) |
0.2 | 1.1 | GO:0032355 | response to estradiol(GO:0032355) |
0.2 | 0.4 | GO:1902230 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902230) |
0.2 | 0.2 | GO:0050849 | negative regulation of calcium-mediated signaling(GO:0050849) |
0.2 | 0.4 | GO:0000101 | sulfur amino acid transport(GO:0000101) |
0.2 | 0.2 | GO:1902254 | negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902254) |
0.2 | 0.4 | GO:0000096 | sulfur amino acid metabolic process(GO:0000096) |
0.2 | 0.2 | GO:0046618 | drug export(GO:0046618) |
0.2 | 3.0 | GO:0006888 | ER to Golgi vesicle-mediated transport(GO:0006888) |
0.2 | 0.2 | GO:0046349 | amino sugar biosynthetic process(GO:0046349) |
0.2 | 1.7 | GO:0031122 | cytoplasmic microtubule organization(GO:0031122) |
0.2 | 1.2 | GO:0016926 | protein desumoylation(GO:0016926) |
0.2 | 1.0 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
0.2 | 1.5 | GO:0045123 | cellular extravasation(GO:0045123) |
0.2 | 2.2 | GO:0000045 | autophagosome assembly(GO:0000045) |
0.2 | 2.0 | GO:0007602 | phototransduction(GO:0007602) |
0.2 | 2.8 | GO:0002757 | immune response-activating signal transduction(GO:0002757) |
0.2 | 0.3 | GO:0030641 | regulation of cellular pH(GO:0030641) |
0.2 | 0.2 | GO:0045739 | positive regulation of DNA repair(GO:0045739) |
0.2 | 1.5 | GO:0042269 | regulation of natural killer cell mediated cytotoxicity(GO:0042269) |
0.2 | 0.2 | GO:0001907 | killing by symbiont of host cells(GO:0001907) disruption by symbiont of host cell(GO:0044004) |
0.2 | 1.6 | GO:0050853 | B cell receptor signaling pathway(GO:0050853) |
0.2 | 0.3 | GO:0060252 | positive regulation of glial cell proliferation(GO:0060252) |
0.2 | 1.1 | GO:0042753 | positive regulation of circadian rhythm(GO:0042753) |
0.2 | 0.2 | GO:0002314 | germinal center B cell differentiation(GO:0002314) |
0.2 | 0.3 | GO:0036297 | interstrand cross-link repair(GO:0036297) |
0.2 | 0.6 | GO:0030890 | positive regulation of B cell proliferation(GO:0030890) |
0.2 | 0.3 | GO:0061299 | retina vasculature morphogenesis in camera-type eye(GO:0061299) |
0.2 | 2.1 | GO:0006953 | acute-phase response(GO:0006953) |
0.2 | 0.6 | GO:0061000 | negative regulation of dendritic spine development(GO:0061000) |
0.1 | 0.1 | GO:0007567 | parturition(GO:0007567) |
0.1 | 2.7 | GO:0001666 | response to hypoxia(GO:0001666) |
0.1 | 1.3 | GO:0034976 | response to endoplasmic reticulum stress(GO:0034976) |
0.1 | 0.3 | GO:0006497 | protein lipidation(GO:0006497) lipoprotein biosynthetic process(GO:0042158) |
0.1 | 0.7 | GO:0008053 | mitochondrial fusion(GO:0008053) |
0.1 | 0.3 | GO:0016572 | histone phosphorylation(GO:0016572) |
0.1 | 0.9 | GO:0035306 | positive regulation of dephosphorylation(GO:0035306) |
0.1 | 4.6 | GO:0032868 | response to insulin(GO:0032868) |
0.1 | 1.9 | GO:0043433 | negative regulation of sequence-specific DNA binding transcription factor activity(GO:0043433) |
0.1 | 0.1 | GO:0048633 | positive regulation of skeletal muscle tissue growth(GO:0048633) |
0.1 | 0.1 | GO:0060510 | Type II pneumocyte differentiation(GO:0060510) |
0.1 | 0.3 | GO:1902261 | positive regulation of delayed rectifier potassium channel activity(GO:1902261) positive regulation of voltage-gated potassium channel activity(GO:1903818) |
0.1 | 0.1 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
0.1 | 0.1 | GO:0042359 | vitamin D metabolic process(GO:0042359) |
0.1 | 2.1 | GO:0060976 | coronary vasculature development(GO:0060976) |
0.1 | 0.4 | GO:0010955 | negative regulation of protein processing(GO:0010955) negative regulation of protein maturation(GO:1903318) |
0.1 | 1.4 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.1 | 0.1 | GO:0097531 | mast cell chemotaxis(GO:0002551) mast cell migration(GO:0097531) |
0.1 | 0.7 | GO:0043462 | regulation of ATPase activity(GO:0043462) |
0.1 | 0.3 | GO:0033227 | dsRNA transport(GO:0033227) |
0.1 | 0.3 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
0.1 | 0.4 | GO:0072520 | seminiferous tubule development(GO:0072520) |
0.1 | 0.4 | GO:0033198 | response to ATP(GO:0033198) |
0.1 | 0.5 | GO:0030033 | microvillus assembly(GO:0030033) |
0.1 | 0.3 | GO:0033622 | integrin activation(GO:0033622) |
0.1 | 0.8 | GO:0010508 | positive regulation of autophagy(GO:0010508) |
0.1 | 0.4 | GO:0035590 | purinergic nucleotide receptor signaling pathway(GO:0035590) |
0.1 | 3.7 | GO:0006818 | hydrogen transport(GO:0006818) |
0.1 | 0.1 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.1 | 0.1 | GO:0098535 | de novo centriole assembly(GO:0098535) |
0.1 | 0.5 | GO:1903361 | protein localization to basolateral plasma membrane(GO:1903361) |
0.1 | 0.1 | GO:0060741 | prostate gland stromal morphogenesis(GO:0060741) |
0.1 | 0.1 | GO:1901028 | regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901028) |
0.1 | 4.1 | GO:0006413 | translational initiation(GO:0006413) |
0.1 | 0.1 | GO:1902369 | negative regulation of RNA catabolic process(GO:1902369) |
0.1 | 0.1 | GO:0051657 | maintenance of organelle location(GO:0051657) |
0.1 | 0.7 | GO:0046579 | positive regulation of Ras protein signal transduction(GO:0046579) |
0.1 | 0.4 | GO:0006026 | aminoglycan catabolic process(GO:0006026) |
0.1 | 1.2 | GO:0090280 | positive regulation of calcium ion import(GO:0090280) |
0.1 | 0.2 | GO:1901068 | guanosine-containing compound metabolic process(GO:1901068) |
0.1 | 0.1 | GO:1902630 | regulation of membrane hyperpolarization(GO:1902630) |
0.1 | 7.0 | GO:0006869 | lipid transport(GO:0006869) |
0.1 | 0.2 | GO:0006490 | oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
0.1 | 3.5 | GO:0051603 | proteolysis involved in cellular protein catabolic process(GO:0051603) |
0.1 | 0.2 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.1 | 0.6 | GO:0050994 | regulation of lipid catabolic process(GO:0050994) |
0.1 | 0.4 | GO:0030521 | androgen receptor signaling pathway(GO:0030521) |
0.1 | 0.3 | GO:0042178 | xenobiotic catabolic process(GO:0042178) |
0.1 | 0.5 | GO:0071353 | cellular response to interleukin-4(GO:0071353) |
0.1 | 0.3 | GO:0042501 | serine phosphorylation of STAT protein(GO:0042501) |
0.1 | 0.3 | GO:0006903 | vesicle targeting(GO:0006903) |
0.1 | 0.1 | GO:0051898 | negative regulation of protein kinase B signaling(GO:0051898) |
0.1 | 0.2 | GO:0050892 | intestinal absorption(GO:0050892) |
0.1 | 0.2 | GO:0010667 | negative regulation of cardiac muscle cell apoptotic process(GO:0010667) |
0.1 | 0.1 | GO:0010829 | negative regulation of glucose transport(GO:0010829) |
0.1 | 0.1 | GO:0002517 | T cell tolerance induction(GO:0002517) |
0.1 | 0.1 | GO:0035767 | endothelial cell chemotaxis(GO:0035767) |
0.1 | 0.8 | GO:0006182 | cGMP biosynthetic process(GO:0006182) |
0.1 | 11.7 | GO:0007264 | small GTPase mediated signal transduction(GO:0007264) |
0.1 | 1.4 | GO:0003009 | skeletal muscle contraction(GO:0003009) |
0.1 | 0.2 | GO:0032693 | negative regulation of interleukin-10 production(GO:0032693) |
0.1 | 0.8 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
0.1 | 0.1 | GO:0042226 | interleukin-6 biosynthetic process(GO:0042226) |
0.1 | 3.8 | GO:0002250 | adaptive immune response(GO:0002250) |
0.1 | 0.1 | GO:0006119 | oxidative phosphorylation(GO:0006119) |
0.1 | 0.3 | GO:0030593 | neutrophil chemotaxis(GO:0030593) |
0.1 | 0.1 | GO:0032506 | cytokinetic process(GO:0032506) |
0.1 | 1.1 | GO:0044243 | multicellular organism catabolic process(GO:0044243) |
0.1 | 0.1 | GO:0034312 | diol biosynthetic process(GO:0034312) sphingosine biosynthetic process(GO:0046512) |
0.1 | 0.1 | GO:1901661 | quinone metabolic process(GO:1901661) |
0.1 | 7.6 | GO:0042742 | defense response to bacterium(GO:0042742) |
0.1 | 0.2 | GO:0003433 | chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
0.1 | 0.1 | GO:0051683 | establishment of Golgi localization(GO:0051683) |
0.1 | 0.4 | GO:0032400 | melanosome localization(GO:0032400) pigment granule localization(GO:0051875) |
0.1 | 0.3 | GO:0007207 | adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
0.1 | 0.1 | GO:0018879 | biphenyl metabolic process(GO:0018879) |
0.1 | 0.5 | GO:0072337 | modified amino acid transport(GO:0072337) |
0.1 | 0.2 | GO:2001243 | negative regulation of intrinsic apoptotic signaling pathway(GO:2001243) |
0.1 | 0.3 | GO:0046329 | negative regulation of JNK cascade(GO:0046329) |
0.1 | 0.2 | GO:0048808 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
0.1 | 0.6 | GO:0006284 | base-excision repair(GO:0006284) |
0.1 | 0.2 | GO:1902004 | positive regulation of beta-amyloid formation(GO:1902004) positive regulation of amyloid precursor protein catabolic process(GO:1902993) |
0.1 | 0.2 | GO:0046599 | regulation of centriole replication(GO:0046599) |
0.1 | 0.2 | GO:0050965 | detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
0.1 | 0.2 | GO:0002016 | regulation of blood volume by renin-angiotensin(GO:0002016) |
0.1 | 0.1 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.1 | 0.1 | GO:0045724 | positive regulation of cilium assembly(GO:0045724) |
0.1 | 0.2 | GO:0032007 | negative regulation of TOR signaling(GO:0032007) |
0.1 | 0.2 | GO:0060468 | prevention of polyspermy(GO:0060468) |
0.1 | 0.2 | GO:0045779 | negative regulation of bone resorption(GO:0045779) |
0.1 | 5.9 | GO:0007286 | spermatid development(GO:0007286) |
0.1 | 0.1 | GO:1901222 | regulation of NIK/NF-kappaB signaling(GO:1901222) |
0.1 | 0.5 | GO:0097576 | vacuole fusion(GO:0097576) |
0.1 | 0.1 | GO:0032623 | interleukin-2 production(GO:0032623) |
0.1 | 0.4 | GO:0033561 | regulation of water loss via skin(GO:0033561) |
0.1 | 2.6 | GO:0050913 | sensory perception of bitter taste(GO:0050913) |
0.1 | 12.6 | GO:0055114 | oxidation-reduction process(GO:0055114) |
0.1 | 0.1 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
0.1 | 0.1 | GO:0032815 | negative regulation of natural killer cell activation(GO:0032815) |
0.1 | 0.1 | GO:0090311 | regulation of protein deacetylation(GO:0090311) |
0.1 | 1.1 | GO:0006352 | DNA-templated transcription, initiation(GO:0006352) |
0.1 | 0.1 | GO:0051204 | protein insertion into mitochondrial membrane(GO:0051204) |
0.1 | 0.8 | GO:0045600 | positive regulation of fat cell differentiation(GO:0045600) |
0.1 | 0.1 | GO:2000255 | negative regulation of male germ cell proliferation(GO:2000255) |
0.1 | 0.7 | GO:0042254 | ribosome biogenesis(GO:0042254) |
0.1 | 0.4 | GO:0048017 | inositol lipid-mediated signaling(GO:0048017) |
0.1 | 0.1 | GO:0009127 | purine nucleoside monophosphate biosynthetic process(GO:0009127) purine ribonucleoside monophosphate biosynthetic process(GO:0009168) |
0.1 | 0.8 | GO:0071560 | cellular response to transforming growth factor beta stimulus(GO:0071560) |
0.1 | 0.1 | GO:0009070 | serine family amino acid biosynthetic process(GO:0009070) |
0.1 | 0.1 | GO:0046605 | regulation of centrosome cycle(GO:0046605) |
0.0 | 0.0 | GO:0038066 | p38MAPK cascade(GO:0038066) |
0.0 | 0.1 | GO:0007343 | egg activation(GO:0007343) |
0.0 | 0.4 | GO:1902572 | regulation of serine-type endopeptidase activity(GO:1900003) negative regulation of serine-type endopeptidase activity(GO:1900004) regulation of serine-type peptidase activity(GO:1902571) negative regulation of serine-type peptidase activity(GO:1902572) |
0.0 | 0.0 | GO:0019730 | antimicrobial humoral response(GO:0019730) |
0.0 | 0.0 | GO:0050872 | white fat cell differentiation(GO:0050872) |
0.0 | 0.4 | GO:0044724 | single-organism carbohydrate catabolic process(GO:0044724) |
0.0 | 0.1 | GO:0044704 | single-organism reproductive behavior(GO:0044704) |
0.0 | 0.1 | GO:0070988 | demethylation(GO:0070988) |
0.0 | 0.3 | GO:0052697 | xenobiotic glucuronidation(GO:0052697) |
0.0 | 0.3 | GO:0006308 | DNA catabolic process(GO:0006308) |
0.0 | 0.4 | GO:0034341 | response to interferon-gamma(GO:0034341) |
0.0 | 0.0 | GO:0000255 | allantoin metabolic process(GO:0000255) |
0.0 | 0.2 | GO:0032784 | regulation of DNA-templated transcription, elongation(GO:0032784) |
0.0 | 0.3 | GO:0006383 | transcription from RNA polymerase III promoter(GO:0006383) |
0.0 | 0.0 | GO:0000711 | meiotic DNA repair synthesis(GO:0000711) |
0.0 | 0.1 | GO:0035268 | protein mannosylation(GO:0035268) mannosylation(GO:0097502) |
0.0 | 0.1 | GO:0042398 | cellular modified amino acid biosynthetic process(GO:0042398) |
0.0 | 0.1 | GO:0045925 | positive regulation of female receptivity(GO:0045925) |
0.0 | 0.1 | GO:0000070 | mitotic sister chromatid segregation(GO:0000070) |
0.0 | 0.0 | GO:0032689 | negative regulation of interferon-gamma production(GO:0032689) |
0.0 | 0.0 | GO:0009068 | aspartate family amino acid catabolic process(GO:0009068) |
0.0 | 0.2 | GO:0045744 | negative regulation of G-protein coupled receptor protein signaling pathway(GO:0045744) |
0.0 | 0.0 | GO:0006083 | acetate metabolic process(GO:0006083) |
0.0 | 0.1 | GO:0097194 | execution phase of apoptosis(GO:0097194) |
0.0 | 0.0 | GO:0098543 | detection of bacterium(GO:0016045) detection of other organism(GO:0098543) |
0.0 | 0.0 | GO:0045839 | negative regulation of mitotic nuclear division(GO:0045839) |
0.0 | 0.4 | GO:0002181 | cytoplasmic translation(GO:0002181) |
0.0 | 0.1 | GO:0045576 | mast cell activation(GO:0045576) |
0.0 | 0.0 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
0.0 | 0.3 | GO:0010950 | positive regulation of endopeptidase activity(GO:0010950) |
0.0 | 0.0 | GO:0030851 | granulocyte differentiation(GO:0030851) |
0.0 | 0.1 | GO:0008630 | intrinsic apoptotic signaling pathway in response to DNA damage(GO:0008630) |
0.0 | 0.0 | GO:1902117 | positive regulation of organelle assembly(GO:1902117) |
0.0 | 0.0 | GO:0001834 | trophectodermal cell proliferation(GO:0001834) |
0.0 | 0.0 | GO:0070584 | mitochondrion morphogenesis(GO:0070584) |
0.0 | 0.0 | GO:0072402 | response to cell cycle checkpoint signaling(GO:0072396) response to DNA integrity checkpoint signaling(GO:0072402) response to DNA damage checkpoint signaling(GO:0072423) |
0.0 | 0.1 | GO:0017144 | drug metabolic process(GO:0017144) |
0.0 | 0.0 | GO:0046686 | response to cadmium ion(GO:0046686) |
0.0 | 0.0 | GO:0003081 | regulation of systemic arterial blood pressure by renin-angiotensin(GO:0003081) |
0.0 | 0.0 | GO:0032277 | negative regulation of gonadotropin secretion(GO:0032277) |
0.0 | 0.0 | GO:1902172 | keratinocyte apoptotic process(GO:0097283) regulation of keratinocyte apoptotic process(GO:1902172) |
0.0 | 0.1 | GO:0010507 | negative regulation of autophagy(GO:0010507) |
0.0 | 0.1 | GO:0030643 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.1 | 20.5 | GO:0016461 | unconventional myosin complex(GO:0016461) |
3.7 | 29.6 | GO:0030056 | hemidesmosome(GO:0030056) |
3.5 | 10.5 | GO:1990597 | AIP1-IRE1 complex(GO:1990597) |
3.5 | 17.4 | GO:0033093 | Weibel-Palade body(GO:0033093) |
3.4 | 3.4 | GO:0071953 | elastic fiber(GO:0071953) |
3.4 | 10.2 | GO:0097451 | glial limiting end-foot(GO:0097451) |
2.7 | 13.6 | GO:0031094 | platelet dense tubular network(GO:0031094) |
2.6 | 7.7 | GO:0005914 | spot adherens junction(GO:0005914) |
2.6 | 10.3 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) |
2.5 | 12.5 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
2.5 | 7.5 | GO:0097512 | cardiac myofibril(GO:0097512) |
2.4 | 9.6 | GO:0044354 | pinosome(GO:0044352) macropinosome(GO:0044354) |
2.2 | 8.8 | GO:0030478 | actin cap(GO:0030478) |
2.2 | 8.8 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
2.2 | 21.7 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
2.1 | 8.6 | GO:0071203 | WASH complex(GO:0071203) |
2.1 | 4.2 | GO:0097057 | TRAF2-GSTP1 complex(GO:0097057) |
2.0 | 6.0 | GO:0005899 | insulin receptor complex(GO:0005899) |
2.0 | 11.7 | GO:0031983 | vesicle lumen(GO:0031983) |
1.9 | 13.5 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
1.9 | 13.2 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
1.8 | 27.4 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
1.8 | 36.8 | GO:0031307 | integral component of mitochondrial outer membrane(GO:0031307) |
1.7 | 5.1 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
1.7 | 3.4 | GO:0030135 | coated vesicle(GO:0030135) |
1.7 | 5.1 | GO:0032127 | dense core granule membrane(GO:0032127) |
1.7 | 14.9 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
1.6 | 9.9 | GO:0005915 | zonula adherens(GO:0005915) |
1.6 | 9.8 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
1.6 | 6.5 | GO:0042825 | TAP complex(GO:0042825) |
1.6 | 4.9 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
1.6 | 8.1 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
1.6 | 6.3 | GO:0030891 | VCB complex(GO:0030891) |
1.6 | 14.2 | GO:0000124 | SAGA complex(GO:0000124) |
1.6 | 1.6 | GO:0043296 | apical junction complex(GO:0043296) |
1.6 | 6.2 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
1.6 | 1.6 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
1.6 | 4.7 | GO:0043259 | laminin-10 complex(GO:0043259) |
1.5 | 1.5 | GO:0034399 | nuclear periphery(GO:0034399) |
1.5 | 17.8 | GO:0071564 | npBAF complex(GO:0071564) |
1.5 | 3.0 | GO:0010009 | cytoplasmic side of endosome membrane(GO:0010009) |
1.5 | 13.3 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
1.5 | 5.9 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
1.5 | 2.9 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
1.5 | 10.2 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
1.4 | 5.7 | GO:0072487 | MSL complex(GO:0072487) |
1.4 | 4.2 | GO:0034365 | discoidal high-density lipoprotein particle(GO:0034365) |
1.4 | 7.0 | GO:0045180 | basal cortex(GO:0045180) |
1.4 | 1.4 | GO:0030175 | filopodium(GO:0030175) |
1.4 | 42.9 | GO:0012505 | endomembrane system(GO:0012505) |
1.4 | 4.1 | GO:0097342 | ripoptosome(GO:0097342) |
1.4 | 4.1 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
1.4 | 2.8 | GO:0005610 | laminin-5 complex(GO:0005610) |
1.4 | 11.0 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
1.4 | 2.7 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
1.4 | 4.1 | GO:0097443 | sorting endosome(GO:0097443) |
1.3 | 6.7 | GO:0000805 | X chromosome(GO:0000805) |
1.3 | 12.1 | GO:0031143 | pseudopodium(GO:0031143) |
1.3 | 6.7 | GO:0005638 | lamin filament(GO:0005638) |
1.3 | 2.7 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
1.3 | 8.0 | GO:0044233 | ER-mitochondrion membrane contact site(GO:0044233) |
1.3 | 5.3 | GO:0045298 | tubulin complex(GO:0045298) |
1.3 | 7.9 | GO:0070775 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
1.3 | 5.2 | GO:1990246 | uniplex complex(GO:1990246) |
1.3 | 5.2 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
1.3 | 82.7 | GO:0042641 | actomyosin(GO:0042641) |
1.3 | 3.9 | GO:0031523 | Myb complex(GO:0031523) |
1.3 | 2.5 | GO:0033186 | CAF-1 complex(GO:0033186) |
1.3 | 10.2 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
1.3 | 10.2 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
1.3 | 6.4 | GO:0016600 | flotillin complex(GO:0016600) |
1.3 | 3.8 | GO:0044214 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
1.3 | 13.8 | GO:0031332 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
1.2 | 5.0 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
1.2 | 6.2 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
1.2 | 5.0 | GO:0070876 | SOSS complex(GO:0070876) |
1.2 | 3.7 | GO:0030027 | lamellipodium(GO:0030027) |
1.2 | 3.7 | GO:0070820 | tertiary granule(GO:0070820) |
1.2 | 4.9 | GO:0035363 | histone locus body(GO:0035363) |
1.2 | 1.2 | GO:0031306 | intrinsic component of mitochondrial outer membrane(GO:0031306) |
1.2 | 1.2 | GO:0070688 | MLL5-L complex(GO:0070688) |
1.2 | 2.4 | GO:0036452 | ESCRT complex(GO:0036452) |
1.2 | 1.2 | GO:0044292 | dendrite terminus(GO:0044292) |
1.2 | 77.4 | GO:0030863 | cortical cytoskeleton(GO:0030863) |
1.2 | 3.5 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
1.2 | 4.7 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
1.2 | 4.7 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
1.2 | 4.7 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
1.2 | 7.0 | GO:0031209 | SCAR complex(GO:0031209) |
1.2 | 4.6 | GO:0044462 | cell outer membrane(GO:0009279) cell envelope(GO:0030313) external encapsulating structure part(GO:0044462) |
1.2 | 3.5 | GO:0031084 | BLOC-2 complex(GO:0031084) |
1.2 | 4.6 | GO:0005784 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
1.2 | 28.9 | GO:0001772 | immunological synapse(GO:0001772) |
1.1 | 2.3 | GO:0005869 | dynactin complex(GO:0005869) |
1.1 | 7.9 | GO:0090543 | Flemming body(GO:0090543) |
1.1 | 1.1 | GO:0000938 | GARP complex(GO:0000938) |
1.1 | 5.6 | GO:0045098 | type III intermediate filament(GO:0045098) |
1.1 | 3.3 | GO:0005766 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
1.1 | 13.3 | GO:0001891 | phagocytic cup(GO:0001891) |
1.1 | 291.5 | GO:0005925 | focal adhesion(GO:0005925) |
1.1 | 1.1 | GO:0005845 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
1.1 | 14.1 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
1.1 | 4.3 | GO:0030127 | COPII vesicle coat(GO:0030127) |
1.1 | 3.2 | GO:0005863 | striated muscle myosin thick filament(GO:0005863) |
1.1 | 12.9 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
1.1 | 8.5 | GO:0001650 | fibrillar center(GO:0001650) |
1.1 | 12.8 | GO:0070822 | Sin3-type complex(GO:0070822) |
1.1 | 3.2 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
1.1 | 9.6 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
1.1 | 1.1 | GO:0000306 | extrinsic component of vacuolar membrane(GO:0000306) extrinsic component of endosome membrane(GO:0031313) |
1.1 | 3.2 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
1.1 | 5.3 | GO:0044666 | MLL3/4 complex(GO:0044666) |
1.0 | 12.5 | GO:0005640 | nuclear outer membrane(GO:0005640) |
1.0 | 4.1 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
1.0 | 4.1 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
1.0 | 7.2 | GO:0001939 | female pronucleus(GO:0001939) |
1.0 | 2.1 | GO:0016328 | lateral plasma membrane(GO:0016328) |
1.0 | 2.1 | GO:0036488 | CHOP-C/EBP complex(GO:0036488) |
1.0 | 16.3 | GO:0071339 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
1.0 | 8.1 | GO:0005861 | troponin complex(GO:0005861) |
1.0 | 3.0 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
1.0 | 3.0 | GO:0000322 | storage vacuole(GO:0000322) |
1.0 | 14.0 | GO:0033643 | host(GO:0018995) host cell part(GO:0033643) host cell(GO:0043657) |
1.0 | 3.0 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
1.0 | 2.0 | GO:0051233 | spindle midzone(GO:0051233) |
1.0 | 2.9 | GO:0070522 | ERCC4-ERCC1 complex(GO:0070522) |
1.0 | 2.9 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
1.0 | 3.9 | GO:0031262 | Ndc80 complex(GO:0031262) |
1.0 | 3.9 | GO:0035189 | Rb-E2F complex(GO:0035189) |
1.0 | 3.9 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
1.0 | 34.8 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
1.0 | 2.9 | GO:0030130 | clathrin coat of trans-Golgi network vesicle(GO:0030130) |
1.0 | 2.9 | GO:0012510 | trans-Golgi network transport vesicle membrane(GO:0012510) |
1.0 | 30.5 | GO:0032587 | ruffle membrane(GO:0032587) |
0.9 | 1.9 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
0.9 | 4.7 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.9 | 4.7 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.9 | 3.7 | GO:0031519 | PcG protein complex(GO:0031519) |
0.9 | 4.7 | GO:0097422 | tubular endosome(GO:0097422) |
0.9 | 2.8 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.9 | 14.8 | GO:0000145 | exocyst(GO:0000145) |
0.9 | 2.7 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.9 | 4.6 | GO:0032133 | chromosome passenger complex(GO:0032133) |
0.9 | 37.3 | GO:0000123 | histone acetyltransferase complex(GO:0000123) |
0.9 | 38.0 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.9 | 3.6 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
0.9 | 2.7 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.9 | 7.2 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.9 | 3.5 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.9 | 7.0 | GO:0016471 | vacuolar proton-transporting V-type ATPase complex(GO:0016471) |
0.9 | 1.7 | GO:0030125 | clathrin vesicle coat(GO:0030125) |
0.9 | 5.2 | GO:0005874 | microtubule(GO:0005874) |
0.9 | 2.6 | GO:0071942 | XPC complex(GO:0071942) |
0.9 | 32.1 | GO:0045171 | intercellular bridge(GO:0045171) |
0.9 | 3.5 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.9 | 11.2 | GO:0016363 | nuclear matrix(GO:0016363) |
0.9 | 9.5 | GO:0031528 | microvillus membrane(GO:0031528) |
0.9 | 2.6 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
0.9 | 0.9 | GO:0030990 | intraciliary transport particle(GO:0030990) |
0.9 | 45.5 | GO:0005902 | microvillus(GO:0005902) |
0.9 | 9.4 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.8 | 11.9 | GO:0005605 | basal lamina(GO:0005605) |
0.8 | 5.1 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.8 | 10.1 | GO:0036379 | myofilament(GO:0036379) |
0.8 | 2.5 | GO:0035749 | myelin sheath adaxonal region(GO:0035749) |
0.8 | 3.4 | GO:0044452 | nucleolar part(GO:0044452) |
0.8 | 0.8 | GO:0031261 | GINS complex(GO:0000811) DNA replication preinitiation complex(GO:0031261) |
0.8 | 0.8 | GO:0071439 | clathrin complex(GO:0071439) |
0.8 | 2.5 | GO:0005955 | calcineurin complex(GO:0005955) |
0.8 | 6.7 | GO:0000792 | heterochromatin(GO:0000792) |
0.8 | 2.5 | GO:0036396 | MIS complex(GO:0036396) |
0.8 | 0.8 | GO:0030055 | cell-substrate junction(GO:0030055) |
0.8 | 0.8 | GO:0070603 | SWI/SNF superfamily-type complex(GO:0070603) |
0.8 | 12.4 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.8 | 5.8 | GO:0030008 | TRAPP complex(GO:0030008) |
0.8 | 2.5 | GO:0072379 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.8 | 2.5 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
0.8 | 5.7 | GO:0061700 | GATOR2 complex(GO:0061700) |
0.8 | 2.5 | GO:0043293 | apoptosome(GO:0043293) |
0.8 | 2.4 | GO:0045251 | mitochondrial electron transfer flavoprotein complex(GO:0017133) electron transfer flavoprotein complex(GO:0045251) |
0.8 | 4.1 | GO:0000235 | astral microtubule(GO:0000235) |
0.8 | 4.1 | GO:0005827 | polar microtubule(GO:0005827) |
0.8 | 6.5 | GO:0031932 | TORC2 complex(GO:0031932) |
0.8 | 8.9 | GO:0035869 | ciliary transition zone(GO:0035869) |
0.8 | 14.5 | GO:0042588 | zymogen granule(GO:0042588) |
0.8 | 2.4 | GO:0005642 | annulate lamellae(GO:0005642) |
0.8 | 1.6 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
0.8 | 2.4 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.8 | 5.5 | GO:0042581 | specific granule(GO:0042581) |
0.8 | 1.6 | GO:0008622 | epsilon DNA polymerase complex(GO:0008622) |
0.8 | 7.9 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
0.8 | 7.1 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.8 | 3.1 | GO:0005583 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.8 | 29.8 | GO:0001726 | ruffle(GO:0001726) |
0.8 | 2.3 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
0.8 | 7.8 | GO:0043218 | compact myelin(GO:0043218) |
0.8 | 3.9 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
0.8 | 8.6 | GO:0005779 | integral component of peroxisomal membrane(GO:0005779) |
0.8 | 0.8 | GO:0046691 | intracellular canaliculus(GO:0046691) |
0.8 | 50.2 | GO:0005938 | cell cortex(GO:0005938) |
0.8 | 1.5 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
0.8 | 10.0 | GO:1990204 | oxidoreductase complex(GO:1990204) |
0.8 | 5.4 | GO:0033061 | DNA recombinase mediator complex(GO:0033061) |
0.8 | 3.1 | GO:0032009 | early phagosome(GO:0032009) |
0.8 | 7.7 | GO:0032039 | integrator complex(GO:0032039) |
0.8 | 4.6 | GO:0031415 | NatA complex(GO:0031415) |
0.8 | 9.9 | GO:0036038 | MKS complex(GO:0036038) |
0.8 | 1.5 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
0.8 | 25.8 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.8 | 2.3 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
0.8 | 15.1 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.8 | 3.8 | GO:0070695 | FHF complex(GO:0070695) |
0.8 | 3.0 | GO:0005652 | nuclear lamina(GO:0005652) |
0.8 | 18.8 | GO:0031984 | organelle subcompartment(GO:0031984) |
0.7 | 5.2 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.7 | 3.7 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.7 | 1.5 | GO:0044615 | nuclear pore nuclear basket(GO:0044615) |
0.7 | 1.5 | GO:0042555 | MCM complex(GO:0042555) |
0.7 | 5.2 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.7 | 9.6 | GO:0000242 | pericentriolar material(GO:0000242) |
0.7 | 2.2 | GO:0036156 | inner dynein arm(GO:0036156) |
0.7 | 2.2 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.7 | 2.2 | GO:0031417 | NatC complex(GO:0031417) |
0.7 | 5.2 | GO:0033263 | CORVET complex(GO:0033263) |
0.7 | 90.9 | GO:0005765 | lysosomal membrane(GO:0005765) lytic vacuole membrane(GO:0098852) |
0.7 | 0.7 | GO:0098576 | lumenal side of membrane(GO:0098576) |
0.7 | 29.1 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.7 | 5.1 | GO:0098827 | endoplasmic reticulum subcompartment(GO:0098827) |
0.7 | 2.2 | GO:0035355 | Toll-like receptor 2-Toll-like receptor 6 protein complex(GO:0035355) |
0.7 | 39.8 | GO:0016605 | PML body(GO:0016605) |
0.7 | 7.2 | GO:0072546 | ER membrane protein complex(GO:0072546) |
0.7 | 1.4 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.7 | 33.8 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
0.7 | 4.3 | GO:0045120 | pronucleus(GO:0045120) |
0.7 | 3.6 | GO:0097542 | ciliary tip(GO:0097542) |
0.7 | 2.1 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
0.7 | 6.4 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.7 | 2.8 | GO:0005916 | fascia adherens(GO:0005916) |
0.7 | 4.9 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.7 | 15.5 | GO:0032592 | integral component of mitochondrial membrane(GO:0032592) |
0.7 | 31.6 | GO:0005811 | lipid particle(GO:0005811) |
0.7 | 4.2 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.7 | 2.1 | GO:0005879 | axonemal microtubule(GO:0005879) |
0.7 | 1.4 | GO:0010369 | chromocenter(GO:0010369) |
0.7 | 6.3 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
0.7 | 3.5 | GO:0000796 | condensin complex(GO:0000796) |
0.7 | 2.1 | GO:0045335 | phagocytic vesicle(GO:0045335) |
0.7 | 2.1 | GO:0090661 | box H/ACA telomerase RNP complex(GO:0090661) |
0.7 | 1.4 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.7 | 11.5 | GO:0005782 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
0.7 | 2.0 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
0.7 | 4.7 | GO:0005664 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.7 | 5.4 | GO:0044439 | microbody part(GO:0044438) peroxisomal part(GO:0044439) |
0.7 | 2.7 | GO:0071986 | Ragulator complex(GO:0071986) |
0.7 | 2.0 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.7 | 19.3 | GO:0005657 | replication fork(GO:0005657) |
0.7 | 6.6 | GO:0002178 | palmitoyltransferase complex(GO:0002178) |
0.7 | 4.0 | GO:0031501 | mannosyltransferase complex(GO:0031501) |
0.7 | 2.6 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
0.7 | 11.9 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.7 | 5.9 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.7 | 2.6 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
0.7 | 6.6 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
0.7 | 2.0 | GO:0002142 | stereocilia ankle link complex(GO:0002142) |
0.7 | 2.6 | GO:0072559 | NLRP3 inflammasome complex(GO:0072559) |
0.7 | 5.2 | GO:0001527 | microfibril(GO:0001527) |
0.6 | 19.5 | GO:0030667 | secretory granule membrane(GO:0030667) |
0.6 | 51.2 | GO:0005923 | bicellular tight junction(GO:0005923) |
0.6 | 1.3 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
0.6 | 12.2 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.6 | 12.1 | GO:0090575 | RNA polymerase II transcription factor complex(GO:0090575) |
0.6 | 3.8 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
0.6 | 2.5 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.6 | 4.4 | GO:0001520 | outer dense fiber(GO:0001520) |
0.6 | 0.6 | GO:0071817 | MMXD complex(GO:0071817) |
0.6 | 24.5 | GO:0030173 | integral component of Golgi membrane(GO:0030173) intrinsic component of Golgi membrane(GO:0031228) |
0.6 | 1.9 | GO:1990462 | omegasome(GO:1990462) |
0.6 | 37.3 | GO:0030496 | midbody(GO:0030496) |
0.6 | 7.4 | GO:0005614 | interstitial matrix(GO:0005614) |
0.6 | 10.5 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.6 | 8.0 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.6 | 19.5 | GO:0005798 | Golgi-associated vesicle(GO:0005798) |
0.6 | 9.1 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.6 | 1.8 | GO:0030689 | Noc complex(GO:0030689) |
0.6 | 3.6 | GO:0031010 | ISWI-type complex(GO:0031010) |
0.6 | 10.2 | GO:0005685 | U1 snRNP(GO:0005685) |
0.6 | 2.4 | GO:0042382 | paraspeckles(GO:0042382) |
0.6 | 57.2 | GO:0005741 | mitochondrial outer membrane(GO:0005741) |
0.6 | 4.7 | GO:0070652 | HAUS complex(GO:0070652) |
0.6 | 1.2 | GO:0045259 | proton-transporting ATP synthase complex(GO:0045259) |
0.6 | 4.7 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.6 | 1.2 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
0.6 | 1.2 | GO:0043205 | fibril(GO:0043205) |
0.6 | 1.2 | GO:0031931 | TORC1 complex(GO:0031931) |
0.6 | 5.3 | GO:0035371 | microtubule plus-end(GO:0035371) |
0.6 | 3.5 | GO:0000801 | central element(GO:0000801) |
0.6 | 0.6 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
0.6 | 4.1 | GO:0015629 | actin cytoskeleton(GO:0015629) |
0.6 | 2.3 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
0.6 | 1.7 | GO:0071141 | SMAD protein complex(GO:0071141) |
0.6 | 1.7 | GO:0005840 | ribosome(GO:0005840) |
0.6 | 1.7 | GO:0000275 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
0.6 | 1.7 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.6 | 2.9 | GO:0042405 | nuclear inclusion body(GO:0042405) |
0.6 | 18.9 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.6 | 1.1 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
0.6 | 0.6 | GO:0034750 | Scrib-APC-beta-catenin complex(GO:0034750) |
0.6 | 3.4 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
0.6 | 1.1 | GO:0072687 | meiotic spindle(GO:0072687) |
0.6 | 11.3 | GO:0005740 | mitochondrial envelope(GO:0005740) |
0.6 | 1.1 | GO:0001651 | dense fibrillar component(GO:0001651) |
0.6 | 2.8 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.5 | 113.4 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
0.5 | 2.7 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
0.5 | 3.8 | GO:0097539 | ciliary transition fiber(GO:0097539) |
0.5 | 95.0 | GO:0005759 | mitochondrial matrix(GO:0005759) |
0.5 | 2.2 | GO:0031090 | organelle membrane(GO:0031090) |
0.5 | 4.8 | GO:0034719 | SMN-Sm protein complex(GO:0034719) |
0.5 | 3.2 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.5 | 7.5 | GO:0005849 | mRNA cleavage factor complex(GO:0005849) |
0.5 | 2.1 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.5 | 1.6 | GO:0048179 | activin receptor complex(GO:0048179) |
0.5 | 1.1 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
0.5 | 922.1 | GO:0070062 | extracellular exosome(GO:0070062) |
0.5 | 9.5 | GO:0072562 | blood microparticle(GO:0072562) |
0.5 | 4.2 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
0.5 | 44.7 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.5 | 0.5 | GO:0030120 | vesicle coat(GO:0030120) |
0.5 | 1.6 | GO:0030686 | 90S preribosome(GO:0030686) |
0.5 | 27.3 | GO:0030176 | integral component of endoplasmic reticulum membrane(GO:0030176) |
0.5 | 1.5 | GO:0072557 | IPAF inflammasome complex(GO:0072557) |
0.5 | 5.7 | GO:0030139 | endocytic vesicle(GO:0030139) |
0.5 | 23.1 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.5 | 16.4 | GO:0016592 | mediator complex(GO:0016592) |
0.5 | 31.1 | GO:0016607 | nuclear speck(GO:0016607) |
0.5 | 0.5 | GO:0000439 | core TFIIH complex(GO:0000439) |
0.5 | 7.6 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.5 | 1.5 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.5 | 9.1 | GO:0005776 | autophagosome(GO:0005776) |
0.5 | 1.5 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
0.5 | 8.1 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
0.5 | 4.0 | GO:0032300 | mismatch repair complex(GO:0032300) |
0.5 | 7.5 | GO:0044815 | DNA packaging complex(GO:0044815) |
0.5 | 0.5 | GO:1990393 | 3M complex(GO:1990393) |
0.5 | 21.3 | GO:0000775 | chromosome, centromeric region(GO:0000775) |
0.5 | 9.4 | GO:0016459 | myosin complex(GO:0016459) |
0.5 | 8.8 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.5 | 15.2 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
0.5 | 2.4 | GO:0002102 | podosome(GO:0002102) |
0.5 | 2.4 | GO:0035861 | site of double-strand break(GO:0035861) |
0.5 | 2.9 | GO:0071014 | post-mRNA release spliceosomal complex(GO:0071014) |
0.5 | 11.0 | GO:0000922 | spindle pole(GO:0000922) |
0.5 | 2.9 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.5 | 1.4 | GO:1990923 | PET complex(GO:1990923) |
0.5 | 1.4 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
0.5 | 10.8 | GO:0000502 | proteasome complex(GO:0000502) |
0.5 | 2.4 | GO:0034464 | BBSome(GO:0034464) |
0.5 | 1.9 | GO:0000923 | equatorial microtubule organizing center(GO:0000923) |
0.5 | 1.9 | GO:0000445 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.5 | 0.5 | GO:0033270 | paranode region of axon(GO:0033270) |
0.5 | 6.0 | GO:0000784 | nuclear chromosome, telomeric region(GO:0000784) |
0.5 | 1.4 | GO:0097431 | mitotic spindle pole(GO:0097431) |
0.5 | 2.3 | GO:0016272 | prefoldin complex(GO:0016272) |
0.5 | 0.9 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.4 | 1.8 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.4 | 3.1 | GO:0005655 | nucleolar ribonuclease P complex(GO:0005655) ribonuclease P complex(GO:0030677) multimeric ribonuclease P complex(GO:0030681) |
0.4 | 11.1 | GO:0005901 | caveola(GO:0005901) |
0.4 | 16.5 | GO:0005643 | nuclear pore(GO:0005643) |
0.4 | 236.6 | GO:0005739 | mitochondrion(GO:0005739) |
0.4 | 0.4 | GO:0070765 | gamma-secretase complex(GO:0070765) |
0.4 | 1.8 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.4 | 437.0 | GO:0005654 | nucleoplasm(GO:0005654) |
0.4 | 31.8 | GO:0000785 | chromatin(GO:0000785) |
0.4 | 0.9 | GO:0070531 | BRCA1-A complex(GO:0070531) |
0.4 | 3.0 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.4 | 1.7 | GO:0005682 | U5 snRNP(GO:0005682) |
0.4 | 2.8 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
0.4 | 1.2 | GO:0071797 | LUBAC complex(GO:0071797) |
0.4 | 1.2 | GO:0043511 | inhibin complex(GO:0043511) |
0.4 | 1.2 | GO:0097546 | ciliary base(GO:0097546) |
0.4 | 0.4 | GO:1990716 | axonemal central apparatus(GO:1990716) |
0.4 | 2.3 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
0.4 | 0.4 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
0.4 | 0.4 | GO:0042575 | DNA polymerase complex(GO:0042575) |
0.4 | 0.8 | GO:0000243 | commitment complex(GO:0000243) |
0.4 | 6.4 | GO:0005604 | basement membrane(GO:0005604) |
0.4 | 12.6 | GO:0005814 | centriole(GO:0005814) |
0.4 | 1.1 | GO:0089701 | U2AF(GO:0089701) |
0.4 | 1.1 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
0.4 | 7.7 | GO:0005844 | polysome(GO:0005844) |
0.4 | 0.4 | GO:0000153 | cytoplasmic ubiquitin ligase complex(GO:0000153) |
0.4 | 6.3 | GO:0055037 | recycling endosome(GO:0055037) |
0.4 | 28.1 | GO:0000151 | ubiquitin ligase complex(GO:0000151) |
0.4 | 3.9 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.3 | 2.4 | GO:0036157 | outer dynein arm(GO:0036157) |
0.3 | 2.7 | GO:0016235 | aggresome(GO:0016235) |
0.3 | 3.0 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.3 | 22.3 | GO:0031965 | nuclear membrane(GO:0031965) |
0.3 | 1.7 | GO:0032994 | protein-lipid complex(GO:0032994) |
0.3 | 1.0 | GO:1902555 | endoribonuclease complex(GO:1902555) |
0.3 | 0.3 | GO:0005588 | collagen type V trimer(GO:0005588) |
0.3 | 1.0 | GO:0030665 | clathrin-coated vesicle membrane(GO:0030665) |
0.3 | 58.6 | GO:0005730 | nucleolus(GO:0005730) |
0.3 | 1.0 | GO:0009898 | cytoplasmic side of plasma membrane(GO:0009898) |
0.3 | 7.6 | GO:0042579 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.3 | 1.3 | GO:0031091 | platelet alpha granule(GO:0031091) |
0.3 | 4.7 | GO:0015935 | small ribosomal subunit(GO:0015935) |
0.3 | 0.6 | GO:0097208 | alveolar lamellar body(GO:0097208) |
0.3 | 144.5 | GO:0005829 | cytosol(GO:0005829) |
0.3 | 0.3 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
0.3 | 1.5 | GO:0042587 | glycogen granule(GO:0042587) |
0.3 | 4.6 | GO:0032040 | small-subunit processome(GO:0032040) |
0.3 | 1.7 | GO:0030119 | AP-type membrane coat adaptor complex(GO:0030119) |
0.3 | 0.9 | GO:0002177 | manchette(GO:0002177) |
0.3 | 0.8 | GO:0032279 | asymmetric synapse(GO:0032279) |
0.3 | 0.6 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
0.3 | 2.5 | GO:0015630 | microtubule cytoskeleton(GO:0015630) |
0.3 | 0.8 | GO:0098642 | collagen type IV trimer(GO:0005587) network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) basement membrane collagen trimer(GO:0098651) |
0.3 | 37.9 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.3 | 0.3 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.3 | 0.3 | GO:0031902 | late endosome membrane(GO:0031902) |
0.3 | 159.1 | GO:0005783 | endoplasmic reticulum(GO:0005783) |
0.3 | 2.9 | GO:0031252 | cell leading edge(GO:0031252) |
0.3 | 1.3 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.3 | 29.6 | GO:0005815 | microtubule organizing center(GO:0005815) |
0.3 | 0.5 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
0.2 | 0.9 | GO:0000781 | chromosome, telomeric region(GO:0000781) |
0.2 | 3.3 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.2 | 0.4 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.2 | 1.5 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.2 | 0.8 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.2 | 4.0 | GO:0005903 | brush border(GO:0005903) |
0.2 | 1.3 | GO:0005732 | small nucleolar ribonucleoprotein complex(GO:0005732) |
0.2 | 0.4 | GO:0033176 | proton-transporting V-type ATPase complex(GO:0033176) |
0.2 | 1.1 | GO:0071011 | precatalytic spliceosome(GO:0071011) |
0.2 | 2.6 | GO:0000793 | condensed chromosome(GO:0000793) |
0.2 | 0.5 | GO:0046540 | U4/U6 x U5 tri-snRNP complex(GO:0046540) |
0.2 | 8.7 | GO:0005856 | cytoskeleton(GO:0005856) |
0.2 | 13.8 | GO:0005764 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
0.2 | 0.2 | GO:0034993 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.2 | 2.2 | GO:0005795 | Golgi stack(GO:0005795) |
0.2 | 1.5 | GO:0090665 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.2 | 0.6 | GO:0098636 | protein complex involved in cell adhesion(GO:0098636) |
0.1 | 3.3 | GO:0071013 | catalytic step 2 spliceosome(GO:0071013) |
0.1 | 3.2 | GO:0005681 | spliceosomal complex(GO:0005681) |
0.1 | 0.1 | GO:0000346 | transcription export complex(GO:0000346) |
0.1 | 0.1 | GO:0090576 | RNA polymerase III transcription factor complex(GO:0090576) |
0.1 | 0.4 | GO:0060091 | kinocilium(GO:0060091) |
0.1 | 0.1 | GO:0030880 | RNA polymerase complex(GO:0030880) |
0.1 | 0.1 | GO:0033178 | proton-transporting two-sector ATPase complex, catalytic domain(GO:0033178) |
0.1 | 0.1 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.1 | 0.5 | GO:0031988 | membrane-bounded vesicle(GO:0031988) |
0.1 | 16.4 | GO:0005773 | vacuole(GO:0005773) |
0.1 | 232.4 | GO:0005737 | cytoplasm(GO:0005737) |
0.1 | 2.6 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
0.1 | 3.0 | GO:0005581 | collagen trimer(GO:0005581) |
0.0 | 0.1 | GO:0001533 | cornified envelope(GO:0001533) |
0.0 | 0.1 | GO:0097225 | sperm midpiece(GO:0097225) |
0.0 | 0.0 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
0.0 | 0.0 | GO:0030057 | desmosome(GO:0030057) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.2 | 12.6 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
3.9 | 11.7 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
3.9 | 11.7 | GO:0015440 | peptide-transporting ATPase activity(GO:0015440) |
3.9 | 15.6 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
3.6 | 10.7 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
3.5 | 10.6 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
3.3 | 13.0 | GO:0098748 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
3.2 | 6.4 | GO:0048030 | disaccharide binding(GO:0048030) |
3.2 | 9.6 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
3.1 | 30.7 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
3.0 | 8.9 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
3.0 | 8.9 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
2.9 | 23.3 | GO:0030235 | nitric-oxide synthase regulator activity(GO:0030235) |
2.9 | 11.4 | GO:0002060 | purine nucleobase binding(GO:0002060) |
2.8 | 19.8 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
2.8 | 2.8 | GO:0010340 | carboxyl-O-methyltransferase activity(GO:0010340) protein carboxyl O-methyltransferase activity(GO:0051998) |
2.7 | 8.2 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
2.7 | 10.7 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
2.6 | 12.9 | GO:1990239 | steroid hormone binding(GO:1990239) |
2.6 | 12.9 | GO:0051525 | NFAT protein binding(GO:0051525) |
2.5 | 7.6 | GO:0008142 | oxysterol binding(GO:0008142) |
2.5 | 27.9 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
2.5 | 12.6 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
2.5 | 7.5 | GO:0035175 | histone kinase activity (H3-S10 specific)(GO:0035175) |
2.5 | 17.5 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
2.5 | 9.9 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
2.5 | 2.5 | GO:0005168 | neurotrophin TRKA receptor binding(GO:0005168) |
2.4 | 21.8 | GO:0017166 | vinculin binding(GO:0017166) |
2.4 | 9.5 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
2.4 | 11.8 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
2.3 | 11.6 | GO:0043426 | MRF binding(GO:0043426) |
2.3 | 6.9 | GO:0004104 | cholinesterase activity(GO:0004104) |
2.2 | 6.7 | GO:0001226 | RNA polymerase II transcription corepressor binding(GO:0001226) |
2.2 | 6.7 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
2.2 | 37.1 | GO:0008307 | structural constituent of muscle(GO:0008307) |
2.2 | 10.9 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
2.1 | 6.4 | GO:0035877 | death effector domain binding(GO:0035877) |
2.1 | 12.7 | GO:0001727 | lipid kinase activity(GO:0001727) |
2.1 | 8.4 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
2.1 | 6.3 | GO:1990460 | leptin receptor binding(GO:1990460) |
2.1 | 12.4 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
2.1 | 6.2 | GO:0016971 | flavin-linked sulfhydryl oxidase activity(GO:0016971) |
2.1 | 8.2 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
2.1 | 6.2 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
2.0 | 26.0 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
2.0 | 21.8 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
1.9 | 1.9 | GO:0046978 | TAP1 binding(GO:0046978) TAP2 binding(GO:0046979) |
1.9 | 9.4 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
1.9 | 5.6 | GO:0050816 | phosphothreonine binding(GO:0050816) |
1.9 | 9.3 | GO:0019960 | C-X3-C chemokine binding(GO:0019960) |
1.9 | 3.7 | GO:0047623 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
1.8 | 7.4 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
1.8 | 1.8 | GO:0001224 | RNA polymerase II transcription cofactor binding(GO:0001224) |
1.8 | 5.5 | GO:0051425 | PTB domain binding(GO:0051425) |
1.8 | 3.7 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
1.8 | 5.5 | GO:0030620 | U2 snRNA binding(GO:0030620) |
1.8 | 23.8 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
1.8 | 5.5 | GO:0030911 | TPR domain binding(GO:0030911) |
1.8 | 5.5 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
1.8 | 5.4 | GO:0031493 | nucleosomal histone binding(GO:0031493) |
1.8 | 5.4 | GO:0015065 | uridine nucleotide receptor activity(GO:0015065) G-protein coupled pyrimidinergic nucleotide receptor activity(GO:0071553) |
1.8 | 7.2 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
1.8 | 5.4 | GO:0050692 | DBD domain binding(GO:0050692) |
1.8 | 7.1 | GO:0034713 | type I transforming growth factor beta receptor binding(GO:0034713) |
1.8 | 7.1 | GO:0019158 | fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
1.8 | 8.8 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
1.8 | 1.8 | GO:0070573 | metallodipeptidase activity(GO:0070573) |
1.7 | 7.0 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
1.7 | 31.5 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
1.7 | 7.0 | GO:0003985 | acetyl-CoA C-acetyltransferase activity(GO:0003985) C-acetyltransferase activity(GO:0016453) |
1.7 | 5.2 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) |
1.7 | 5.2 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
1.7 | 1.7 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
1.7 | 8.6 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
1.7 | 13.6 | GO:0001164 | RNA polymerase I regulatory region sequence-specific DNA binding(GO:0001163) RNA polymerase I CORE element sequence-specific DNA binding(GO:0001164) |
1.7 | 6.8 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
1.7 | 5.0 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
1.7 | 15.1 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
1.7 | 6.7 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
1.7 | 5.0 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
1.7 | 10.0 | GO:0004439 | phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity(GO:0004439) |
1.6 | 4.9 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
1.6 | 11.5 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
1.6 | 1.6 | GO:0031852 | mu-type opioid receptor binding(GO:0031852) |
1.6 | 8.1 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
1.6 | 4.9 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
1.6 | 11.3 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
1.6 | 4.8 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
1.6 | 15.8 | GO:0044548 | S100 protein binding(GO:0044548) |
1.6 | 1.6 | GO:0015563 | uptake transmembrane transporter activity(GO:0015563) |
1.6 | 6.3 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
1.6 | 3.1 | GO:0010181 | FMN binding(GO:0010181) |
1.5 | 4.6 | GO:1990188 | euchromatin binding(GO:1990188) |
1.5 | 4.6 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
1.5 | 9.1 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
1.5 | 9.1 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
1.5 | 84.9 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
1.5 | 3.0 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
1.5 | 19.6 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
1.5 | 4.5 | GO:0050815 | phosphoserine binding(GO:0050815) |
1.5 | 7.5 | GO:0035473 | lipase binding(GO:0035473) |
1.5 | 3.0 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
1.5 | 14.8 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
1.5 | 5.9 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
1.5 | 21.8 | GO:0017049 | GTP-Rho binding(GO:0017049) |
1.5 | 5.8 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
1.4 | 7.2 | GO:0042015 | interleukin-20 binding(GO:0042015) |
1.4 | 4.3 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
1.4 | 7.2 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
1.4 | 15.9 | GO:0034946 | 2-oxoglutaryl-CoA thioesterase activity(GO:0034843) 2,4,4-trimethyl-3-oxopentanoyl-CoA thioesterase activity(GO:0034869) 3-isopropylbut-3-enoyl-CoA thioesterase activity(GO:0034946) glutaryl-CoA hydrolase activity(GO:0044466) |
1.4 | 1.4 | GO:0004676 | 3-phosphoinositide-dependent protein kinase activity(GO:0004676) |
1.4 | 8.7 | GO:0048185 | activin binding(GO:0048185) |
1.4 | 11.5 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) |
1.4 | 8.6 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
1.4 | 1.4 | GO:0033142 | progesterone receptor binding(GO:0033142) |
1.4 | 18.6 | GO:0016505 | peptidase activator activity involved in apoptotic process(GO:0016505) |
1.4 | 1.4 | GO:0047391 | alkylglycerophosphoethanolamine phosphodiesterase activity(GO:0047391) |
1.4 | 2.8 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
1.4 | 9.9 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
1.4 | 15.5 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
1.4 | 5.6 | GO:0009374 | biotin binding(GO:0009374) |
1.4 | 5.6 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
1.4 | 8.4 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
1.4 | 5.6 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
1.4 | 8.4 | GO:0004064 | arylesterase activity(GO:0004064) |
1.4 | 8.3 | GO:0016936 | galactoside binding(GO:0016936) |
1.4 | 2.8 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
1.4 | 2.8 | GO:0019956 | chemokine binding(GO:0019956) |
1.4 | 4.1 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
1.4 | 6.8 | GO:0032405 | MutLalpha complex binding(GO:0032405) |
1.4 | 1.4 | GO:0051033 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
1.4 | 29.9 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
1.4 | 4.1 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
1.4 | 2.7 | GO:0004698 | calcium-dependent protein kinase C activity(GO:0004698) |
1.4 | 4.1 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
1.4 | 4.1 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
1.3 | 6.7 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
1.3 | 1.3 | GO:0036435 | K48-linked polyubiquitin binding(GO:0036435) |
1.3 | 2.7 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
1.3 | 5.3 | GO:0010858 | calcium-dependent protein kinase regulator activity(GO:0010858) |
1.3 | 4.0 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
1.3 | 2.6 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
1.3 | 9.2 | GO:0035014 | phosphatidylinositol 3-kinase regulator activity(GO:0035014) |
1.3 | 3.9 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
1.3 | 5.2 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
1.3 | 1.3 | GO:0031014 | troponin T binding(GO:0031014) |
1.3 | 6.5 | GO:0015204 | urea transmembrane transporter activity(GO:0015204) |
1.3 | 6.5 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
1.3 | 2.6 | GO:1904680 | peptide transmembrane transporter activity(GO:1904680) |
1.3 | 5.2 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
1.3 | 1.3 | GO:0034618 | arginine binding(GO:0034618) |
1.3 | 29.7 | GO:0043531 | ADP binding(GO:0043531) |
1.3 | 14.2 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
1.3 | 1.3 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
1.3 | 3.9 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
1.3 | 1.3 | GO:0019238 | cyclohydrolase activity(GO:0019238) |
1.3 | 3.8 | GO:0033613 | activating transcription factor binding(GO:0033613) |
1.3 | 2.5 | GO:0034648 | histone demethylase activity (H3-dimethyl-K4 specific)(GO:0034648) |
1.3 | 3.8 | GO:0042895 | antibiotic transporter activity(GO:0042895) |
1.3 | 6.3 | GO:0004784 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
1.3 | 3.8 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
1.3 | 12.5 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
1.2 | 3.7 | GO:0004359 | glutaminase activity(GO:0004359) |
1.2 | 4.9 | GO:0052744 | phosphatidylinositol monophosphate phosphatase activity(GO:0052744) |
1.2 | 6.2 | GO:0031013 | troponin I binding(GO:0031013) |
1.2 | 13.6 | GO:0004312 | fatty acid synthase activity(GO:0004312) |
1.2 | 6.1 | GO:0017169 | CDP-alcohol phosphatidyltransferase activity(GO:0017169) |
1.2 | 12.3 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
1.2 | 6.1 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
1.2 | 3.7 | GO:0019237 | centromeric DNA binding(GO:0019237) |
1.2 | 4.9 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
1.2 | 4.9 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
1.2 | 4.9 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
1.2 | 13.3 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
1.2 | 4.8 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
1.2 | 4.8 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
1.2 | 2.4 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
1.2 | 8.4 | GO:0005223 | intracellular cGMP activated cation channel activity(GO:0005223) |
1.2 | 3.6 | GO:0016823 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
1.2 | 8.4 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
1.2 | 3.6 | GO:0034191 | apolipoprotein A-I receptor binding(GO:0034191) |
1.2 | 3.6 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
1.2 | 3.6 | GO:0047276 | N-acetyllactosaminide 3-alpha-galactosyltransferase activity(GO:0047276) |
1.2 | 9.4 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
1.2 | 31.5 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
1.2 | 9.3 | GO:0019103 | pyrimidine nucleotide binding(GO:0019103) |
1.2 | 3.5 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
1.2 | 3.5 | GO:0019770 | IgG receptor activity(GO:0019770) |
1.2 | 2.3 | GO:0019145 | aminobutyraldehyde dehydrogenase activity(GO:0019145) 4-trimethylammoniobutyraldehyde dehydrogenase activity(GO:0047105) |
1.2 | 2.3 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
1.1 | 9.1 | GO:0046972 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
1.1 | 9.1 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
1.1 | 19.3 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
1.1 | 4.5 | GO:0034235 | GPI anchor binding(GO:0034235) |
1.1 | 3.4 | GO:0016149 | translation release factor activity, codon specific(GO:0016149) |
1.1 | 2.3 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) |
1.1 | 3.4 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
1.1 | 5.6 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
1.1 | 6.7 | GO:0070991 | medium-chain-acyl-CoA dehydrogenase activity(GO:0070991) |
1.1 | 3.4 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
1.1 | 3.4 | GO:0070840 | dynein complex binding(GO:0070840) |
1.1 | 2.2 | GO:0034040 | lipid-transporting ATPase activity(GO:0034040) |
1.1 | 5.6 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
1.1 | 5.6 | GO:0042609 | CD4 receptor binding(GO:0042609) |
1.1 | 12.2 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
1.1 | 8.9 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
1.1 | 2.2 | GO:2001070 | starch binding(GO:2001070) |
1.1 | 3.3 | GO:0008187 | poly-pyrimidine tract binding(GO:0008187) |
1.1 | 1.1 | GO:0004448 | isocitrate dehydrogenase activity(GO:0004448) |
1.1 | 5.5 | GO:0051920 | peroxiredoxin activity(GO:0051920) |
1.1 | 3.3 | GO:0019153 | protein-disulfide reductase (glutathione) activity(GO:0019153) |
1.1 | 19.8 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
1.1 | 4.4 | GO:0051434 | BH3 domain binding(GO:0051434) |
1.1 | 11.0 | GO:0003993 | acid phosphatase activity(GO:0003993) |
1.1 | 3.3 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
1.1 | 4.4 | GO:0047238 | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047238) |
1.1 | 3.3 | GO:0032767 | copper-dependent protein binding(GO:0032767) |
1.1 | 4.4 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
1.1 | 3.3 | GO:1901702 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
1.1 | 4.4 | GO:0022833 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
1.1 | 3.3 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
1.1 | 10.9 | GO:0043295 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
1.1 | 3.3 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
1.1 | 4.3 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
1.1 | 1.1 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
1.1 | 19.4 | GO:0046961 | proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
1.1 | 4.3 | GO:0052834 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
1.1 | 2.1 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
1.1 | 5.4 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
1.1 | 12.9 | GO:0005521 | lamin binding(GO:0005521) |
1.1 | 3.2 | GO:0016649 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
1.1 | 11.6 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
1.1 | 2.1 | GO:0031697 | beta-1 adrenergic receptor binding(GO:0031697) |
1.1 | 6.3 | GO:0001091 | RNA polymerase II basal transcription factor binding(GO:0001091) |
1.1 | 6.3 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
1.1 | 2.1 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
1.0 | 2.1 | GO:0004096 | catalase activity(GO:0004096) |
1.0 | 16.7 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
1.0 | 5.2 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
1.0 | 19.8 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
1.0 | 5.2 | GO:0003933 | GTP cyclohydrolase activity(GO:0003933) |
1.0 | 3.1 | GO:0015037 | peptide disulfide oxidoreductase activity(GO:0015037) |
1.0 | 29.1 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
1.0 | 9.3 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
1.0 | 54.8 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
1.0 | 4.1 | GO:0004954 | prostanoid receptor activity(GO:0004954) |
1.0 | 7.2 | GO:0043743 | cobinamide kinase activity(GO:0008819) phytol kinase activity(GO:0010276) phenol kinase activity(GO:0018720) cyclin-dependent protein kinase activating kinase regulator activity(GO:0019914) inositol tetrakisphosphate 2-kinase activity(GO:0032942) heptose 7-phosphate kinase activity(GO:0033785) aminoglycoside phosphotransferase activity(GO:0034071) eukaryotic elongation factor-2 kinase regulator activity(GO:0042556) eukaryotic elongation factor-2 kinase activator activity(GO:0042557) LPPG:FO 2-phospho-L-lactate transferase activity(GO:0043743) cytidine kinase activity(GO:0043771) glycerate 2-kinase activity(GO:0043798) (S)-lactate 2-kinase activity(GO:0043841) phosphoserine:homoserine phosphotransferase activity(GO:0043899) L-seryl-tRNA(Sec) kinase activity(GO:0043915) phosphocholine transferase activity(GO:0044605) GTP-dependent polynucleotide kinase activity(GO:0051735) farnesol kinase activity(GO:0052668) CTP:2-trans,-6-trans-farnesol kinase activity(GO:0052669) geraniol kinase activity(GO:0052670) geranylgeraniol kinase activity(GO:0052671) CTP:geranylgeraniol kinase activity(GO:0052672) prenol kinase activity(GO:0052673) 1-phosphatidylinositol-5-kinase activity(GO:0052810) 1-phosphatidylinositol-3-phosphate 4-kinase activity(GO:0052811) phosphatidylinositol-3,4-bisphosphate 5-kinase activity(GO:0052812) inositol-3,4,6-trisphosphate 1-kinase activity(GO:0052835) inositol 5-diphosphate pentakisphosphate 5-kinase activity(GO:0052836) inositol diphosphate tetrakisphosphate kinase activity(GO:0052839) |
1.0 | 6.1 | GO:0004768 | stearoyl-CoA 9-desaturase activity(GO:0004768) |
1.0 | 39.7 | GO:0004402 | histone acetyltransferase activity(GO:0004402) |
1.0 | 4.0 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
1.0 | 9.1 | GO:0005123 | death receptor binding(GO:0005123) |
1.0 | 3.0 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
1.0 | 2.0 | GO:0004611 | phosphoenolpyruvate carboxykinase activity(GO:0004611) |
1.0 | 3.0 | GO:0016215 | acyl-CoA desaturase activity(GO:0016215) |
1.0 | 2.0 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
1.0 | 14.1 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
1.0 | 19.1 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
1.0 | 8.0 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
1.0 | 17.8 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
1.0 | 2.9 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
1.0 | 6.9 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
1.0 | 2.9 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
1.0 | 1.0 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
1.0 | 22.4 | GO:0001103 | RNA polymerase II repressing transcription factor binding(GO:0001103) |
1.0 | 20.5 | GO:0016645 | oxidoreductase activity, acting on the CH-NH group of donors(GO:0016645) |
1.0 | 3.9 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
1.0 | 10.7 | GO:0008432 | JUN kinase binding(GO:0008432) |
1.0 | 10.6 | GO:0016832 | aldehyde-lyase activity(GO:0016832) |
1.0 | 3.9 | GO:0070728 | leucine binding(GO:0070728) |
1.0 | 1.0 | GO:0051380 | norepinephrine binding(GO:0051380) |
1.0 | 3.8 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
1.0 | 1.0 | GO:0035870 | dITP diphosphatase activity(GO:0035870) XTP diphosphatase activity(GO:0036222) |
1.0 | 12.4 | GO:0019789 | SUMO transferase activity(GO:0019789) |
1.0 | 1.9 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
1.0 | 13.3 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
0.9 | 2.8 | GO:0005522 | profilin binding(GO:0005522) |
0.9 | 6.6 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.9 | 3.8 | GO:0102344 | 3-hydroxy-behenoyl-CoA dehydratase activity(GO:0102344) 3-hydroxy-lignoceroyl-CoA dehydratase activity(GO:0102345) |
0.9 | 4.7 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
0.9 | 2.8 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.9 | 6.6 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.9 | 3.8 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.9 | 7.5 | GO:0032041 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) |
0.9 | 2.8 | GO:0030984 | kininogen binding(GO:0030984) |
0.9 | 0.9 | GO:0031749 | D2 dopamine receptor binding(GO:0031749) |
0.9 | 17.7 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.9 | 3.7 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
0.9 | 3.7 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
0.9 | 8.3 | GO:0031996 | thioesterase binding(GO:0031996) |
0.9 | 68.5 | GO:0031072 | heat shock protein binding(GO:0031072) |
0.9 | 4.6 | GO:0035325 | Toll-like receptor binding(GO:0035325) |
0.9 | 8.3 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.9 | 2.7 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
0.9 | 3.7 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.9 | 1.8 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
0.9 | 7.3 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.9 | 18.1 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.9 | 9.9 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.9 | 7.2 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.9 | 5.4 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.9 | 3.6 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.9 | 0.9 | GO:0038181 | bile acid receptor activity(GO:0038181) |
0.9 | 14.3 | GO:0048365 | Rac GTPase binding(GO:0048365) |
0.9 | 8.9 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.9 | 26.7 | GO:0015485 | cholesterol binding(GO:0015485) |
0.9 | 2.7 | GO:0030350 | iron-responsive element binding(GO:0030350) |
0.9 | 3.5 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
0.9 | 8.8 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
0.9 | 28.3 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.9 | 0.9 | GO:0042171 | lysophosphatidic acid acyltransferase activity(GO:0042171) |
0.9 | 3.5 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
0.9 | 4.3 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.9 | 2.6 | GO:0050693 | LBD domain binding(GO:0050693) |
0.9 | 25.1 | GO:0097472 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) cyclin-dependent protein kinase activity(GO:0097472) |
0.9 | 14.7 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) |
0.9 | 12.0 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.9 | 7.7 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.9 | 1.7 | GO:0070411 | I-SMAD binding(GO:0070411) |
0.9 | 2.6 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.9 | 6.8 | GO:0031491 | nucleosome binding(GO:0031491) |
0.8 | 1.7 | GO:0016803 | ether hydrolase activity(GO:0016803) |
0.8 | 5.1 | GO:0035312 | 5'-3' exodeoxyribonuclease activity(GO:0035312) |
0.8 | 5.9 | GO:0034046 | poly(G) binding(GO:0034046) |
0.8 | 3.4 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.8 | 1.7 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
0.8 | 2.5 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.8 | 23.5 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) ubiquitin-like protein conjugating enzyme activity(GO:0061650) |
0.8 | 6.7 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
0.8 | 5.0 | GO:0016868 | intramolecular transferase activity, phosphotransferases(GO:0016868) |
0.8 | 13.3 | GO:0031593 | polyubiquitin binding(GO:0031593) |
0.8 | 9.1 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.8 | 12.3 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.8 | 3.3 | GO:0003840 | gamma-glutamyltransferase activity(GO:0003840) glutathione hydrolase activity(GO:0036374) |
0.8 | 3.3 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.8 | 2.4 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.8 | 4.1 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.8 | 3.2 | GO:0032184 | SUMO polymer binding(GO:0032184) |
0.8 | 12.9 | GO:0001871 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.8 | 3.2 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) |
0.8 | 1.6 | GO:0050145 | nucleoside phosphate kinase activity(GO:0050145) |
0.8 | 6.4 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.8 | 7.2 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.8 | 4.8 | GO:0035591 | signaling adaptor activity(GO:0035591) |
0.8 | 4.8 | GO:0016443 | bidentate ribonuclease III activity(GO:0016443) |
0.8 | 10.3 | GO:0008242 | omega peptidase activity(GO:0008242) |
0.8 | 13.4 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.8 | 147.5 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.8 | 7.9 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.8 | 3.9 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.8 | 3.9 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
0.8 | 6.2 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
0.8 | 4.7 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
0.8 | 3.1 | GO:0098639 | collagen binding involved in cell-matrix adhesion(GO:0098639) |
0.8 | 7.0 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.8 | 7.8 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.8 | 3.1 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
0.8 | 7.7 | GO:0045309 | protein phosphorylated amino acid binding(GO:0045309) |
0.8 | 3.1 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.8 | 1.5 | GO:0008898 | S-adenosylmethionine-homocysteine S-methyltransferase activity(GO:0008898) |
0.8 | 2.3 | GO:0046404 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) |
0.8 | 2.3 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
0.8 | 3.1 | GO:0031705 | bombesin receptor binding(GO:0031705) |
0.8 | 3.1 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.8 | 2.3 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.8 | 11.5 | GO:0071949 | FAD binding(GO:0071949) |
0.8 | 3.1 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.8 | 15.2 | GO:0015002 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.8 | 0.8 | GO:0032357 | oxidized DNA binding(GO:0032356) oxidized purine DNA binding(GO:0032357) |
0.8 | 6.8 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.8 | 0.8 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.8 | 2.3 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
0.7 | 13.5 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.7 | 37.5 | GO:0019003 | GDP binding(GO:0019003) |
0.7 | 7.5 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
0.7 | 11.2 | GO:0008308 | voltage-gated anion channel activity(GO:0008308) |
0.7 | 10.4 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
0.7 | 1.5 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.7 | 2.2 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
0.7 | 2.2 | GO:0048273 | mitogen-activated protein kinase p38 binding(GO:0048273) |
0.7 | 3.7 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
0.7 | 0.7 | GO:0031690 | adrenergic receptor binding(GO:0031690) |
0.7 | 2.9 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.7 | 16.8 | GO:0001102 | RNA polymerase II activating transcription factor binding(GO:0001102) |
0.7 | 8.0 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.7 | 2.9 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.7 | 13.8 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.7 | 6.5 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
0.7 | 2.2 | GO:0046915 | transition metal ion transmembrane transporter activity(GO:0046915) |
0.7 | 2.9 | GO:0004308 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.7 | 8.6 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.7 | 2.1 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.7 | 3.6 | GO:0019206 | nucleoside kinase activity(GO:0019206) |
0.7 | 0.7 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.7 | 2.1 | GO:1901612 | cardiolipin binding(GO:1901612) |
0.7 | 0.7 | GO:0001846 | opsonin binding(GO:0001846) |
0.7 | 13.4 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
0.7 | 0.7 | GO:0016717 | oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water(GO:0016717) |
0.7 | 7.7 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
0.7 | 1.4 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
0.7 | 1.4 | GO:0030371 | translation repressor activity(GO:0030371) |
0.7 | 9.7 | GO:0017022 | myosin binding(GO:0017022) |
0.7 | 2.1 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
0.7 | 17.3 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.7 | 2.1 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
0.7 | 0.7 | GO:0030275 | LRR domain binding(GO:0030275) |
0.7 | 3.4 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.7 | 8.8 | GO:0005351 | sugar:proton symporter activity(GO:0005351) |
0.7 | 4.8 | GO:0008198 | ferrous iron binding(GO:0008198) |
0.7 | 1.4 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
0.7 | 16.3 | GO:0051990 | (R)-2-hydroxyglutarate dehydrogenase activity(GO:0051990) |
0.7 | 9.5 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.7 | 2.0 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.7 | 3.3 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.7 | 2.7 | GO:0015232 | heme transporter activity(GO:0015232) |
0.7 | 85.5 | GO:0061630 | ubiquitin protein ligase activity(GO:0061630) ubiquitin-like protein ligase activity(GO:0061659) |
0.7 | 4.0 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
0.7 | 1.3 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
0.7 | 3.3 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.7 | 4.0 | GO:0070402 | NADPH binding(GO:0070402) |
0.7 | 2.0 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.7 | 2.7 | GO:0000182 | rDNA binding(GO:0000182) |
0.7 | 0.7 | GO:0031369 | translation initiation factor binding(GO:0031369) |
0.7 | 2.0 | GO:0004024 | alcohol dehydrogenase activity, zinc-dependent(GO:0004024) |
0.7 | 4.6 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.7 | 15.8 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.7 | 4.6 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.7 | 3.3 | GO:0042301 | phosphate ion binding(GO:0042301) |
0.7 | 9.2 | GO:0016864 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.7 | 2.0 | GO:0071253 | connexin binding(GO:0071253) |
0.7 | 3.3 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.7 | 2.6 | GO:0008430 | selenium binding(GO:0008430) |
0.7 | 2.6 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
0.7 | 3.3 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.6 | 0.6 | GO:0031711 | bradykinin receptor binding(GO:0031711) |
0.6 | 11.0 | GO:0004551 | nucleotide diphosphatase activity(GO:0004551) |
0.6 | 5.2 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.6 | 3.2 | GO:0050681 | androgen receptor binding(GO:0050681) |
0.6 | 0.6 | GO:0016530 | metallochaperone activity(GO:0016530) |
0.6 | 1.3 | GO:0004630 | phospholipase D activity(GO:0004630) |
0.6 | 1.3 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.6 | 1.9 | GO:0055100 | adiponectin binding(GO:0055100) |
0.6 | 12.7 | GO:0004532 | exoribonuclease activity(GO:0004532) |
0.6 | 7.6 | GO:0070717 | poly-purine tract binding(GO:0070717) |
0.6 | 3.2 | GO:0001223 | transcription coactivator binding(GO:0001223) |
0.6 | 0.6 | GO:0051765 | inositol tetrakisphosphate kinase activity(GO:0051765) |
0.6 | 6.9 | GO:0001221 | transcription cofactor binding(GO:0001221) |
0.6 | 4.4 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.6 | 5.6 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
0.6 | 1.9 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
0.6 | 2.5 | GO:0034793 | succinate-CoA ligase activity(GO:0004774) 3-oxo-2-(2'-pentenyl)cyclopentane-1-octanoic acid CoA ligase activity(GO:0010435) 3-isopropenyl-6-oxoheptanoyl-CoA synthetase activity(GO:0018854) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA synthetase activity(GO:0018855) benzoyl acetate-CoA ligase activity(GO:0018856) 2,4-dichlorobenzoate-CoA ligase activity(GO:0018857) pivalate-CoA ligase activity(GO:0034783) cyclopropanecarboxylate-CoA ligase activity(GO:0034793) adipate-CoA ligase activity(GO:0034796) citronellyl-CoA ligase activity(GO:0034823) mentha-1,3-dione-CoA ligase activity(GO:0034841) thiophene-2-carboxylate-CoA ligase activity(GO:0034842) 2,4,4-trimethylpentanoate-CoA ligase activity(GO:0034865) cis-2-methyl-5-isopropylhexa-2,5-dienoate-CoA ligase activity(GO:0034942) trans-2-methyl-5-isopropylhexa-2,5-dienoate-CoA ligase activity(GO:0034943) branched-chain acyl-CoA synthetase (ADP-forming) activity(GO:0043759) aryl-CoA synthetase (ADP-forming) activity(GO:0043762) 3-hydroxypropionyl-CoA synthetase activity(GO:0043955) perillic acid:CoA ligase (ADP-forming) activity(GO:0052685) perillic acid:CoA ligase (AMP-forming) activity(GO:0052686) (3R)-3-isopropenyl-6-oxoheptanoate:CoA ligase (ADP-forming) activity(GO:0052687) (3R)-3-isopropenyl-6-oxoheptanoate:CoA ligase (AMP-forming) activity(GO:0052688) pristanate-CoA ligase activity(GO:0070251) malonyl-CoA synthetase activity(GO:0090409) |
0.6 | 1.2 | GO:0030957 | Tat protein binding(GO:0030957) |
0.6 | 1.2 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
0.6 | 2.5 | GO:0042974 | retinoic acid receptor binding(GO:0042974) |
0.6 | 3.1 | GO:0032183 | SUMO binding(GO:0032183) |
0.6 | 1.8 | GO:0019976 | interleukin-2 binding(GO:0019976) |
0.6 | 1.8 | GO:0043141 | ATP-dependent 5'-3' DNA helicase activity(GO:0043141) |
0.6 | 0.6 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
0.6 | 3.7 | GO:0031434 | mitogen-activated protein kinase kinase binding(GO:0031434) |
0.6 | 1.8 | GO:0070325 | lipoprotein particle receptor binding(GO:0070325) |
0.6 | 1.2 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
0.6 | 0.6 | GO:0086008 | voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization(GO:0086008) |
0.6 | 1.8 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.6 | 1.2 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
0.6 | 3.0 | GO:0016624 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor(GO:0016624) |
0.6 | 1.8 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
0.6 | 18.1 | GO:0032947 | protein complex scaffold(GO:0032947) |
0.6 | 3.0 | GO:0018501 | enoyl-[acyl-carrier-protein] reductase activity(GO:0016631) 2,3-dihydroxy-2,3-dihydro-phenylpropionate dehydrogenase activity(GO:0018498) cis-2,3-dihydrodiol DDT dehydrogenase activity(GO:0018499) trans-9R,10R-dihydrodiolphenanthrene dehydrogenase activity(GO:0018500) cis-chlorobenzene dihydrodiol dehydrogenase activity(GO:0018501) 2,5-dichloro-2,5-cyclohexadiene-1,4-diol dehydrogenase activity(GO:0018502) trans-1,2-dihydrodiolphenanthrene dehydrogenase activity(GO:0018503) 3,4-dihydroxy-3,4-dihydrofluorene dehydrogenase activity(GO:0034790) benzo(a)pyrene-trans-11,12-dihydrodiol dehydrogenase activity(GO:0034805) benzo(a)pyrene-cis-4,5-dihydrodiol dehydrogenase activity(GO:0034809) citronellyl-CoA dehydrogenase activity(GO:0034824) menthone dehydrogenase activity(GO:0034838) phthalate 3,4-cis-dihydrodiol dehydrogenase activity(GO:0034912) cinnamate reductase activity(GO:0043786) NADPH-dependent curcumin reductase activity(GO:0052849) NADPH-dependent dihydrocurcumin reductase activity(GO:0052850) |
0.6 | 1.8 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
0.6 | 3.0 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.6 | 1.2 | GO:0004779 | sulfate adenylyltransferase activity(GO:0004779) |
0.6 | 2.4 | GO:0036137 | kynurenine-oxoglutarate transaminase activity(GO:0016212) kynurenine aminotransferase activity(GO:0036137) |
0.6 | 1.8 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.6 | 10.6 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
0.6 | 31.2 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
0.6 | 7.6 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
0.6 | 0.6 | GO:0019961 | interferon binding(GO:0019961) |
0.6 | 3.5 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.6 | 3.5 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.6 | 11.1 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
0.6 | 9.4 | GO:0001848 | complement binding(GO:0001848) |
0.6 | 24.6 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.6 | 18.7 | GO:0035064 | methylated histone binding(GO:0035064) |
0.6 | 4.7 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.6 | 1.2 | GO:0070699 | type II activin receptor binding(GO:0070699) |
0.6 | 7.5 | GO:0034573 | protein-N-terminal asparagine amidohydrolase activity(GO:0008418) UDP-3-O-[3-hydroxymyristoyl] N-acetylglucosamine deacetylase activity(GO:0008759) iprodione amidohydrolase activity(GO:0018748) (3,5-dichlorophenylurea)acetate amidohydrolase activity(GO:0018749) 4'-(2-hydroxyisopropyl)phenylurea amidohydrolase activity(GO:0034571) didemethylisoproturon amidohydrolase activity(GO:0034573) N-isopropylacetanilide amidohydrolase activity(GO:0034576) N-cyclohexylformamide amidohydrolase activity(GO:0034781) isonicotinic acid hydrazide hydrolase activity(GO:0034876) cis-aconitamide amidase activity(GO:0034882) gamma-N-formylaminovinylacetate hydrolase activity(GO:0034885) N2-acetyl-L-lysine deacetylase activity(GO:0043747) O-succinylbenzoate synthase activity(GO:0043748) indoleacetamide hydrolase activity(GO:0043864) N-acetylcitrulline deacetylase activity(GO:0043909) N-acetylgalactosamine-6-phosphate deacetylase activity(GO:0047419) diacetylchitobiose deacetylase activity(GO:0052773) chitooligosaccharide deacetylase activity(GO:0052790) |
0.6 | 9.2 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.6 | 2.9 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.6 | 1.7 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.6 | 1.7 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.6 | 1.2 | GO:0019002 | GMP binding(GO:0019002) |
0.6 | 1.1 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.6 | 5.7 | GO:0042805 | actinin binding(GO:0042805) |
0.6 | 1.1 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
0.6 | 6.8 | GO:0005528 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.6 | 0.6 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
0.6 | 2.3 | GO:0042731 | PH domain binding(GO:0042731) |
0.6 | 2.8 | GO:0098505 | G-rich strand telomeric DNA binding(GO:0098505) |
0.6 | 6.2 | GO:0005048 | signal sequence binding(GO:0005048) |
0.6 | 1.1 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.6 | 1.1 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
0.6 | 5.7 | GO:0005542 | folic acid binding(GO:0005542) |
0.6 | 2.3 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
0.6 | 2.3 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.6 | 3.9 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.6 | 1.1 | GO:0070492 | oligosaccharide binding(GO:0070492) |
0.6 | 5.0 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.6 | 1.7 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.6 | 1.1 | GO:0008409 | 5'-3' exonuclease activity(GO:0008409) |
0.6 | 2.2 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.6 | 8.9 | GO:0045502 | dynein binding(GO:0045502) |
0.6 | 1.7 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
0.6 | 56.0 | GO:0016881 | acid-amino acid ligase activity(GO:0016881) |
0.6 | 38.8 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.6 | 8.8 | GO:0042162 | telomeric DNA binding(GO:0042162) |
0.5 | 2.7 | GO:0008097 | 5S rRNA binding(GO:0008097) |
0.5 | 0.5 | GO:0030792 | methylarsonite methyltransferase activity(GO:0030792) |
0.5 | 9.3 | GO:0005537 | mannose binding(GO:0005537) |
0.5 | 1.6 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
0.5 | 1.6 | GO:0035515 | oxidative RNA demethylase activity(GO:0035515) |
0.5 | 35.2 | GO:0036459 | thiol-dependent ubiquitinyl hydrolase activity(GO:0036459) ubiquitinyl hydrolase activity(GO:0101005) |
0.5 | 6.0 | GO:0034185 | apolipoprotein binding(GO:0034185) |
0.5 | 2.2 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.5 | 1.1 | GO:0000339 | RNA cap binding(GO:0000339) |
0.5 | 16.7 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.5 | 23.7 | GO:0005518 | collagen binding(GO:0005518) |
0.5 | 1.6 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) |
0.5 | 3.8 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.5 | 1.1 | GO:1990715 | mRNA CDS binding(GO:1990715) |
0.5 | 2.2 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.5 | 9.1 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.5 | 2.1 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.5 | 4.8 | GO:0033170 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.5 | 132.3 | GO:0003779 | actin binding(GO:0003779) |
0.5 | 7.5 | GO:0016811 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides(GO:0016811) |
0.5 | 1.6 | GO:0050780 | dopamine receptor binding(GO:0050780) |
0.5 | 1.6 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
0.5 | 2.6 | GO:0019203 | carbohydrate phosphatase activity(GO:0019203) sugar-phosphatase activity(GO:0050308) |
0.5 | 1.1 | GO:0015180 | L-alanine transmembrane transporter activity(GO:0015180) alanine transmembrane transporter activity(GO:0022858) |
0.5 | 1.6 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.5 | 14.7 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
0.5 | 0.5 | GO:0004127 | cytidylate kinase activity(GO:0004127) uridylate kinase activity(GO:0009041) |
0.5 | 3.1 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.5 | 1.0 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.5 | 2.1 | GO:0048038 | quinone binding(GO:0048038) |
0.5 | 22.6 | GO:0008565 | protein transporter activity(GO:0008565) |
0.5 | 7.2 | GO:0016684 | oxidoreductase activity, acting on peroxide as acceptor(GO:0016684) |
0.5 | 3.1 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.5 | 2.0 | GO:0015173 | aromatic amino acid transmembrane transporter activity(GO:0015173) |
0.5 | 13.2 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.5 | 1.5 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
0.5 | 2.0 | GO:0004303 | estradiol 17-beta-dehydrogenase activity(GO:0004303) |
0.5 | 0.5 | GO:0038132 | neuregulin binding(GO:0038132) |
0.5 | 1.0 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.5 | 0.5 | GO:0015288 | porin activity(GO:0015288) |
0.5 | 1.0 | GO:0016661 | oxidoreductase activity, acting on other nitrogenous compounds as donors(GO:0016661) |
0.5 | 1.5 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.5 | 5.5 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.5 | 14.6 | GO:0005085 | guanyl-nucleotide exchange factor activity(GO:0005085) |
0.5 | 0.5 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
0.5 | 0.5 | GO:0098847 | sequence-specific single stranded DNA binding(GO:0098847) |
0.5 | 0.5 | GO:0004069 | L-aspartate:2-oxoglutarate aminotransferase activity(GO:0004069) |
0.5 | 3.0 | GO:0016889 | endodeoxyribonuclease activity, producing 3'-phosphomonoesters(GO:0016889) |
0.5 | 17.8 | GO:0051082 | unfolded protein binding(GO:0051082) |
0.5 | 3.0 | GO:0050733 | RS domain binding(GO:0050733) |
0.5 | 4.4 | GO:0008408 | 3'-5' exonuclease activity(GO:0008408) |
0.5 | 16.7 | GO:0016627 | oxidoreductase activity, acting on the CH-CH group of donors(GO:0016627) |
0.5 | 9.3 | GO:0016655 | oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor(GO:0016655) |
0.5 | 1.5 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.5 | 3.9 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
0.5 | 5.4 | GO:0016814 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines(GO:0016814) |
0.5 | 6.8 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.5 | 10.7 | GO:0052712 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) cGMP-inhibited cyclic-nucleotide phosphodiesterase activity(GO:0004119) photoreceptor cyclic-nucleotide phosphodiesterase activity(GO:0004120) 7,8-dihydro-D-neopterin 2',3'-cyclic phosphate phosphodiesterase activity(GO:0044688) inositol phosphosphingolipid phospholipase activity(GO:0052712) inositol phosphorylceramide phospholipase activity(GO:0052713) mannosyl-inositol phosphorylceramide phospholipase activity(GO:0052714) mannosyl-diinositol phosphorylceramide phospholipase activity(GO:0052715) |
0.5 | 6.3 | GO:0016854 | racemase and epimerase activity(GO:0016854) |
0.5 | 2.9 | GO:0003910 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
0.5 | 1.0 | GO:0032451 | demethylase activity(GO:0032451) |
0.5 | 13.9 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.5 | 0.5 | GO:0015301 | anion:anion antiporter activity(GO:0015301) |
0.5 | 1.4 | GO:0033691 | sialic acid binding(GO:0033691) |
0.5 | 7.1 | GO:0004029 | aldehyde dehydrogenase (NAD) activity(GO:0004029) |
0.5 | 1.9 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
0.5 | 0.9 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.5 | 0.5 | GO:0008309 | double-stranded DNA exodeoxyribonuclease activity(GO:0008309) |
0.5 | 1.4 | GO:0019808 | polyamine binding(GO:0019808) |
0.5 | 1.4 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
0.5 | 0.9 | GO:0070548 | L-glutamine aminotransferase activity(GO:0070548) |
0.5 | 2.3 | GO:0000405 | bubble DNA binding(GO:0000405) |
0.5 | 4.2 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.5 | 2.8 | GO:0019966 | interleukin-1 binding(GO:0019966) |
0.5 | 1.4 | GO:0061731 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.5 | 0.5 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
0.5 | 15.8 | GO:0000049 | tRNA binding(GO:0000049) |
0.5 | 3.3 | GO:0035004 | phosphatidylinositol 3-kinase activity(GO:0035004) |
0.5 | 3.7 | GO:0018447 | pinocarveol dehydrogenase activity(GO:0018446) chloral hydrate dehydrogenase activity(GO:0018447) hydroxymethylmethylsilanediol oxidase activity(GO:0018448) 1-phenylethanol dehydrogenase activity(GO:0018449) myrtenol dehydrogenase activity(GO:0018450) cis-1,2-dihydroxy-1,2-dihydro-8-carboxynaphthalene dehydrogenase activity(GO:0034522) 3-hydroxy-4-methyloctanoyl-CoA dehydrogenase activity(GO:0034582) 2-hydroxy-4-isopropenylcyclohexane-1-carboxyl-CoA dehydrogenase activity(GO:0034778) cis-9,10-dihydroanthracene-9,10-diol dehydrogenase activity(GO:0034817) citronellol dehydrogenase activity(GO:0034821) naphthyl-2-hydroxymethyl-succinyl-CoA dehydrogenase activity(GO:0034847) 2,4,4-trimethyl-1-pentanol dehydrogenase activity(GO:0034863) 2,4,4-trimethyl-3-hydroxypentanoyl-CoA dehydrogenase activity(GO:0034868) 1-hydroxy-4,4-dimethylpentan-3-one dehydrogenase activity(GO:0034871) endosulfan diol dehydrogenase activity(GO:0034891) endosulfan hydroxyether dehydrogenase activity(GO:0034901) 3-hydroxy-2-methylhexanoyl-CoA dehydrogenase activity(GO:0034918) 3-hydroxy-2,6-dimethyl-5-methylene-heptanoyl-CoA dehydrogenase activity(GO:0034944) versicolorin reductase activity(GO:0042469) ketoreductase activity(GO:0045703) |
0.5 | 1.4 | GO:0043140 | ATP-dependent 3'-5' DNA helicase activity(GO:0043140) |
0.5 | 0.9 | GO:0004938 | alpha2-adrenergic receptor activity(GO:0004938) |
0.5 | 3.7 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.5 | 3.7 | GO:0016799 | hydrolase activity, hydrolyzing N-glycosyl compounds(GO:0016799) |
0.5 | 1.4 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.5 | 0.9 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
0.5 | 1.8 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.5 | 0.5 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.4 | 9.0 | GO:0070063 | RNA polymerase binding(GO:0070063) |
0.4 | 2.7 | GO:0031386 | protein tag(GO:0031386) |
0.4 | 2.2 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
0.4 | 12.4 | GO:0005507 | copper ion binding(GO:0005507) |
0.4 | 4.0 | GO:0032452 | histone demethylase activity(GO:0032452) |
0.4 | 0.9 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
0.4 | 4.4 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.4 | 1.3 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
0.4 | 6.1 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.4 | 9.0 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.4 | 0.4 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.4 | 0.4 | GO:0032554 | purine deoxyribonucleotide binding(GO:0032554) |
0.4 | 3.4 | GO:0046977 | TAP binding(GO:0046977) |
0.4 | 2.6 | GO:0043274 | phospholipase binding(GO:0043274) |
0.4 | 3.4 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
0.4 | 0.8 | GO:0005047 | signal recognition particle binding(GO:0005047) |
0.4 | 6.3 | GO:0051536 | iron-sulfur cluster binding(GO:0051536) metal cluster binding(GO:0051540) |
0.4 | 0.4 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.4 | 24.0 | GO:0004896 | cytokine receptor activity(GO:0004896) |
0.4 | 1.3 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
0.4 | 1.2 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
0.4 | 7.4 | GO:0032813 | tumor necrosis factor receptor binding(GO:0005164) tumor necrosis factor receptor superfamily binding(GO:0032813) |
0.4 | 8.2 | GO:0043022 | ribosome binding(GO:0043022) |
0.4 | 3.3 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.4 | 0.8 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
0.4 | 0.4 | GO:0086056 | voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
0.4 | 3.7 | GO:0000980 | RNA polymerase II distal enhancer sequence-specific DNA binding(GO:0000980) |
0.4 | 10.6 | GO:0016836 | hydro-lyase activity(GO:0016836) |
0.4 | 23.2 | GO:0005178 | integrin binding(GO:0005178) |
0.4 | 2.0 | GO:0045545 | syndecan binding(GO:0045545) |
0.4 | 0.8 | GO:0009881 | photoreceptor activity(GO:0009881) |
0.4 | 1.2 | GO:0030881 | beta-2-microglobulin binding(GO:0030881) |
0.4 | 14.2 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.4 | 5.7 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.4 | 1.6 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
0.4 | 1.2 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
0.4 | 2.0 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.4 | 2.8 | GO:0008329 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
0.4 | 1.6 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.4 | 7.6 | GO:0032182 | ubiquitin-like protein binding(GO:0032182) |
0.4 | 0.4 | GO:0019198 | transmembrane receptor protein phosphatase activity(GO:0019198) |
0.4 | 9.1 | GO:0016790 | thiolester hydrolase activity(GO:0016790) |
0.4 | 1.6 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.4 | 4.0 | GO:0001618 | virus receptor activity(GO:0001618) |
0.4 | 3.2 | GO:1990446 | U1 snRNP binding(GO:1990446) |
0.4 | 0.4 | GO:0003696 | satellite DNA binding(GO:0003696) |
0.4 | 1.2 | GO:0019767 | IgE receptor activity(GO:0019767) |
0.4 | 1.2 | GO:0015315 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
0.4 | 2.3 | GO:0043236 | laminin binding(GO:0043236) |
0.4 | 3.1 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
0.4 | 1.5 | GO:0016209 | antioxidant activity(GO:0016209) |
0.4 | 70.2 | GO:0005525 | GTP binding(GO:0005525) |
0.4 | 4.6 | GO:0030674 | protein binding, bridging(GO:0030674) |
0.4 | 0.8 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
0.4 | 0.8 | GO:0015928 | fucosidase activity(GO:0015928) |
0.4 | 2.3 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.4 | 1.1 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
0.4 | 1.1 | GO:0004738 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase [NAD(P)+] activity(GO:0034603) pyruvate dehydrogenase (NAD+) activity(GO:0034604) |
0.4 | 2.2 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.4 | 0.7 | GO:0004322 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.4 | 14.6 | GO:0004540 | ribonuclease activity(GO:0004540) |
0.4 | 1.5 | GO:0050072 | m7G(5')pppN diphosphatase activity(GO:0050072) |
0.4 | 0.4 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
0.4 | 8.1 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) |
0.4 | 2.9 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
0.4 | 4.7 | GO:0015925 | galactosidase activity(GO:0015925) |
0.4 | 2.5 | GO:0036442 | hydrogen-exporting ATPase activity(GO:0036442) |
0.4 | 4.6 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.4 | 13.5 | GO:0042393 | histone binding(GO:0042393) |
0.4 | 1.4 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.4 | 2.5 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.4 | 4.3 | GO:0004622 | lysophospholipase activity(GO:0004622) |
0.4 | 0.4 | GO:0051373 | FATZ binding(GO:0051373) |
0.4 | 0.7 | GO:0042285 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.4 | 6.3 | GO:0008094 | DNA-dependent ATPase activity(GO:0008094) |
0.4 | 1.4 | GO:0045296 | cadherin binding(GO:0045296) |
0.3 | 0.3 | GO:0015645 | fatty acid ligase activity(GO:0015645) |
0.3 | 2.4 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.3 | 3.5 | GO:0004519 | endonuclease activity(GO:0004519) |
0.3 | 6.2 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
0.3 | 0.7 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.3 | 1.0 | GO:0005113 | patched binding(GO:0005113) |
0.3 | 1.4 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.3 | 4.1 | GO:0051287 | NAD binding(GO:0051287) |
0.3 | 4.8 | GO:0015299 | solute:proton antiporter activity(GO:0015299) |
0.3 | 14.0 | GO:0005496 | steroid binding(GO:0005496) |
0.3 | 1.0 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
0.3 | 0.3 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
0.3 | 0.3 | GO:0016886 | ligase activity, forming phosphoric ester bonds(GO:0016886) |
0.3 | 12.8 | GO:0019903 | protein phosphatase binding(GO:0019903) |
0.3 | 0.7 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
0.3 | 1.0 | GO:0070996 | type 1 melanocortin receptor binding(GO:0070996) |
0.3 | 19.0 | GO:0008234 | cysteine-type peptidase activity(GO:0008234) |
0.3 | 0.3 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
0.3 | 1.0 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
0.3 | 4.3 | GO:0051117 | ATPase binding(GO:0051117) |
0.3 | 60.4 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.3 | 1.3 | GO:0042979 | ornithine decarboxylase regulator activity(GO:0042979) |
0.3 | 1.0 | GO:0043199 | sulfate binding(GO:0043199) |
0.3 | 1.6 | GO:0009055 | electron carrier activity(GO:0009055) |
0.3 | 0.6 | GO:0034061 | DNA polymerase activity(GO:0034061) |
0.3 | 1.0 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
0.3 | 2.2 | GO:0015194 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.3 | 7.9 | GO:0008907 | integrase activity(GO:0008907) T/G mismatch-specific endonuclease activity(GO:0043765) retroviral integrase activity(GO:0044823) retroviral 3' processing activity(GO:0044824) |
0.3 | 0.6 | GO:0016229 | steroid dehydrogenase activity(GO:0016229) |
0.3 | 0.9 | GO:0052742 | phosphatidylinositol kinase activity(GO:0052742) |
0.3 | 0.9 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.3 | 0.6 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.3 | 0.9 | GO:0008260 | 3-oxoacid CoA-transferase activity(GO:0008260) |
0.3 | 0.9 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
0.3 | 0.6 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
0.3 | 0.3 | GO:0004942 | anaphylatoxin receptor activity(GO:0004942) |
0.3 | 0.3 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.3 | 0.9 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
0.3 | 5.6 | GO:0070003 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.3 | 7.7 | GO:0016875 | ligase activity, forming carbon-oxygen bonds(GO:0016875) ligase activity, forming aminoacyl-tRNA and related compounds(GO:0016876) |
0.3 | 1.2 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
0.3 | 0.3 | GO:0008312 | 7S RNA binding(GO:0008312) |
0.3 | 1.8 | GO:0001104 | RNA polymerase II transcription cofactor activity(GO:0001104) |
0.3 | 1.5 | GO:0030515 | snoRNA binding(GO:0030515) |
0.3 | 4.8 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
0.3 | 3.6 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.3 | 0.9 | GO:0031545 | peptidyl-proline 4-dioxygenase activity(GO:0031545) |
0.3 | 0.3 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
0.3 | 1.8 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.3 | 1.2 | GO:0004518 | nuclease activity(GO:0004518) |
0.3 | 9.1 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.3 | 5.8 | GO:0016763 | transferase activity, transferring pentosyl groups(GO:0016763) |
0.3 | 1.2 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
0.3 | 3.5 | GO:0016776 | phosphotransferase activity, phosphate group as acceptor(GO:0016776) |
0.3 | 1.7 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.3 | 1.4 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
0.3 | 3.4 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.3 | 2.3 | GO:0019865 | immunoglobulin binding(GO:0019865) |
0.3 | 2.5 | GO:0016879 | ligase activity, forming carbon-nitrogen bonds(GO:0016879) |
0.3 | 2.8 | GO:0004629 | phospholipase C activity(GO:0004629) |
0.3 | 0.3 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
0.3 | 1.1 | GO:0000099 | sulfur amino acid transmembrane transporter activity(GO:0000099) |
0.3 | 3.9 | GO:0000287 | magnesium ion binding(GO:0000287) |
0.3 | 22.6 | GO:0004842 | ubiquitin-protein transferase activity(GO:0004842) |
0.3 | 1.1 | GO:0017048 | Rho GTPase binding(GO:0017048) |
0.3 | 2.2 | GO:0017016 | Ras GTPase binding(GO:0017016) |
0.3 | 2.9 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) |
0.3 | 1.3 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
0.3 | 5.0 | GO:0051087 | chaperone binding(GO:0051087) |
0.3 | 6.0 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
0.3 | 3.4 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
0.3 | 4.5 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
0.3 | 0.3 | GO:0032138 | single base insertion or deletion binding(GO:0032138) |
0.3 | 0.8 | GO:1901567 | icosanoid binding(GO:0050542) icosatetraenoic acid binding(GO:0050543) arachidonic acid binding(GO:0050544) fatty acid derivative binding(GO:1901567) |
0.3 | 0.3 | GO:0003954 | NADH dehydrogenase activity(GO:0003954) |
0.3 | 0.5 | GO:0043515 | kinetochore binding(GO:0043515) |
0.3 | 3.4 | GO:0016874 | ligase activity(GO:0016874) |
0.3 | 0.5 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
0.3 | 1.5 | GO:0030249 | guanylate cyclase regulator activity(GO:0030249) |
0.3 | 1.3 | GO:0016820 | hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances(GO:0016820) |
0.3 | 2.0 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.3 | 0.8 | GO:0034062 | RNA polymerase activity(GO:0034062) |
0.2 | 1.2 | GO:0016681 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
0.2 | 15.9 | GO:0003774 | motor activity(GO:0003774) |
0.2 | 3.2 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.2 | 0.2 | GO:0016679 | oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) |
0.2 | 1.2 | GO:0016307 | phosphatidylinositol phosphate kinase activity(GO:0016307) |
0.2 | 7.3 | GO:0016853 | isomerase activity(GO:0016853) |
0.2 | 11.1 | GO:0070035 | ATP-dependent helicase activity(GO:0008026) purine NTP-dependent helicase activity(GO:0070035) |
0.2 | 0.7 | GO:0016015 | morphogen activity(GO:0016015) |
0.2 | 0.7 | GO:0031432 | titin binding(GO:0031432) |
0.2 | 0.5 | GO:1901677 | phosphate transmembrane transporter activity(GO:1901677) |
0.2 | 0.7 | GO:1901505 | carbohydrate derivative transporter activity(GO:1901505) |
0.2 | 1.9 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.2 | 6.5 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
0.2 | 0.9 | GO:1990405 | protein antigen binding(GO:1990405) |
0.2 | 0.9 | GO:0004945 | angiotensin type II receptor activity(GO:0004945) |
0.2 | 0.5 | GO:0050660 | flavin adenine dinucleotide binding(GO:0050660) |
0.2 | 6.5 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.2 | 1.1 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.2 | 1.8 | GO:0043021 | ribonucleoprotein complex binding(GO:0043021) |
0.2 | 107.0 | GO:0044822 | poly(A) RNA binding(GO:0044822) |
0.2 | 22.7 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.2 | 2.2 | GO:0090484 | drug transporter activity(GO:0090484) |
0.2 | 1.9 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.2 | 0.4 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
0.2 | 0.4 | GO:0034593 | phosphatidylinositol bisphosphate phosphatase activity(GO:0034593) phosphatidylinositol phosphate phosphatase activity(GO:0052866) |
0.2 | 0.6 | GO:0016671 | oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor(GO:0016671) |
0.2 | 0.2 | GO:0030507 | spectrin binding(GO:0030507) |
0.2 | 5.8 | GO:0016614 | oxidoreductase activity, acting on CH-OH group of donors(GO:0016614) |
0.2 | 0.4 | GO:0016801 | hydrolase activity, acting on ether bonds(GO:0016801) |
0.2 | 1.0 | GO:0015643 | toxic substance binding(GO:0015643) |
0.2 | 1.0 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) |
0.2 | 1.0 | GO:0008237 | metallopeptidase activity(GO:0008237) |
0.2 | 2.0 | GO:0004177 | aminopeptidase activity(GO:0004177) |
0.2 | 17.7 | GO:0003714 | transcription corepressor activity(GO:0003714) |
0.2 | 0.2 | GO:0034452 | dynactin binding(GO:0034452) |
0.2 | 0.2 | GO:0016769 | transferase activity, transferring nitrogenous groups(GO:0016769) |
0.2 | 0.2 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
0.2 | 2.1 | GO:0008483 | transaminase activity(GO:0008483) |
0.2 | 1.3 | GO:0072349 | modified amino acid transmembrane transporter activity(GO:0072349) |
0.2 | 0.6 | GO:0008823 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
0.2 | 4.0 | GO:0008276 | protein methyltransferase activity(GO:0008276) |
0.2 | 7.4 | GO:0000149 | SNARE binding(GO:0000149) |
0.2 | 3.6 | GO:0042605 | peptide antigen binding(GO:0042605) |
0.2 | 10.6 | GO:0008173 | RNA methyltransferase activity(GO:0008173) |
0.2 | 1.4 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.2 | 1.8 | GO:0016667 | oxidoreductase activity, acting on a sulfur group of donors(GO:0016667) |
0.2 | 0.3 | GO:0003958 | NADPH-hemoprotein reductase activity(GO:0003958) |
0.2 | 0.2 | GO:0034584 | piRNA binding(GO:0034584) |
0.2 | 0.9 | GO:0070628 | proteasome binding(GO:0070628) |
0.2 | 0.5 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.2 | 0.5 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
0.2 | 0.8 | GO:0005111 | type 2 fibroblast growth factor receptor binding(GO:0005111) |
0.2 | 0.3 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
0.2 | 0.2 | GO:0030621 | U4 snRNA binding(GO:0030621) |
0.2 | 0.2 | GO:0031433 | telethonin binding(GO:0031433) |
0.2 | 0.8 | GO:0016641 | oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor(GO:0016641) |
0.2 | 0.2 | GO:0031781 | melanocortin receptor binding(GO:0031779) type 3 melanocortin receptor binding(GO:0031781) type 4 melanocortin receptor binding(GO:0031782) |
0.2 | 9.7 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
0.2 | 0.2 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.2 | 1.2 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.2 | 1.1 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.2 | 0.9 | GO:0016504 | peptidase activator activity(GO:0016504) |
0.2 | 0.3 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
0.2 | 0.9 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.1 | 0.3 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.1 | 0.1 | GO:0001013 | RNA polymerase I regulatory region DNA binding(GO:0001013) |
0.1 | 0.1 | GO:0017098 | sulfonylurea receptor binding(GO:0017098) |
0.1 | 1.2 | GO:0030551 | cyclic nucleotide binding(GO:0030551) |
0.1 | 0.4 | GO:0051431 | corticotropin-releasing hormone receptor 2 binding(GO:0051431) |
0.1 | 1.4 | GO:0045543 | sulfonate dioxygenase activity(GO:0000907) 2,4-dichlorophenoxyacetate alpha-ketoglutarate dioxygenase activity(GO:0018602) hypophosphite dioxygenase activity(GO:0034792) DNA-N1-methyladenine dioxygenase activity(GO:0043734) gibberellin 2-beta-dioxygenase activity(GO:0045543) C-19 gibberellin 2-beta-dioxygenase activity(GO:0052634) C-20 gibberellin 2-beta-dioxygenase activity(GO:0052635) |
0.1 | 0.6 | GO:0031419 | cobalamin binding(GO:0031419) |
0.1 | 2.3 | GO:0016702 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen(GO:0016702) |
0.1 | 0.1 | GO:0016742 | hydroxymethyl-, formyl- and related transferase activity(GO:0016742) |
0.1 | 0.8 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.1 | 0.1 | GO:0015662 | ATPase activity, coupled to transmembrane movement of ions, phosphorylative mechanism(GO:0015662) |
0.1 | 0.4 | GO:0015114 | phosphate ion transmembrane transporter activity(GO:0015114) |
0.1 | 0.4 | GO:0008422 | beta-glucosidase activity(GO:0008422) |
0.1 | 2.2 | GO:0004386 | helicase activity(GO:0004386) |
0.1 | 5.1 | GO:0030165 | PDZ domain binding(GO:0030165) |
0.1 | 0.8 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.1 | 0.1 | GO:0051021 | GDP-dissociation inhibitor binding(GO:0051021) |
0.1 | 0.9 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
0.1 | 0.5 | GO:0017040 | ceramidase activity(GO:0017040) |
0.1 | 32.0 | GO:0004175 | endopeptidase activity(GO:0004175) |
0.1 | 9.3 | GO:0004857 | enzyme inhibitor activity(GO:0004857) |
0.1 | 0.1 | GO:1901611 | phosphatidylglycerol binding(GO:1901611) |
0.1 | 0.1 | GO:0019239 | deaminase activity(GO:0019239) |
0.1 | 0.1 | GO:0043559 | insulin binding(GO:0043559) |
0.1 | 0.4 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
0.1 | 0.8 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.1 | 3.3 | GO:0002161 | aminoacyl-tRNA editing activity(GO:0002161) |
0.1 | 0.1 | GO:0035173 | histone kinase activity(GO:0035173) |
0.1 | 1.4 | GO:0015125 | bile acid transmembrane transporter activity(GO:0015125) |
0.1 | 0.1 | GO:0016004 | phospholipase activator activity(GO:0016004) |
0.1 | 0.6 | GO:0050700 | CARD domain binding(GO:0050700) |
0.1 | 0.1 | GO:0004559 | alpha-mannosidase activity(GO:0004559) |
0.1 | 0.1 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.1 | 0.2 | GO:0071209 | U7 snRNA binding(GO:0071209) |
0.1 | 1.2 | GO:0005112 | Notch binding(GO:0005112) |
0.1 | 18.1 | GO:0004674 | protein serine/threonine kinase activity(GO:0004674) |
0.1 | 0.2 | GO:0017153 | sodium:dicarboxylate symporter activity(GO:0017153) |
0.1 | 0.7 | GO:0045028 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.1 | 0.4 | GO:0015298 | solute:cation antiporter activity(GO:0015298) |
0.1 | 15.3 | GO:0005198 | structural molecule activity(GO:0005198) |
0.1 | 2.2 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
0.1 | 0.2 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.1 | 0.2 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.1 | 0.4 | GO:0051400 | BH domain binding(GO:0051400) |
0.1 | 0.1 | GO:0019787 | ubiquitin-like protein transferase activity(GO:0019787) |
0.1 | 1.7 | GO:0016765 | transferase activity, transferring alkyl or aryl (other than methyl) groups(GO:0016765) |
0.1 | 0.1 | GO:0032190 | acrosin binding(GO:0032190) |
0.1 | 2.5 | GO:0008022 | protein C-terminus binding(GO:0008022) |
0.1 | 0.9 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.1 | 0.9 | GO:1901682 | sulfur compound transmembrane transporter activity(GO:1901682) |
0.1 | 0.1 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
0.1 | 4.1 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
0.1 | 0.1 | GO:0070883 | pre-miRNA binding(GO:0070883) |
0.1 | 0.1 | GO:0050897 | cobalt ion binding(GO:0050897) |
0.1 | 0.5 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.1 | 0.1 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.1 | 0.5 | GO:0015078 | hydrogen ion transmembrane transporter activity(GO:0015078) |
0.1 | 0.2 | GO:0070513 | death domain binding(GO:0070513) |
0.1 | 1.2 | GO:0019902 | phosphatase binding(GO:0019902) |
0.1 | 12.4 | GO:0005524 | ATP binding(GO:0005524) |
0.1 | 0.1 | GO:0008410 | CoA-transferase activity(GO:0008410) |
0.1 | 1.6 | GO:0042826 | histone deacetylase binding(GO:0042826) |
0.1 | 0.2 | GO:0002046 | opsin binding(GO:0002046) |
0.1 | 1.1 | GO:0016818 | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides(GO:0016818) |
0.1 | 0.4 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
0.1 | 0.5 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.0 | 0.1 | GO:0016755 | transferase activity, transferring amino-acyl groups(GO:0016755) |
0.0 | 11.7 | GO:0008270 | zinc ion binding(GO:0008270) |
0.0 | 0.4 | GO:0001085 | RNA polymerase II transcription factor binding(GO:0001085) |
0.0 | 1.7 | GO:0004721 | phosphoprotein phosphatase activity(GO:0004721) |
0.0 | 2.0 | GO:0003713 | transcription coactivator activity(GO:0003713) |
0.0 | 0.2 | GO:0001191 | transcriptional repressor activity, RNA polymerase II transcription factor binding(GO:0001191) |
0.0 | 0.1 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
0.0 | 0.0 | GO:0004620 | phospholipase activity(GO:0004620) |
0.0 | 0.1 | GO:0031727 | CCR2 chemokine receptor binding(GO:0031727) |
0.0 | 0.1 | GO:0016620 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor(GO:0016620) |
0.0 | 0.2 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.0 | 7.3 | GO:0042802 | identical protein binding(GO:0042802) |
0.0 | 0.0 | GO:0030274 | LIM domain binding(GO:0030274) |
0.0 | 0.0 | GO:0042608 | T cell receptor binding(GO:0042608) |
0.0 | 0.1 | GO:0003823 | antigen binding(GO:0003823) |
0.0 | 0.6 | GO:0008527 | taste receptor activity(GO:0008527) |
0.0 | 0.0 | GO:0003707 | steroid hormone receptor activity(GO:0003707) |
0.0 | 0.2 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.2 | 20.2 | ST STAT3 PATHWAY | STAT3 Pathway |
2.1 | 38.3 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
2.1 | 95.0 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
2.1 | 43.1 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
2.0 | 47.2 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
1.8 | 12.5 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
1.8 | 35.2 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
1.7 | 48.4 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
1.7 | 8.6 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
1.7 | 11.9 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
1.7 | 6.8 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
1.7 | 23.6 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
1.7 | 69.3 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
1.6 | 39.6 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
1.6 | 40.8 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
1.6 | 3.3 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
1.6 | 25.5 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
1.6 | 29.6 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
1.5 | 29.3 | PID RAS PATHWAY | Regulation of Ras family activation |
1.5 | 16.9 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
1.5 | 3.1 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
1.5 | 15.2 | PID NECTIN PATHWAY | Nectin adhesion pathway |
1.5 | 58.9 | PID ILK PATHWAY | Integrin-linked kinase signaling |
1.5 | 19.4 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
1.5 | 19.3 | PID EPO PATHWAY | EPO signaling pathway |
1.5 | 11.8 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
1.4 | 7.2 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
1.4 | 10.0 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
1.4 | 1.4 | ST GA12 PATHWAY | G alpha 12 Pathway |
1.4 | 11.3 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
1.4 | 25.3 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
1.4 | 26.7 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
1.4 | 1.4 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
1.4 | 8.2 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
1.4 | 10.9 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
1.4 | 53.1 | PID RAC1 PATHWAY | RAC1 signaling pathway |
1.4 | 24.3 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
1.3 | 30.7 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
1.3 | 8.0 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
1.3 | 2.7 | PID S1P S1P2 PATHWAY | S1P2 pathway |
1.3 | 32.6 | PID TNF PATHWAY | TNF receptor signaling pathway |
1.3 | 7.8 | PID IL2 1PATHWAY | IL2-mediated signaling events |
1.3 | 7.7 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
1.2 | 6.2 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
1.2 | 16.0 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
1.2 | 19.5 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
1.2 | 24.4 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
1.2 | 8.5 | ST G ALPHA S PATHWAY | G alpha s Pathway |
1.2 | 7.3 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
1.2 | 46.3 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
1.2 | 2.4 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
1.2 | 10.6 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
1.2 | 12.9 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
1.2 | 12.8 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
1.2 | 17.4 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
1.1 | 20.4 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
1.1 | 20.3 | PID MYC PATHWAY | C-MYC pathway |
1.1 | 5.6 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
1.1 | 8.9 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
1.1 | 21.0 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
1.1 | 8.8 | ST GAQ PATHWAY | G alpha q Pathway |
1.1 | 2.2 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
1.1 | 38.0 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
1.1 | 13.0 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
1.1 | 9.5 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
1.1 | 2.1 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
1.0 | 6.3 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
1.0 | 1.0 | PID ERBB1 RECEPTOR PROXIMAL PATHWAY | EGF receptor (ErbB1) signaling pathway |
1.0 | 6.1 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
1.0 | 9.1 | PID IFNG PATHWAY | IFN-gamma pathway |
1.0 | 7.9 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
1.0 | 35.1 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
1.0 | 1.9 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
1.0 | 6.7 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.9 | 13.9 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.9 | 2.8 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.9 | 15.5 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.9 | 8.1 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.9 | 6.2 | PID RHOA PATHWAY | RhoA signaling pathway |
0.9 | 26.5 | PID PLK1 PATHWAY | PLK1 signaling events |
0.9 | 12.3 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
0.9 | 6.1 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.9 | 11.3 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.8 | 23.8 | PID P53 REGULATION PATHWAY | p53 pathway |
0.8 | 30.5 | PID E2F PATHWAY | E2F transcription factor network |
0.8 | 0.8 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.8 | 21.0 | PID AURORA B PATHWAY | Aurora B signaling |
0.8 | 27.6 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.8 | 8.3 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.8 | 5.8 | PID FOXO PATHWAY | FoxO family signaling |
0.8 | 5.6 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.8 | 0.8 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.8 | 0.8 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.8 | 3.2 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.8 | 8.6 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.8 | 23.4 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.8 | 18.5 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.8 | 2.3 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
0.8 | 14.6 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.8 | 18.4 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.8 | 8.3 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.7 | 9.0 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.7 | 3.7 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.7 | 17.0 | PID P73PATHWAY | p73 transcription factor network |
0.7 | 10.9 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.7 | 10.7 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.7 | 1.4 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.7 | 3.4 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.7 | 2.7 | PID SHP2 PATHWAY | SHP2 signaling |
0.6 | 9.6 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.6 | 7.0 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.6 | 6.2 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.6 | 4.3 | PID INSULIN PATHWAY | Insulin Pathway |
0.6 | 6.7 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.6 | 4.2 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.6 | 5.5 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.6 | 7.7 | PID ARF6 PATHWAY | Arf6 signaling events |
0.6 | 5.8 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.6 | 6.3 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.6 | 5.7 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.6 | 7.9 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.6 | 11.1 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.6 | 29.3 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.5 | 2.2 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.5 | 12.3 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.5 | 6.3 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
0.5 | 0.5 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.5 | 4.6 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.5 | 2.5 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.5 | 1.0 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.5 | 2.8 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.5 | 10.3 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.5 | 8.2 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.5 | 6.4 | PID ATR PATHWAY | ATR signaling pathway |
0.4 | 2.9 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.4 | 1.1 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.4 | 1.9 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.4 | 2.6 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.4 | 0.4 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.4 | 0.7 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.3 | 2.8 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.3 | 3.7 | PID ALK1 PATHWAY | ALK1 signaling events |
0.3 | 7.7 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
0.3 | 3.9 | PID ARF 3PATHWAY | Arf1 pathway |
0.3 | 2.6 | PID BCR 5PATHWAY | BCR signaling pathway |
0.3 | 2.2 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.3 | 2.5 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.3 | 39.7 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.3 | 0.3 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.3 | 0.6 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.3 | 8.9 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.3 | 4.3 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.3 | 0.5 | ST GA13 PATHWAY | G alpha 13 Pathway |
0.3 | 4.4 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.3 | 4.6 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.3 | 2.5 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.2 | 2.7 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.2 | 44.9 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.2 | 0.9 | SIG CHEMOTAXIS | Genes related to chemotaxis |
0.2 | 3.4 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.2 | 1.8 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.2 | 2.9 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.2 | 2.6 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.2 | 1.1 | PID ATM PATHWAY | ATM pathway |
0.2 | 0.2 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.2 | 3.6 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.2 | 2.8 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.2 | 2.4 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.2 | 1.2 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.1 | 3.9 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.1 | 1.5 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.1 | 0.7 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.1 | 1.3 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.1 | 0.4 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.1 | 0.6 | ST INTEGRIN SIGNALING PATHWAY | Integrin Signaling Pathway |
0.1 | 0.2 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.1 | 0.2 | PID BARD1 PATHWAY | BARD1 signaling events |
0.0 | 0.2 | PID ENDOTHELIN PATHWAY | Endothelins |
0.0 | 0.2 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.0 | 0.2 | PID AURORA A PATHWAY | Aurora A signaling |
0.0 | 0.4 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.0 | 0.0 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.0 | 0.4 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.0 | 1.5 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.4 | 8.9 | REACTOME RORA ACTIVATES CIRCADIAN EXPRESSION | Genes involved in RORA Activates Circadian Expression |
3.2 | 38.8 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
2.8 | 14.1 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
2.8 | 2.8 | REACTOME CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION | Genes involved in Cyclin E associated events during G1/S transition |
2.7 | 2.7 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
2.5 | 14.7 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
2.3 | 30.4 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
2.2 | 2.2 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
2.2 | 39.8 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
2.2 | 19.8 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
2.0 | 2.0 | REACTOME PI3K CASCADE | Genes involved in PI3K Cascade |
2.0 | 2.0 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
2.0 | 14.1 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
2.0 | 25.9 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
1.9 | 26.4 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
1.9 | 49.0 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
1.8 | 3.6 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
1.8 | 36.2 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
1.8 | 26.9 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
1.7 | 11.9 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
1.7 | 20.1 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
1.6 | 19.8 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
1.6 | 26.4 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
1.6 | 13.0 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
1.6 | 9.5 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
1.6 | 9.4 | REACTOME SOS MEDIATED SIGNALLING | Genes involved in SOS-mediated signalling |
1.5 | 26.1 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
1.5 | 16.8 | REACTOME ASSOCIATION OF LICENSING FACTORS WITH THE PRE REPLICATIVE COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
1.5 | 49.4 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
1.5 | 14.9 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
1.5 | 4.5 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling |
1.4 | 20.3 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
1.4 | 11.4 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
1.4 | 27.1 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
1.4 | 1.4 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
1.4 | 16.9 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
1.4 | 11.2 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
1.4 | 7.0 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
1.3 | 13.4 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
1.3 | 4.0 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
1.3 | 1.3 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
1.3 | 18.2 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
1.3 | 1.3 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
1.3 | 14.2 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
1.3 | 28.0 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
1.3 | 57.2 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
1.3 | 97.5 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
1.3 | 19.0 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
1.3 | 29.0 | REACTOME G1 PHASE | Genes involved in G1 Phase |
1.2 | 6.2 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
1.2 | 6.2 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
1.2 | 4.9 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
1.2 | 6.1 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
1.2 | 2.4 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
1.2 | 115.1 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
1.2 | 6.0 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
1.2 | 17.8 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
1.2 | 19.9 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
1.2 | 1.2 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
1.2 | 12.9 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
1.2 | 21.0 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
1.2 | 8.1 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
1.1 | 15.9 | REACTOME PIP3 ACTIVATES AKT SIGNALING | Genes involved in PIP3 activates AKT signaling |
1.1 | 11.2 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
1.1 | 7.8 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
1.1 | 8.9 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
1.1 | 8.7 | REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
1.1 | 15.3 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
1.1 | 8.6 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
1.1 | 19.1 | REACTOME APC CDC20 MEDIATED DEGRADATION OF NEK2A | Genes involved in APC-Cdc20 mediated degradation of Nek2A |
1.1 | 27.5 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
1.1 | 10.5 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
1.0 | 10.5 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
1.0 | 21.9 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
1.0 | 36.3 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
1.0 | 2.0 | REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
1.0 | 14.2 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
1.0 | 21.3 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
1.0 | 10.1 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
1.0 | 5.0 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
1.0 | 23.1 | REACTOME DOWNSTREAM SIGNAL TRANSDUCTION | Genes involved in Downstream signal transduction |
1.0 | 6.0 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
1.0 | 18.6 | REACTOME TRIGLYCERIDE BIOSYNTHESIS | Genes involved in Triglyceride Biosynthesis |
1.0 | 14.7 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
1.0 | 8.8 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
1.0 | 14.3 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
1.0 | 1.0 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
0.9 | 10.4 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.9 | 25.1 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.9 | 5.6 | REACTOME IKK COMPLEX RECRUITMENT MEDIATED BY RIP1 | Genes involved in IKK complex recruitment mediated by RIP1 |
0.9 | 5.6 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.9 | 20.4 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.9 | 0.9 | REACTOME INTEGRIN ALPHAIIB BETA3 SIGNALING | Genes involved in Integrin alphaIIb beta3 signaling |
0.9 | 3.6 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.9 | 14.4 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.9 | 12.4 | REACTOME PYRUVATE METABOLISM | Genes involved in Pyruvate metabolism |
0.9 | 11.4 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.9 | 22.8 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.9 | 17.5 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.9 | 34.9 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.9 | 0.9 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.9 | 17.3 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.9 | 17.9 | REACTOME PYRUVATE METABOLISM AND CITRIC ACID TCA CYCLE | Genes involved in Pyruvate metabolism and Citric Acid (TCA) cycle |
0.8 | 5.1 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.8 | 1.7 | REACTOME CDC6 ASSOCIATION WITH THE ORC ORIGIN COMPLEX | Genes involved in CDC6 association with the ORC:origin complex |
0.8 | 18.4 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.8 | 20.8 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.8 | 9.2 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.8 | 5.8 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.8 | 6.6 | REACTOME OPSINS | Genes involved in Opsins |
0.8 | 18.1 | REACTOME MUSCLE CONTRACTION | Genes involved in Muscle contraction |
0.8 | 7.3 | REACTOME N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | Genes involved in N-glycan trimming in the ER and Calnexin/Calreticulin cycle |
0.8 | 7.3 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.8 | 47.6 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.8 | 16.6 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.8 | 28.5 | REACTOME TOLL RECEPTOR CASCADES | Genes involved in Toll Receptor Cascades |
0.8 | 15.8 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.8 | 24.3 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.8 | 3.9 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.8 | 10.0 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.8 | 3.1 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.8 | 3.8 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
0.8 | 7.6 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.8 | 9.8 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.7 | 3.7 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
0.7 | 13.3 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.7 | 6.6 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.7 | 4.4 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.7 | 19.1 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
0.7 | 4.4 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.7 | 3.6 | REACTOME PROLONGED ERK ACTIVATION EVENTS | Genes involved in Prolonged ERK activation events |
0.7 | 2.9 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.7 | 12.2 | REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
0.7 | 2.8 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
0.7 | 2.8 | REACTOME ADP SIGNALLING THROUGH P2RY12 | Genes involved in ADP signalling through P2Y purinoceptor 12 |
0.7 | 14.1 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.7 | 6.3 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.7 | 4.9 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.7 | 3.5 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.7 | 2.8 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
0.7 | 1.4 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.7 | 6.9 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.7 | 4.8 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.7 | 4.8 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.7 | 2.7 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
0.7 | 9.4 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.7 | 5.3 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.7 | 7.9 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.7 | 17.6 | REACTOME TRANS GOLGI NETWORK VESICLE BUDDING | Genes involved in trans-Golgi Network Vesicle Budding |
0.7 | 5.9 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.6 | 32.6 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.6 | 2.5 | REACTOME SIGNALING BY EGFR IN CANCER | Genes involved in Signaling by EGFR in Cancer |
0.6 | 5.6 | REACTOME RNA POL I TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |
0.6 | 5.6 | REACTOME REMOVAL OF THE FLAP INTERMEDIATE FROM THE C STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
0.6 | 9.2 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.6 | 13.1 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.6 | 3.6 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.6 | 24.7 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.6 | 23.5 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.6 | 17.6 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.6 | 0.6 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.6 | 3.5 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.6 | 4.6 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
0.6 | 1.7 | REACTOME RIG I MDA5 MEDIATED INDUCTION OF IFN ALPHA BETA PATHWAYS | Genes involved in RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways |
0.6 | 41.1 | REACTOME TCA CYCLE AND RESPIRATORY ELECTRON TRANSPORT | Genes involved in The citric acid (TCA) cycle and respiratory electron transport |
0.6 | 9.2 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.6 | 1.2 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.6 | 4.6 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.6 | 14.9 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.6 | 13.6 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.6 | 1.7 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.6 | 13.4 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.5 | 90.0 | REACTOME CLASS I MHC MEDIATED ANTIGEN PROCESSING PRESENTATION | Genes involved in Class I MHC mediated antigen processing & presentation |
0.5 | 4.9 | REACTOME ACYL CHAIN REMODELLING OF PC | Genes involved in Acyl chain remodelling of PC |
0.5 | 10.9 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.5 | 4.3 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.5 | 4.9 | REACTOME FATTY ACID TRIACYLGLYCEROL AND KETONE BODY METABOLISM | Genes involved in Fatty acid, triacylglycerol, and ketone body metabolism |
0.5 | 9.2 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.5 | 11.8 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
0.5 | 1.0 | REACTOME PRE NOTCH EXPRESSION AND PROCESSING | Genes involved in Pre-NOTCH Expression and Processing |
0.5 | 4.6 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.5 | 10.6 | REACTOME GLOBAL GENOMIC NER GG NER | Genes involved in Global Genomic NER (GG-NER) |
0.5 | 9.1 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
0.5 | 5.5 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.5 | 1.0 | REACTOME ACTIVATION OF CHAPERONES BY ATF6 ALPHA | Genes involved in Activation of Chaperones by ATF6-alpha |
0.5 | 3.9 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.5 | 17.8 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.5 | 0.9 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
0.5 | 14.2 | REACTOME RECRUITMENT OF MITOTIC CENTROSOME PROTEINS AND COMPLEXES | Genes involved in Recruitment of mitotic centrosome proteins and complexes |
0.5 | 0.9 | REACTOME TRANSCRIPTION COUPLED NER TC NER | Genes involved in Transcription-coupled NER (TC-NER) |
0.4 | 8.2 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.4 | 0.9 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.4 | 2.1 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.4 | 6.8 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.4 | 2.8 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.4 | 1.2 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
0.4 | 4.3 | REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | Genes involved in SRP-dependent cotranslational protein targeting to membrane |
0.4 | 8.1 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.4 | 5.0 | REACTOME MITOTIC M M G1 PHASES | Genes involved in Mitotic M-M/G1 phases |
0.4 | 4.2 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |
0.4 | 4.1 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.4 | 4.4 | REACTOME PROCESSING OF INTRONLESS PRE MRNAS | Genes involved in Processing of Intronless Pre-mRNAs |
0.4 | 3.7 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.4 | 0.4 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.4 | 6.5 | REACTOME SIGNALING BY ERBB4 | Genes involved in Signaling by ERBB4 |
0.4 | 6.8 | REACTOME MRNA 3 END PROCESSING | Genes involved in mRNA 3'-end processing |
0.4 | 5.3 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.4 | 10.3 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.4 | 1.1 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
0.4 | 2.5 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
0.3 | 3.8 | REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
0.3 | 26.4 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
0.3 | 2.4 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
0.3 | 3.8 | REACTOME SIGNALING BY ACTIVATED POINT MUTANTS OF FGFR1 | Genes involved in Signaling by activated point mutants of FGFR1 |
0.3 | 6.5 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.3 | 0.3 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.3 | 4.7 | REACTOME ACTIVATION OF THE MRNA UPON BINDING OF THE CAP BINDING COMPLEX AND EIFS AND SUBSEQUENT BINDING TO 43S | Genes involved in Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S |
0.3 | 1.0 | REACTOME DNA REPLICATION | Genes involved in DNA Replication |
0.3 | 8.2 | REACTOME SPHINGOLIPID METABOLISM | Genes involved in Sphingolipid metabolism |
0.3 | 4.4 | REACTOME GENERIC TRANSCRIPTION PATHWAY | Genes involved in Generic Transcription Pathway |
0.3 | 26.9 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.3 | 3.7 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.3 | 1.2 | REACTOME CELL CYCLE CHECKPOINTS | Genes involved in Cell Cycle Checkpoints |
0.3 | 1.5 | REACTOME PLC BETA MEDIATED EVENTS | Genes involved in PLC beta mediated events |
0.3 | 1.7 | REACTOME DOUBLE STRAND BREAK REPAIR | Genes involved in Double-Strand Break Repair |
0.3 | 4.1 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.3 | 2.2 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
0.3 | 1.4 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.3 | 2.9 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.3 | 2.7 | REACTOME TRANSLATION | Genes involved in Translation |
0.3 | 13.5 | REACTOME MRNA PROCESSING | Genes involved in mRNA Processing |
0.3 | 1.1 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
0.3 | 1.8 | REACTOME REGULATION OF APOPTOSIS | Genes involved in Regulation of Apoptosis |
0.3 | 17.2 | REACTOME TRANSCRIPTION | Genes involved in Transcription |
0.2 | 1.2 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.2 | 1.6 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
0.2 | 2.3 | REACTOME RESOLUTION OF AP SITES VIA THE MULTIPLE NUCLEOTIDE PATCH REPLACEMENT PATHWAY | Genes involved in Resolution of AP sites via the multiple-nucleotide patch replacement pathway |
0.2 | 0.7 | REACTOME SIGNAL TRANSDUCTION BY L1 | Genes involved in Signal transduction by L1 |
0.2 | 2.6 | REACTOME PLATELET ACTIVATION SIGNALING AND AGGREGATION | Genes involved in Platelet activation, signaling and aggregation |
0.2 | 1.3 | REACTOME PURINE METABOLISM | Genes involved in Purine metabolism |
0.2 | 1.0 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
0.2 | 1.0 | REACTOME PERK REGULATED GENE EXPRESSION | Genes involved in PERK regulated gene expression |
0.2 | 0.2 | REACTOME APC C CDC20 MEDIATED DEGRADATION OF MITOTIC PROTEINS | Genes involved in APC/C:Cdc20 mediated degradation of mitotic proteins |
0.2 | 2.6 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.2 | 0.2 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
0.2 | 3.2 | REACTOME PROTEIN FOLDING | Genes involved in Protein folding |
0.2 | 0.7 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.2 | 0.5 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
0.2 | 0.3 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.2 | 0.5 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.1 | 1.4 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.1 | 1.1 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.1 | 0.1 | REACTOME INFLUENZA LIFE CYCLE | Genes involved in Influenza Life Cycle |
0.1 | 7.5 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.1 | 0.2 | REACTOME BASE EXCISION REPAIR | Genes involved in Base Excision Repair |
0.1 | 2.7 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.1 | 0.2 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.1 | 1.5 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.1 | 0.1 | REACTOME APOPTOTIC EXECUTION PHASE | Genes involved in Apoptotic execution phase |
0.1 | 0.3 | REACTOME DOWNSTREAM SIGNALING EVENTS OF B CELL RECEPTOR BCR | Genes involved in Downstream Signaling Events Of B Cell Receptor (BCR) |
0.1 | 4.3 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.1 | 0.4 | REACTOME PKB MEDIATED EVENTS | Genes involved in PKB-mediated events |
0.1 | 0.4 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.1 | 0.1 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.1 | 0.4 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.1 | 0.3 | REACTOME SIGNALING BY TGF BETA RECEPTOR COMPLEX | Genes involved in Signaling by TGF-beta Receptor Complex |
0.1 | 0.1 | REACTOME METABOLISM OF RNA | Genes involved in Metabolism of RNA |
0.1 | 0.6 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.1 | 0.5 | REACTOME CHONDROITIN SULFATE DERMATAN SULFATE METABOLISM | Genes involved in Chondroitin sulfate/dermatan sulfate metabolism |
0.1 | 0.3 | REACTOME MICRORNA MIRNA BIOGENESIS | Genes involved in MicroRNA (miRNA) Biogenesis |
0.1 | 1.2 | REACTOME METABOLISM OF PROTEINS | Genes involved in Metabolism of proteins |
0.0 | 0.7 | REACTOME PHASE II CONJUGATION | Genes involved in Phase II conjugation |
0.0 | 1.8 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.0 | 0.5 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.0 | 0.4 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.0 | 0.1 | REACTOME DEFENSINS | Genes involved in Defensins |
0.0 | 0.1 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.0 | 0.2 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |